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1. Introduction 
 
 
The cytoskeleton is a highly dynamic system of filaments that enables the cell to 
organize its intracellular processes as well as its interaction with the environment. In 
eukaryotic cells, the cytoskeleton consists of three components: the microfilament 
system, the microtubule network and the intermediate filaments. These filament 
systems consist of small subunits, which assemble to polymers. In case of the 
microfilaments and the microtubules, the incorporation of actin and tubulin subunits, 
respectively, results in polar filaments. In contrast, intermediate filaments are apolar 
polymers, which are assembled from antiparallel dimers. Although being rigid 
structures, all three filament systems have a dynamic behaviour in common. In 
conjunction, these intertwined cytoskeletal networks are responsible for maintaining 
cell shape as well as physical stability and organize the general intracellular 
structure. Intermediate filaments provide mechanical strength, whereas actin 
filaments mainly provide cell shape, cell polarity and cell motility (Alberts et al., 2008; 
Galjart, 2005). 
The microtubule network fulfils a broad range of cellular functions. Besides the actin 
cytoskeleton, it plays a substantial role in arranging and adapting the cell shape as 
well as establishing cell polarity. As stable components of cilia and flagella, 
microtubules provide cell motility. Furthermore, microtubules are configured in a 
bipolar mitotic spindle and segregate the replicated chromosomes into the daughter 
cells during mitosis. By serving as tracks for motor proteins, microtubules are 
involved in intracellular cargo transport and additionally determine the position of 
organelles. The great diversity of cellular functions, in which microtubules participate, 
is not only based on their biochemical characteristics but also on several 
posttranslational modifications and a large variety of interaction partners (Alberts et 
al., 2008; Galjart, 2005; Wade, 2009). 
This study focusses on the influence on cellular processes and microtubule binding 
partners by the tyrosination cycle, a posttranslational α-tubulin modification. 
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1.1. Microtubule structure and organization 
Microtubules are formed by the assembly of heterodimers comprised of the globular 
α-tubulin and β-tubulin subunits, both of which consist of about 450 amino acids and 
possess a molecular weight of approximately 55 kDa. In vertebrates, α- and β-tubulin 
are both encoded by at least six differentially expressed genes in a species-specific 
manner resulting in a set of isotypes, which differ slightly in their amino acid 
sequences, particularly in the respective C-terminal regions (Wade, 2009). Although 
both α- and β-tubulin have a binding site for guanosine triphosphate (GTP), only the 
nucleotide bound to β-tubulin can be hydrolysed or substituted, whereas the GTP 
molecule of the α-tubulin subunit is spatially fixed within the heterodimer (Fig. 1a). 
For microtubule formation, the heterodimers assemble in linear protofilaments in a 
head-to-tail manner and, by that, create polar filaments (Fig. 1b). The addition of αβ-
tubulin subunits can take place at both filament ends but preferentially occurs at the 
end that is exposing β-tubulin. This end is termed plus-end and usually grows faster, 
whereas the slower growing, α-tubulin-exposing end is referred to as the minus-end. 
Notably, minus-end growth could only be observed in vitro (Dammermann et al., 
2003). 
In general, 13 protofilaments are arranged in parallel to form a cylindrical tube with a 
diameter of 25 nm (Fig. 1c). Still, the number of protofilaments in microtubules differs 
in some organisms and cell types. Neighbouring protofilaments align with a shift of 
approximately 0.9 nm resulting in a helical succession of tubulin subunits around the 
microtubule as illustrated in Figure 1c. Since the heterodimers have a length of 8 nm, 
the mentioned protofilament shift leads to a discontinuity in the microtubule surface 
that is called the lattice seam (illustrated in Fig. 4b). 
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Fig. 1: Structure of tubulin subunits and microtubules. a) Structure of an αβ-tubulin heterodimer 
with bound GTP molecules (red). b) Scheme of an αβ-tubulin heterodimer and a protofilament 
consisting of head-to-tail assembled heterodimers. c) Scheme of a microtubule consisting of 13 
linearly arranged protofilaments. Note the shift in protofilaments. d) Electron microscope image of a 
microtubule segment. e) Electron microscope image of a cross section of a microtubule consisting of 
13 protofilaments (from Alberts et al., 2008). 
 
In most cell types, the microtubule minus-ends are embedded in a so-called 
microtubule-organizing centre (MTOC), which is located close to the nucleus and 
prevents depolymerization of microtubules from their minus-ends. Typically, animal 
cells possess only a single MTOC, which is also referred to as the centrosome. The 
microtubule minus-ends are generally nucleated in the MTOC by γ-tubulin that shares 
30 % identity with α- and β-tubulin (Oakely & Oakely, 1989). Two γ-tubulin molecules 
and two associated proteins form the γ-tubulin small complex (γ-TuSC) that, together 
with accessory proteins, assemble to the microtubule-nucleating γ-tubulin ring 
complex (γ-TuRC). This complex is present in all eukaryotic cells with the exception 
for yeast (Moritz & Agard, 2001). Models for the nucleation of microtubules in the 
MTOC are shown in Figures 2a and b. 
Introduction 
 
 
 
 4 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Microtubule nucleation in the microtubule-organizing centre of animal cells. a) Model of 
microtubule nucleation by the γ-tubulin ring complex. A subunit of the ring complex, the γ-tubulin small 
complex, is outlined in red. b) Model of a centrosome with γ-tubulin ring complexes. Note the 
embedded pair of centrioles, another microtubule-based protein complex (from Alberts et al., 2008). 
 
Microtubules can be organized differently depending on the cell cycle phase or the 
cell type. First, in interphase cells, microtubules radiate from the MTOC into the cell 
periphery. Except for a stable subpopulation, most of the microtubules are highly 
dynamic and undergo phases of growth and shrinkage. This mechanism enables the 
microtubule network to probe and interact with the entire cytoplasmic space (Fig. 3a). 
Second, during mitosis, the centrosome duplicates and the daughter centrosomes 
migrate to opposite poles, from which microtubules form the mitotic spindle. 
Originating in the daughter centrosomes, three types of microtubules can be found: 
Astral microtubules emanate in the cell cortex, kinetochore microtubules bind to the 
chromosomes’ kinetochores and interpolar microtubules provide stability of the 
spindle (Fig. 3b). Usually, microtubules occur as single filaments, but they can also 
appear as doublets or triplets. Finally, in the core of cilia and flagella nine doublet 
microtubules are arranged in a tube with two single microtubules in the centre. In 
contrast, basal bodies, which anchor cilia and flagella in the surface of eukaryotic 
cells, consist of nine triplet microtubules. This typical microtubule arrangement can 
additionally be found in centrioles (see Fig. 2b; Verhey & Gaertig, 2007). 
Besides α-, β- and γ-tubulin, other tubulins have been discovered in eukaryotes. In 
Chlamydomonas δ-tubulin was found, ε-tubulin is expressed in Paramecium, 
a) b)
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Chlamydomonas as well as in mammals, η-tubulin is present in Paramecium and, 
finally, ζ-tubulin is found in trypanosomes and some animal cells. Although not 
ubiquitously expressed, these tubulins are all involved in protein complexes of the 
aforementioned centrioles and/or basal bodies (Dutcher, 2003). 
 
 
 
 
 
 
 
 
 
Fig. 3: Microtubule organization in an interphase fibroblast and a dividing cell. a) Scheme of the 
microtubule network in a migrating fibroblast. Growing microtubules are shown in red, shrinking 
microtubules in green and stable microtubules in blue. Plus-end tracking proteins (+TIP) are bound to 
growing microtubule plus-ends. b) Scheme of the microtubule network during mitosis. Growing 
microtubules are shown in red and shrinking microtubules in green. Capitals mark different types of 
microtubules: A) astral microtubules, B) kinetochore microtubules, and C) interpolar microtubules 
(from Galjart, 2005). 
 
1.2. Dynamic instability 
As already mentioned above, microtubules alternate between phases of growth and 
shrinkage. This process of dynamic instability was discovered in 1986 by direct 
microscopical observation (Horio & Hotani, 1986), but had already been predicted 
two years earlier (Mitchison & Kirschner, 1984). The switch from growth or pausing to 
shrinkage is referred to as catastrophe. The change from microtubule shrinkage to 
growth is referred to as rescue. As the microtubule minus-ends are embedded in the 
MTOC in most of the cells, dynamic instability usually occurs at plus-ends. The 
polymerization at growing microtubule ends requires αβ-tubulin heterodimers 
containing a GTP-loaded β-tubulin subunit. At its very end, a growing microtubule 
exists as an open sheet-like structure, to which additional heterodimers assemble in 
a non-helical fashion (Fig. 4c, step 1). After incorporation, the GTP molecule on the 
β-tubulin subunit is hydrolysed due to binding to the penultimate heterodimer. As a 
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consequence, microtubules primarily contain GDP-loaded β-tubulin subunits except 
for the newly assembled heterodimers and some randomly distributed GTP-loaded 
subunits in the lattice, which are proposed to be involved in a rescue mechanism 
(Dimitrov et al., 2008). With proceeding of microtubule growth the protofilament sheet 
closes to a cylindrical tube, but the exact mechanism is still unknown. Terminal sheet 
closure results in a metastable intermediate microtubule that could either pause or 
start to grow or shrink again (Fig. 4c, step 2). GTP hydrolysis may trigger the 
conformational change at the very plus-end. Also the opposite mechanism with GTP 
hydrolysis as result of conformational changes within microtubules is discussed as a 
possibility. Although GTP is not necessarily needed for the polymerization reaction 
itself, it is necessary for longitudinal contacts in the growing microtubule (Rice et al., 
2008). Additionally, by creating a so-called GTP-cap, it protects the microtubule plus-
ends from immediate depolymerization. When a microtubule is capped by GDP-
loaded tubulin due to a higher rate of hydrolysis than heterodimer assembly, the 
subunits can dissociate and cause a phase of shrinkage. Depolymerization appears 
in a fountain-like release of GDP-loaded heterodimers and small protofilament 
fragments (Fig. 4c, step 3). After disassembly, the GDP molecule in the β-tubulin 
subunits of the free heterodimers is being exchanged with GTP (Fig. 4c, step 4). The 
resulting heterodimers are then able to enter a new round of microtubule 
polymerization and depolymerization. If these processes occur in a single non-
nucleated microtubule with polymerization at the plus-end and depolymerization at 
the minus-end, tubulin subunits can treadmill through the microtubule (Waterman-
Storer & Salmon, 1997). 
Regulation of dynamic instability depends on a large variety of interacting proteins 
influencing the rate and speed of either catastrophe or rescue events. As many 
interaction partners fulfil additional tasks, the regulation of microtubule dynamics is 
described in separate chapters. 
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Fig. 4: Microtubule dynamic instability. a) Scheme of the αβ-tubulin heterodimer with either GTP 
(pink) or GDP (purple) bound to β-tubulin. Additionally, a linear protofilament is shown. b) Scheme of a 
microtubule consisting of 13 protofilaments. The red dashed line marks the lattice seam. c) Model of 
dynamic instability. Numbers mark the different steps of microtubule dynamics: 1) Growing 
microtubule with polymerization of GTP-loaded tubulin heterodimers at the sheet-shaped plus-end. 2) 
Metastable intermediate microtubule after closure of the terminal sheet. 3) Shrinking microtubule with 
depolymerization of GDP-bound subunits. 4) Exchange of GDP with GTP on the depolymerized β-
tubulin subunits (from Akhmanova & Steinmetz, 2008). 
 
1.3. Microtubule interaction partners 
Microtubule function and dynamics rely on the interaction with other proteins that are 
known as microtubule-associated proteins (MAPs). In general, MAPs can be 
differentiated into microtubule lattice-binding and plus-end tracking proteins (+TIPs). 
Many of those proteins are involved in the regulation of microtubule dynamics by 
modulating microtubule stability or promoting either rescue or catastrophe events. 
Others influence either the speed of microtubule growth or shrinkage. Yet another 
group of MAPs fulfil more specific functions as cargo transport along microtubules or 
a) c)
b)
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building up a blockage on the microtubule lattice to hinder motor protein movement. 
The most important MAP types are subsequently described in more detail. 
 
1.3.1. Lattice-binding MAPs 
The class of traditional MAPs, which bind to the microtubule lattice contains many 
proteins that influence the stability of microtubules. Structural MAPs increase the 
stability of the microtubule by decorating the microtubule lattice. In contrast, 
destabilizing MAPs often possess enzymatic activity and promote depolymerization 
by introducing breaks in the microtubule. Finally, motor proteins are responsible for 
intracellular transport, but additionally could be involved in decreasing microtubule 
stability (Van der Vaart et al., 2009). A model illustrating the interplay of lattice-
binding MAPs is shown in Figure 5. 
 
1.3.1.1. Structural MAPs 
The group of structural MAPs covers proteins without any enzymatic activity that bind 
to the microtubule lattice. The members of the MAP1 family, MAP2, tau, MAP4 and 
doublecortin (DCX) are the most prominent structural MAPs in vertebrates. 
In most vertebrates, the MAP1 family consists of MAP1A, MAP1B and MAP1S, which 
all are complexes of multiple heavy chains and light chains. However, the exact 
stoichiometric compositions are still unknown (Halpain & Dehmelt, 2006). In contrast, 
MAP2, tau, MAP4 and doublecortin appear as single chain proteins (Drewes et al., 
1997). Structural MAPs are predominantly expressed in neurons and play an 
important role in neuronal development, degeneration and cortical migration (Halpain 
& Dehmelt, 2006; Gleeson et al., 1999). Still, those MAPs differ in their respective 
spatial and temporal expression pattern. MAP1A is located in dendrites of adult 
neurons, whereas MAP1B is expressed in developing neurons and is enriched in 
axons. The localisation of MAP2 is limited to the neuronal cell body and dendrites, 
whereas tau is enriched in axons. However, both MAP2 as well as tau show 
functional redundancy with MAP1B (DiTella et al., 1996; Teng et al., 2001). 
In contrast to the expression of the aforementioned MAPs, doublecortin is only 
expressed in migrating and differentiating neurons (Francis et al., 1999). 
All structural MAPs stabilize microtubules by decorating the microtubule lattice and, 
thereby, decreasing catastrophe frequency and shrinkage speed. Furthermore, they 
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protect the microtubules from being severed by destabilizing enzymes (Halpain & 
Dehmelt, 2006) and, additionally, hinder motor proteins to move along the 
microtubule lattice by diminishing the frequency of possible motor-microtubule 
interactions (see Fig. 5; Baas & Qiang, 2005). Microtubule-binding domains on both 
the heavy and the light chains mediate microtubule binding of MAP1A and B, 
whereas MAP1S only has a microtubule-binding domain in its light chain. In addition 
to their microtubule binding character, the light chains of the MAP1 family members 
are also able to bind filamentous actin (F-actin). However, it is unknown whether a 
single MAP1 molecule can bind tubulin and actin simultaneously. MAP2, tau and 
MAP4 all have conserved C-terminal microtubule-binding domains characterized by 
three to four basic pseudorepeats framed by two proline-rich regions (Drewes et al., 
1997). The microtubule binding affinity of structural MAPs is regulated by their 
phosphorylation state. MAP1B is reported to be phosphorylated by the glycogen 
synthase kinase-3β (GSK3β) at serine residue 1260 and threonine residue 1265 
(Trivedi et al., 2005), whereas tau is phosphorylated by the microtubule-affinity 
regulating kinase (MARK; Drewes et al., 1997). In both cases, this phosphorylation 
strongly reduces the microtubule binding affinity and results in dissociation from the 
microtubule lattice. The hyperphosphorylation of tau leads to its aggregation in paired 
helical filaments and is found in neurodegenerative diseases like Alzheimer`s 
disease (Baas & Qiang, 2005). 
 
1.3.1.2. Destabilizing MAPs 
Beside structural MAPs that promote microtubule stability there are other lattice-
binding MAPs, which destabilize microtubules by breaking them or by promoting 
depolymerization. 
In general, microtubule-severing proteins possess an ATPase activity and use the 
energy from ATP hydrolysis to fragment microtubules. Most prominent microtubule-
severing proteins are katanin and spastin, both belonging to the family of ATPases 
associated with various cellular activities (AAA proteins). A close relative is fidgetin, a 
third microtubule-severing AAA protein that is much less investigated. Katanin is the 
best-studied AAA protein and appears as a heterodimer consisting of a 60 kDa (p60) 
and an 80 kDa (p80) subunit. The p60 subunit is composed of an N-terminal 
microtubule-binding domain and a C-terminal catalytic domain homologous to 
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ATPases of the AAA-protein family. In contrast, the p80 subunit mediates katanin 
targeting and regulates ATPase activity (McNally et al., 2000). Both katanin and 
spastin play an important role in mitotic spindle dynamics, neuron differentiation and 
flagellar physiology in animal cells (Wade, 2009; Zhang et al., 2007). According to 
the model for microtubule severing, the AAA proteins form a hexameric ring around 
the microtubule lattice followed by the introduction of a break (Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Model illustrating the interplay of lattice-binding microtubule-associated proteins. The 
upper scheme shows a microtubule that is decorated with unphosphorylated MAPs (e.g. tau). By that, 
kinesin motor proteins (see chapter 1.3.1.3.) are hindered in their plus-end-directed movement. 
Furthermore, bound MAPs suppress the formation of an active hexamer ring of katanin subunits 
around the microtubule (upper part). If the microtubule-affinity regulating kinase (MARK) is 
phosphorylated by the MARK kinase (MARKK), it can phosphorylate MAPs and thereby induce their 
dissociation from the microtubule. As a consequence, motor proteins can interact more frequently with 
the microtubule and move in direction of the plus-end, whereas katanin subunits can hexamerize and 
sever the microtubule (lower part; from Baas & Qiang, 2005). 
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In mitosis, katanin is reported to sever microtubules close to the kinetochore-
attached plus-ends, whereas spastin and fidgetin release nucleated microtubule 
minus-ends. These effects result in microtubule depolymerization from both ends 
leading to the poleward flow of kinetochore-microtubules, thereby segregating the 
chromosomes (Zhang et al., 2007). 
In addition to microtubule-severing proteins, also three kinesin families contain 
members with microtubule-depolymerizing activity. In general, kinesins are motor 
proteins that conventionally move along the microtubule lattice towards the plus-end 
(see chapter 1.3.1.3. and Fig. 5 and 6). Yet, the kinesin-13 family includes non-motile 
members that promote microtubule depolymerization. Additionally, members of the 
kinesin-8 and kinesin-14 families with slow motor activities also promote the 
depolymerization of microtubules (Van der Vaart et al., 2009; Wade, 2009). The 
kinesin-13 family is represented in mammals by the proteins Kif2A, Kif2B and 
Kif2C/MCAK (Mitotic centromere-associated kinesin), which predominantly bind 
microtubule plus-ends and promote catastrophe events in an ATP-dependent 
manner (Newton et al., 2004). For example, MCAK is reported to be a processive 
depolymerase that forms an ATP-hydrolyzing complex at the microtubule plus-end 
and removes up to twenty αβ-tubulin heterodimers from a protofilament. As a 
consequence, the dissociation rate of tubulin dimers can be increased up to 100-fold 
by the presence of MCAK proteins (Hunter et al., 2003). Finally, kinesin-13 family 
members play an important role in microtubule depolymerization during mitosis, 
though at different places. Kif2A and B are primarily located at the centrosomes, 
whereas Kif2C/MCAK is concentrated at kinetochores. 
Another microtubule-destabilizing kinesin is Kif18A, a member of the kinesin-8 family. 
Both Kif18A and Kip3, the Saccharomyces cerevisiae orthologue, possess a slow 
plus-end-directed motor activity and accumulate at the microtubule plus-ends, where 
they promote disassembly of αβ-tubulin heterodimers (Gupta et al., 2006). 
Finally, the stimulation of microtubule depolymerization by the kinesin-14 family 
members Ncd (from Drosophila melanogaster), Kar3 (from Saccharomyces 
cerevisiae) and Klp2 (from Schizosaccharomyces pombe) has been reported. In 
contrast to the previously mentioned and conventional kinesins, kinesin-14 members 
are characterized by a slow minus-end-directed movement along microtubules while 
depolymerizing them from the plus-end (Van der Vaart et al., 2009). 
Introduction 
 
 
 
 12 
1.3.1.3. Motor proteins 
Intracellular trafficking is mediated by the so-called motor proteins, which use the 
energy of ATP hydrolysis to move along cytoskeletal filaments. In eukaryotes, two 
families of microtubule-based molecular motors exist, the already mentioned kinesins 
and the dyneins. In general, both protein families possess a head or motor domain 
that binds to the microtubule and determines the direction of movement. The tail, 
however, determines the intracellular function due to its cargo-specificity. 
Kinesins form a superfamily of ATPases with fourteen subfamilies in mammals. The 
majority of kinesins have an N-terminal motor domain and move along microtubules 
towards the plus-end. Interestingly, kinesin-13 members contain a central motor 
domain and are non-motile, whereas kinesin-14 members use a C-terminal motor 
domain to move towards the minus-end. Conventional kinesins as kinesin-1 consist 
of two heavy and two light chains, but also monomeric, homodimeric, trimeric and 
homotetrameric kinesins exist. Motor domains usually are located in the heavy 
chains followed by a coiled-coil region involved in dimer formation (Wade, 2009). The 
motor activity of motile kinesins is regulated by their conformation. Folding of the 
protein inactivates the motor domain, while cargo-binding is still possible and unfolds 
the molecule (Dunn et al., 2008). Moreover, phosphorylation of kinesin light chains 
results in inactivation. Movement along microtubules occurs by ATP hydrolysis-driven 
conformational changes that alternate between the two motor domains of the kinesin 
dimer and lead to cycling between microtubule binding, release and rebinding of the 
single head domains (Alberts et al., 2008; Dunn et al., 2008). By that, the protein 
moves along the microtubule in steps of 8 nm, the exact length of a αβ-tubulin 
heterodimer (Nan et al., 2005). In contrast, monomeric kinesins move diffusively from 
binding-site to binding-site while complete detachment is prevented by electrostatic 
interaction between a kinesin region called K-loop and the tubulin C-termini (Okada & 
Hirokawa, 2000). 
In their function as intracellular transporters, kinesins transport a large variety of 
cargo, as for instance vesicles, membrane-enclosed organelles, protein complexes, 
mRNA, membrane proteins and signalling-molecules. In addition to that, they are 
associated with several kinases like the c-Jun N-terminal kinase (JNK) and the 
mitogen-activated protein kinase-kinases 4 and 7 (MKK4 and MKK7; Daire et al., 
2009). The transport of kinases is mediated by scaffold proteins like the JNK-
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interacting protein 1 (JIP1), which directly bind to motor proteins (Verhey et al., 
2001). Furthermore, kinesins play an important role in mitosis and, as described in 
chapter 1.3.1.2., kinesin-8, -13 and -14 members promote microtubule 
depolymerization. However, the spatial and temporal regulation of kinesin activity is 
not completely understood. The affinity to microtubules and, therefore, the velocity of 
kinesin movement is influenced by posttranslational modifications at microtubules 
(see chapter 1.4.), which can act as regulatory mechanisms (Dunn et al., 2008). 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Schematic molecular structures of kinesin and dynein. Models for the microtubule-based 
motor proteins kinesin and dynein. The majority of kinesins mediate the intracellular cargo transport on 
microtubules in plus-end direction, whereas dyneins move towards the minus-end. The illustrated 
kinesin structure corresponds to the conventional kinesins formed by two heavy and two light chains. 
The head domain possesses the motor activity, whereas the tail determines the cargo. The coiled-coil 
region mediates dimerization. Dyneins usually are composed of at least two heavy chains, which form 
the head domains including the motor and microtubule-binding domains. Additionally, many dyneins 
are complexed with a number of intermediate, light intermediate and light chains, which mediate cargo 
interaction (figure from http://bernstein.harvard.edu/research/motor_protein.htm). 
 
Dyneins are the largest and fastest molecular motors and can be divided into two 
types, the cytoplasmic and the axonemal dyneins. Cytoplasmic dyneins fulfil a broad 
range of functions in eukaryotic cells, as for example vesicle and organelle transport, 
Golgi and nucleus localisation, chromosome segregation and orientation of the 
mitotic spindle. In contrast, axonemal dyneins mainly mediate the beating of cilia and 
flagella (Vallee et al., 2003). They are composed of up to three heavy chains with a 
molecular weight of more than 500 kDa each and a variety of intermediate, light 
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intermediate and light chains. The heavy chains include an N-terminal cargo-binding 
site as well as the motor domain and the microtubule-binding domain (Wade, 2009). 
Motor activity is driven by energy from ATP hydrolysis and enables minus-end-
directed movement along the microtubule (Fig. 6). Dyneins belong to the AAA protein 
family and possess a ring of six ATPase domains (AAA1 – AAA6) within the motor 
domain (Samso et al., 1998). Between AAA4 and AAA5 of the heavy chain the so-
called stalk is positioned, which is a 325 amino acid projection with a microtubule-
binding site at its tip (Gee et al., 1997). When ATP is bound, the microtubule-binding 
domain is detached from the microtubule, but gets reattached by a conformational 
change resulting from the release of ADP and an inorganic phosphate. As a result, 
the dynein complex moves with a step of 8 nm towards the microtubule minus-end 
(Alberts et al., 2008). The N-terminal part of dynein heavy chains interacts not only 
with the respective cargo, but is also responsible for binding of accessory chains. 
Particularly intermediate chains interact with the cargo and, additionally, with 
p150Glued, a subunit of the dynactin complex. Since p150Glued interacts with the 
microtubule plus-end tracking proteins EB1 and CLIP-170, it links the dynein/dynactin 
complex to microtubule plus-ends (see chapter 1.3.2.). The dynactin complex 
supports dynein targeting and, therefore, is important for cargo loading and transport 
initiation. Interestingly, p150Glued is also reported to act as an anchor for the plus-end-
directed motors kinesin-2 and kinesin-5 (Blangy et al., 1997; Deacon et al., 2003; 
Kardon & Vale, 2009; Vaughan & Vallee, 1995; Watson & Stephens, 2006). 
 
1.3.2. Microtubule plus-end tracking proteins 
The plus-end tracking proteins (+TIP) form a group of MAPs consisting of unrelated 
multidomain proteins that, in most cases, associate with growing microtubule plus-
ends. In general, these proteins influence microtubule dynamics and mainly act as 
rescue factors by preventing catastrophes or promoting polymerization resulting in 
increased microtubule growth and stability. Additionally, +TIPs are involved in the 
attachment of microtubule ends to cellular structures for targeted microtubule 
function. In eukaryotes, the most prominent +TIPs are the end binding proteins (EB), 
the cytoplasmic linker proteins (CLIP), the CLIP-associated proteins (CLASP), 
Xenopus laevis microtubule-associated protein of 215 kDa (XMAP215) and the 
dynactin subunit p150Glued. The vertebrate +TIPs as well as their homologues in 
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Saccharomyces cerevisiae (budding yeast) and Schizo-saccharomyces pompe 
(fission yeast) are summarized in Table 1. 
 
Table 1: Vertebrate plus-end tracking proteins with their homologues in budding yeast and 
fission yeast. 
Vertebrates Budding yeast Fission yeast Microtubule-binding 
domain(s) 
EB1, EB2, EB3 Bim1p Mal3p Calponin homology domain 
CLIP-170, CLIP-115 Bik1p Tip1p two CAP-Gly domains 
p150Glued Nip100p Ssm4p CAP-Gly domain 
Dynein heavy chain Dyn1 Dhc1 Dynein motor domain 
LIS1 (Lissencephaly 1) Pac1p - WD40 repeats 
CLASP1, CLASP2 Stu1p - TOG domain (HEAT repeats) 
XMAP215 Stu2p Dis1p, Alp14p TOG domains (HEAT repeats) 
Adapted from Lansbergen & Akhmanova, 2006 
 
Besides the microtubule binding itself, the localisation at microtubule plus-ends and 
the functionality also depend on interactions with other plus-end tracking proteins. 
Furthermore, dimerization of some +TIPs is rather common. Although all +TIPs bind 
to microtubule plus-ends, the microtubule-binding domains differ between the +TIP 
families. Binding of +TIPs is spatially restricted to a 0.5 – 2 µm distal region at the 
very plus-end, in which the accumulation of +TIP resemble a comet-like structure. As 
this region appears to be larger than the length of the GTP-cap, binding of +TIPs 
seems to depend on other differences between the near plus-end region and the 
microtubule lattice (Akhmanova & Steinmetz, 2008; Van der Vaart, 2009; Wade, 
2009). The exact structural property at microtubule plus-ends that is recognized by 
+TIPs and used as their binding site is still unknown. Since for instance CLIP-170 
can bind cytoplasmic tubulin heterodimers, a co-polymerization of +TIPs and tubulin 
subunits at microtubule plus-ends was proposed (Arnal et al., 2004). Alternatively, it 
was hypothesized that +TIPs are immobilized at the very plus-end and undergo 
treadmilling, that is they dissociate when the microtubule end is converted into a 
lattice structure (Perez et al., 1999). In contrast to that, the current model of +TIP 
binding to microtubule plus-ends describes a fast turnover instead of a constant 
binding. Fluorescence recovery after photobleaching (FRAP) experiments showed 
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reappearance of fluorescence in plus-end comets after bleaching GFP-fused EB3 or 
CLIP-170. This reappearance implies that bleached GFP-labelled proteins were 
rapidly exchanged by non-bleached proteins indicating that multiple binding events 
occur at a single binding site (Bieling et al., 2008; Dragestein et al., 2008). Similar 
results were also obtained for CLASP2 (Wittmann & Waterman-Storer, 2005). 
According to the fast exchange model, specific binding sites for +TIPs disappear with 
further distance to the microtubule plus-end resulting from conformational changes 
as for instance closure of the terminal protofilament sheet (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: Fast exchange model for microtubule binding of plus-end tracking proteins. 
a) Polymerization of αβ-tubulin heterodimers at the microtubule plus-end generates a large number of 
potential binding sites for +TIPs (depicted in orange). During microtubule growth, binding sites 
disappear in further distance from the plus-end most probably due to conformational changes in the 
microtubule structure as shown in the region marked by the rectangle. b) The +TIP CLIP-170 
exchanges on binding sites in a rapid manner (reaction 1). By that, a binding site can interact several 
times with CLIP-170 molecules until it disappears. On the other hand, co-polymerization of CLIP-170 
(reaction 2) cannot completely be excluded although it does not explain the comet-like appearance at 
microtubule plus-ends. Moreover, posttranslational modifications of CLIP-170 could influence its 
affinity towards tubulin (reaction 3; from Dragestein et al., 2008). 
binding site
αβ-tubulin heterodimer αβ-tubulin heterodimer
CLIP-170
a) b)
1
1
2
2
3
3
Introduction 
 
 
 
 17 
Although +TIPs usually bind to growing microtubule plus-ends, there are a few 
exceptions. The most prominent +TIP that has the ability to bind depolymerizing 
microtubule plus-ends is XMAP215, while its Saccharomyces cerevisiae homologue 
Stu2 is able to bind plus-ends of both stable and shrinking microtubules (Lansbergen 
& Akhmanova, 2006). XMAP215 forms a complex with free tubulin in a 1:1 ratio and 
is capable of adding up to 25 αβ-tubulin heterodimers to the plus-end before it 
detaches. By that, XMAP215 functions as a processive microtubule polymerase and 
inverts depolymerization to polymerization. Especially during mitosis XMAP215 and 
homologous proteins play a key role in promoting microtubule polymerization for 
spindle elongation (Brouhard et al., 2008; Severin et al., 2001). 
Different mechanisms are engaged to regulate microtubule binding as well as the 
activity of plus-end tracking proteins. First, several multidomain +TIPs possess the 
ability to undergo intramolecular interactions and, by that, to inhibit themselves. In 
that state, the +TIP is not able to localise at microtubule plus-ends and has to be 
unfolded by the interaction with another ligand. Second, the phosphorylation of amino 
acid residues within the microtubule-binding domain of +TIPs represents an 
additional mechanism to reduce the affinity for microtubules, as microtubules carry a 
negative charge. Finally, posttranslational modifications of the tubulin subunits 
incorporated in microtubules can influence +TIP localisation as described later. 
In the following chapters, the +TIP members of end binding proteins, cytoplasmic 
linker proteins and cytoplasmic linker protein-associated proteins are described in 
more detail. 
 
1.3.2.1. End binding proteins 
In vertebrates, the family of end binding proteins (EBs) is represented by EB1, EB2 
and EB3. The family members are highly conserved, small dimeric proteins 
consisting of 268, 326 and 281 amino acids, respectively. Microtubule binding is 
primarily mediated by a globular calponin homology (CH) domain located at the N-
terminus and requires the presence of GTP-loaded β-tubulin subunits (Dragestein et 
al., 2008). The C-terminus contains a coiled-coil domain for parallel dimerization that 
is essential for EB activity and is connected to the N-terminal CH domain by a flexible 
linker. Furthermore, the C-terminal amino acid motif EEY/F resembles that of α-
tubulin C-terminus and can fold back on the CH domain resulting in an autoinhibitory 
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conformation. Both the flexible linker and the acidic tail of EB proteins are also 
involved in microtubule binding, which is based on electrostatic interactions (Zhu et 
al., 2009). Moreover, the C-terminal tail serves as interaction site for other +TIPs as 
for instance CLIP-170, p150Glued or the APC (adenomatous polyposis coli) tumor 
suppressor protein (Bieling et al., 2008; Honnappa et al., 2005; Howard & Hyman, 
2003). The CH domain consists of eight α-helices that are packed around the central 
helix α3 forming a globular structure (Fig. 8). In addition to the acidic tail, the coiled-
coil domain is able to bind interaction partners mediated by a hydrophobic cavity and 
a polar rim (Fig. 8; Honnappa et al., 2005; Slep & Vale, 2007). This specific coiled-
coil region comprises approximately 50 conserved amino acids and is typical for EB 
proteins. Therefore, it is also referred to as end binding homology (EBH) domain 
(Akhmanova & Steinmetz, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Structural organization of an EB1 dimer. Surface view of dimerized active EB1. The globular 
CH domains of monomer 1 and 2 are responsible for microtubule binding. The C-terminal coiled-coil 
domains of the monomeric proteins dimerize and contain the hydrophobic cavity (green), the polar rim 
(blue) and the acidic tail (red), which all are important for the interaction with other +TIPs (from 
Honnappa et al., 2005). 
 
In contrast to the majority of +TIPs, EB proteins are capable of autonomous binding 
to microtubule plus-ends. As they interact with numerous +TIPs through their acidic 
C-terminal tail and target them to the microtubule plus-ends, they occupy a central 
role in the plus-end protein complex. 
CH domain 1
CH domain 2
acidic tail 1
acidic tail 2
coiled coil 1+2
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EB proteins are involved in a large number of cellular functions, particularly by 
facilitating plus-end binding of other +TIPs. By controlling the plus-end-associated 
protein complex, EB proteins highly influence microtubule dynamics. Primarily, EB 
proteins increase the dynamic behaviour of microtubules by inhibiting catastrophes 
and thereby promoting polymerization and rescue events. As a key-regulator of 
microtubule dynamics, EB proteins have a major influence on the formation of the 
mitotic spindle and are involved in the attachment of kinetochores to microtubules. 
Furthermore, plus-end binding of EB stimulates closure of the terminal sheet-like 
structure of plus-ends and favours the formation of microtubules consisting of 13 
protofilaments. EB proteins additionally stabilize contacts between protofilaments and 
the lattice seam as demonstrated for the fission yeast EB1 homolog Mal3p. By 
influencing the structural properties of the microtubule plus-end, EB simultaneously 
affects the presence of binding sites for other +TIPs (Akhmanova & Steinmetz, 2008; 
Komarova et al., 2009; Sandblad et al., 2006; Vitre et al., 2008). However, the 
stimulation of sheet closure by EB can also promote catastrophe, as shown in 
Drosophila melanogaster and for the budding yeast homologue Bim1p (Slep, 2009). 
Moreover, EB proteins are essential for the attachment of microtubule ends to the 
cell cortex by recruiting APC to growing plus-ends, which then mediates the 
interaction between microtubules and the actin cytoskeleton (Honnappa et al., 2005; 
Lansbergen & Akhmanova, 2006). Finally, anchoring of microtubules at centrosomes 
and the formation of cilia in Clamydomonas fibroblasts also depend on the 
involvement of EB proteins (Rehberg and Gräf, 2002; Schröder et al., 2007). 
Regulation of EB localisation at microtubule plus-ends and, thereby, of EB activity 
occurs by phosphorylation. A cluster of six serine residues within the positively 
charged flexible linker region of the budding yeast EB1 homologue Bim1p was 
identified as target of the mitotic Aurora B kinase Ipl1p (Zimniak et al., 2009). Here, 
multiple phosphorylations decreased the affinity of Bim1p for microtubules and 
resulted in its detachment from plus-ends. Particularly during the mitotic anaphase, 
Bim1p disassembly from interpolar microtubules plays an important role for a correct 
spindle elongation. Mutant non-phosphorylatable Bim1p remained at the plus-ends 
and inhibited depolymerization resulting in an overelongated spindle. Furthermore, 
Zimniak and colleagues (2009) showed that the flexible linker of Bim1p is essential 
for its targeting to plus-ends. The flexible linker enhances synergistically with the CH 
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domain microtubule binding of Bim1p, but alone is not sufficient to facilitate the 
binding of Bim1p to microtubules. 
Another phosphorylation-mediated mechanism for EB regulation is its protection from 
degradation. Serine residue 176 of human EB3 was identified to be a 
phosphorylation target of the mitotic kinases Aurora-A and -B. The phosphorylation 
inhibits the interaction of EB3 with the ubiquitin ligase SIAH-1 and, therefore, protects 
EB3 from proteasome-mediated degradation. This mechanism ensures the correct 
cell-cycle progression (Ban et al., 2009). 
 
1.3.2.2. Cytoplasmic linker proteins 
The familiy of cytoplasmic linker proteins (CLIP) consists, in vertebrates, of two 
members, which are termed CLIP-170 and CLIP-115 according to their molecular 
weights. Notably, CLIP-170 has been discovered as first protein that tracks growing 
microtubule plus-ends (Pierre et al., 1992). Both CLIP-170 and CLIP-115 are 
expressed in two splice variants with isoforms A representing the full length proteins 
consisting of 1428 and 1047 amino acids, respectively. Isoforms B are based on 
alternatively spliced mRNA that is lacking one exon. Consequently, isoform B 
proteins lack 35 amino acid residues within the coiled-coil region 
(www.ncbi.nlm.nih.gov). The CLIP-170 isoform A is also referred to as restin (Galjart, 
2005; Griparic & Keller, 1998). 
N-terminal cytoskeleton-associated protein glycine-rich (CAP-Gly) domains represent 
a characteristic of CLIPs. These domains are responsible for interactions with 
microtubules, EB and the CLIP-170 C-terminus. Whereas the yeast homologues only 
have one CAP-Gly domain, CLIPs of higher eukaryotes combine two tandem 
domains at their N-terminus. Both CAP-Gly domains are flanked by serine-rich 
regions, which also possess low microtubule-binding activities and facilitate the 
functionality of the CAP-Gly domains (Gupta et al., 2008; Hoogenraad et al., 2000). 
Next to both CLIPs, also the dynactin subunit p150Glued contains an N-terminal CAP-
Gly domain responsible for its interaction with microtubules and CLIP-170. The 
domain composition of CLIP-115 and CLIP-170 as well as an alignment of human 
CAP-Gly domain sequences and surface views of CAP-Gly domains are illustrated in 
Figure 9. CAP-Gly domains possess a highly conserved GKNDG (glycine-lysine-
asparagine-aspartic acid-glycine) sequence motif as part of a hydrophobic cavity and 
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glycine residues for correct folding of the globular domain structure (Fig. 9b and c). In 
CLIP-170, the GKNDG motif of the first CAP-Gly domain (amino acids 97 – 101) is 
structurally stabilized by two conserved neighbouring salt bridges within the amino 
acid pairs arginine 63 – aspartic acid 93 and aspartic acid 100 – arginine 107 (Slep & 
Vale, 2007). Analogous structural features are conserved in all CAP-Gly domains 
(Fig. 9b). The C-terminal acidic tails of α-tubulin, EB1-3 and CLIP-170 are 
characterized by an EEY/F motif, which could serve as a specific interaction target 
for the GKNDG motif of CAP-Gly domains (Fig. 9d; Honnappa et al., 2006). 
Nevertheless, CLIP-170 has been shown to bind regions of α-tubulin and β-tubulin 
different from the acidic tail (Gupta et al., 2010). 
The by far largest part of both CLIPs comprises a coiled-coil domain that mediates 
parallel homodimerization. In contrast to CLIP-115, CLIP-170 contains two metal-
binding zinc knuckles at its C-terminus. Since the zinc knuckles are able to interact 
with CAP-Gly domains, they can fold back on the intramolecular CAP-Gly domains. 
Consequently, the coiled-coil region is folded and the CLIP-170 molecule transferred 
to an inactive, closed conformation. Interestingly, the first CLIP-170 zinc knuckle is 
preferentially involved in autoinhibition by binding to its second CAP-Gly domain, 
whereas the second zinc knuckle primarily interacts with the CAP-Gly domains of 
CLIP-115 and p150Glued (Lansbergen et al., 2004; Mishima et al., 2007). 
Although the first and second CAP-Gly domains of CLIP-170 share 97 % similarity, 
structure analyses revealed a more positively charged groove in the second CAP-Gly 
domain compared with the first CAP-Gly domain due to additional basic amino acids. 
Therefore, the second CAP-Gly domain binds the negatively charged acidic tails of α-
tubulin and EB1/EB3 more tightly. In contrast, the first CAP-Gly domain of CLIP-170 
and the p150Glued CAP-Gly domain show weaker affinities for the acidic α-tubulin and 
EB tails (Mishima et al., 2007). As the CAP-Gly domains of CLIP-115 are highly 
similar to their respective counterparts in CLIP-170, they most likely possess similar 
binding properties (see Fig. 9b and Hoogenraad et al., 2000). 
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Fig. 9: Domain organization of CLIPs, conserved human CAP-Gly domain sequences, overall 
structure and interaction mode of a CAP-Gly domain. a) Scheme of CLIP-170 and CLIP-115 
domain compositions with the respective dimers (from Bieling et al., 2008). b) Sequence alignment of 
the CAP-Gly domains from human p150Glued, CLIP-170 and CLIP-115. The characteristic GKNDG 
motif is highlighted in light blue, whereas glycine residues are highlighted in red. Coloured boxes 
above the alignment mark residues involved in protein interactions as illustrated by the colour key in d. 
c) Surface view of a CAP-Gly domain with highly conserved and conserved residues in black and 
grey, respectively. The hydrophobic cavity is marked by the dashed oval. d) Surface view of the 
p150Glued CAP-Gly domain in complex with the EEY/F motif of the C-terminal acidic tail of CLIP-170. 
The colours correspond to the colours given in the alignment (from Steinmetz & Akhmanova, 2008). 
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By binding tubulin, CLIPs neutralize the negative charge of the acidic tubulin tails and 
stimulate microtubule polymerization as well as nucleation. Thus, the most prominent 
function of CLIPs is their contribution to microtubule dynamics as rescue factors. 
Both CLIP-170 and CLIP-115 redundantly promote the shift from microtubule 
shrinkage into growth. However, the exact mechanism how CLIPs trigger rescue 
events still remains unclear according to their restricted localisation to growing 
microtubule plus-ends instead of depolymerizing ends (Galjart, 2005). As CLIP-170 
recruits p150Glued via its second zinc knuckle, it links the dynein/dynactin motor 
complex to the growing microtubule plus-ends and, therefore, supports intracellular 
trafficking towards the minus-ends as well as correct positioning of the mitotic spindle 
(Weisbrich et al., 2007). Besides linking the dynein/dynactin motor complex to 
microtubule plus-ends, CLIP-170 additionally interacts with membrane organelles 
facilitating minus-end-directed organelle transport by loading them onto dynein 
motors (Lomakin et al., 2009). In prometaphase of mitosis, CLIP-170 binds 
unattached kinetochore protein complexes through its C-terminus and subsequently 
links them to microtubules (Coquelle et al., 2002). CLIP-170 forms a complex with 
IQGAP1, an effector of the small GTPases Cdc42 and Rac1. This CLIP-170/IQGAP1 
complex links microtubules to the cortical actin network and contributes to cell 
polarization (Fukata et al., 2002; Gundersen, 2002). Moreover, through its metal-
binding domains CLIP-170 recruits the actin-nucleating formin mDia1 to places of 
phagocytosis. The enrichment of mDia1 results in local actin polymerization 
underneath the plasma membrane and, by that, triggers phagocytosis (Lewkowicz et 
al., 2008). 
Interestingly, a hemizygous CLIP-115 deletion is involved in a genetical disorder 
reffered to as Williams syndrome. The CLIP-115 gene (CYLN2, cytoplasmic linker 
protein gene 2) is located in a chromosomal region of approximately 1.6 Mb called 
the Williams syndrome critical region (WSCR). This region contains, besides CLIP-
115, at least 16 genes and is assumed to be deleted by incorrect recombination 
resulting in the Williams syndrome. Symptoms of this haploinsufficiency are growth 
defects, brain abnormalities, hippocampal dysfunction and defective motor 
coordination resembling the phenotype of CLIP-115 knockout mice (Hoogenraad et 
al., 2002). Furthermore, depletion of CLIP-115 leads to increased accumulation of 
dynactin and CLIP-170 at microtubule plus-ends (Hoogenraad et al., 2002). Hence, 
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an additional role of CLIP-115 as regulator of CLIP-170 function by competitive 
inhibition via the metal-binding domains can be taken into account. 
Several factors are known to regulate CLIP-115 and CLIP-170 localisation at 
microtubule plus-ends. In contrast to EB proteins, full length CLIP-170 is not able to 
bind microtubules autonomously and requires the presence of EB1 or EB3 at the 
growing plus-end to become activated from its autoinhibited state in vivo (Komarova 
et al., 2005; Bieling et al., 2008). Autoinhibition acts as a negative regulatory 
mechanism for CLIP-170 binding to microtubule plus-ends, whereas CLIP-115 is not 
capable of autoinhibition since it lacks metal-binding domains. However, CLIP-115 
localisation at microtubule plus-ends has also been reported to be strongly facilitated 
by EB1 and EB3 (Komarova et al., 2005). The fission yeast homologue of CLIP-170 
even is transported to the microtubule plus-ends by a kinesin, which is recruited to 
the plus-ends by the EB1 homologue (Bieling et al., 2007). As for EB proteins, 
phosphorylation plays an important role in CLIP regulation. CLIP-170 is known to be 
phosphorylated at multiple sites by different kinases. For instance, cdc2 
phosphorylates threonine residue 287 resulting in correct plus-end localization of 
CLIP-170 during the later phases of the cell cycle (Yang et al., 2009). Another kinase 
that stimulates microtubule binding of CLIP-170 is the FKBP12-rapamycin-associated 
protein (FRAP). However, it was also demonstrated that phosphorylation of CLIP-170 
leads to its dissociation from microtubules (Choi et al., 2002; Hoogenraad et al., 
2000; Rickard & Kreis, 1991). CLIP-115 phosphorylation also reduces the capacity to 
bind microtubules, as demonstrated by in vitro experiments (Hoogenraad et al., 
2000). Furthermore, posttranslational modifications of microtubules influence CLIP-
115 and CLIP-170 binding. Microtubule association of CLIPs and other CAP-Gly 
domain-containing proteins was reported to depend on the C-terminal tyrosine of the 
α-tubulin subunit, as the affinity for detyrosinated α-tubulin is much lower (Bieling et 
al., 2008; Peris et al., 2006; see also chapter 1.4.1.). 
 
1.3.2.3. Cytoplasmic linker protein-associated proteins 
In mammals, two cytoplasmic linker protein-associated proteins (CLASP1 and 
CLASP2) were identified by yeast two-hybrid experiments (Akhmanova et al., 2001). 
Both proteins directly interact with CLIPs, EB proteins, microtubule plus-ends and the 
Golgi apparatus. The CLASPs appear in several isoforms (CLASP1/2α, -2β and -2γ) 
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with differences in their respective N-termini resulting from alternative splicing. 
CLASP1 isoforms are expressed ubiquitously, whereas CLASP2 isoforms are 
predominantly present in the brain. 
In general, all CLASP isoforms contain a basic serine- and arginine-rich domain that 
can bind to growing microtubule plus-ends and EB1/3. Moreover, CLASP localisation 
to the microtubule lattice in the lamella of migrating PtK1 cells has been reported 
through this region (Wittmann & Waterman-Storer, 2005). The conserved C-terminus 
mediates interactions with CLIPs, the Golgi apparatus and the cell cortex (Mimori-
Kiyosue et al., 2005). It includes huntingtin elongation factor-3, protein phosphatase-
2A and target of rapamycin (HEAT) repeats, which are also present in the N-terminal 
regions and function as protein interaction sites (see Fig. 10a). CLASP1α and 
CLASP2α are the longest isoforms, which possess an additional N-terminal Tumour-
overexpressed gene (TOG)-like domain (Fig. 10a). By that, they resemble the TOG 
domain-containing Drosophila melanogaster homologue Orbit/multiple asters 
(MAST). TOG domains usually contain six HEAT repeats, each comprised of a pair 
of parallel helices (Fig. 10b). The loops connecting the helices contain conserved 
lysine residues as well as a conserved arginine and tryptophan residue creating a 
positive charge that mediates CLASP binding to tubulin monomers as well as 
polymerized microtubules. Generally, TOG domains serve as microtubule interaction 
sites in XMAP215 family proteins that stabilize microtubules and promote 
polymerization at microtubule plus-ends.  (Brouhard et al., 2008; Severin et al., 2001; 
Slep & Vale, 2007). Besides direct microtubule binding through their central serine-
rich region, CLASP1/2 recruitment to plus-ends is enhanced by interactions with 
CLIPs and EB proteins (Mimori-Kiyosue et al., 2005). Interestingly, the brain-specific 
CLASP2β isoform contains an N-terminal palmitoylation motif that includes two 
cysteines as attachment sites for palmitate, a saturated fatty acid that targets the 
protein to membranes (Akhmanova et al., 2001). 
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Fig. 10: Domain organization of CLASP1α and TOG domain structure. a) CLASP1α is the longest 
CLASP isoform and possesses the same domain structure as its Drosophila melanogaster 
homologue, Orbit/MAST. The N-terminal domain, which is isoform-specific in mammals, contains a 
TOG-like domain similar to those in microtubule-stabilizing proteins of the XMAP215 family. The 
central serine-rich domain contributes to the interaction with EB1 and microtubules (MT), whereas the 
C-terminus interacts with CLIPs, the Golgi apparatus and cell cortex components. Arrowheads 
indicate positions of potential HEAT repeats, which mediate protein interactions. Conserved domains 
are labelled in different colours (adapted from Galjart, 2005). b) Ribbon diagram of the second TOG 
domain from Stu2p, the XMAP215 homologue of Saccharomyces cerevisiae, showing the six parallel 
helix pairs of the HEAT repeats (A – F) and the connecting loops (from Slep & Vale, 2007). 
 
In contrast to CLIPs, which promote microtubule rescue events throughout the entire 
cell, the functions of CLASPs are spatially restricted to the mitotic spindle and the cell 
cortex. Respective homologues in Saccharomyces cerevisiae (Stu1p), Drosophila 
melanogaster (Orbit/MAST) and Caenorhabditis elegans (cls-2) all are associated 
with the mitotic spindle and play essential roles during mitosis. Orbit/MAST is the 
best investigated family member and, besides maintaining the bipolarity of the mitotic 
spindle, is involved in kinetochore attachment, chromosome alignment and 
cytokinesis by stabilizing interior spindle microtubules (marked by a “C” in Fig. 3; 
Inoue et al., 2004; Maiato et al., 2002). Also mammalian CLASPs are present at 
kinetochores and fulfil comparable functions as illustrated by the formation of 
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monopolar spindles in cells microinjected with CLASP1-specific antibodies (Maiato et 
al., 2003). In migrating fibroblasts, CLASPs mainly localise to microtubule plus-ends 
at the leading edge of the cell. By capturing microtubules at the cell cortex through an 
interaction with the cortex-associated proteins LL5β and ELKS (Lansbergen et al., 
2006), CLASPs contribute to cell polarization. Moreover, CLASP2α has been shown 
to bind filamentous actin via both its N-terminal TOG-like domain and the central 
serine-rich region (Tsvetkov et al., 2007). Therefore, it links the microtubule plus-
ends to the actin cytoskeleton in the cell cortex and supports cell polarization. 
The main function of CLASPs at dynamic microtubule plus-ends is to promote 
pausing, or rather shorten the phases of growth and shrinkage. During catastrophe, 
CLASPs partially remain at the shrinking end and recruit EB1 resulting in stimulation 
of rescue events (Lansbergen & Akhmanova, 2006). As demonstrated by RNA 
interference experiments, CLASPs stabilize microtubules and, as a consequence, 
levels of acetylated and detyrosinated tubulin are increased. Since CLASP 
knockdown additionally leads to a reduction of microtubule density and CLASPs also 
localise to centrosomes, an additional function in microtubule nucleation can be 
assumed. Knockdown of either CLASP1 or CLASP2 alone did not result in the 
described effects, and the double knockdown phenotype could be rescued by the 
expression of only one of both CLASPs demonstrating functional redundancy for both 
proteins (Mimori-Kiyosue et al., 2005). 
The binding of CLASPs to microtubules is regulated by phosphorylation through the 
glycogen synthase kinase-3β (GSK3β). Analogous to structural MAPs (see chapter 
1.3.1.1.), phosphorylation decreases the affinity for microtubules and leads to 
dissociation of CLASPs. Thus, the spatial activity of GSK3β regulates the subcellular 
microtubule-binding pattern of CLASPs. In migrating epithelial cells, a high GSK3β 
activity in the cell body restricts CLASPs to microtubule plus-ends, whereas local 
GSK3β inactivation results in microtubule lattice binding in the very distal region of 
the leading edge (Wittmann & Waterman-Storer, 2005). Furthermore, the presence of 
distinct motifs for microtubule plus-end binding and lattice association within the 
microtubule-binding domain of CLASP2 could be shown. Only the motif responsible 
for plus-end binding is phosphorylated by GSK3β at multiple sites. Partial 
phosphorylation of this motif reduces the affinity for the microtubule lattice, whereas 
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the phosphorylation of all included sites results in the complete inhibition of 
microtubule plus-end binding as well as EB1 interaction (Kumar et al., 2009). 
 
1.4. Posttranslational modifications of tubulin 
As described in the previous chapter, microtubule functions are widely regulated by 
microtubule-associated proteins. Additionally, posttranslational modifications of the 
incorporated α- and/or β-tubulin subunits contribute to the regulation of interactions 
with MAPs and therefore directly influence microtubule functions. Posttranslational 
modifications also affect microtubule dynamics, for example by altering interactions 
with +TIPs. In general, stable microtubules accumulate more posttranslational 
modifications than dynamic microtubules. The physiological impact of the tubulin 
modifications and the involved enzymes are still poorly understood (Hammond et al., 
2008). A schematic overview of posttranslational modifications concerning α- and β-
tubulin subunits is shown in Figure 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11: Overview of posttranslational modifications of tubulin. Several posttranslational 
modifications affect microtubule dynamics and functions. Tubulin molecules are illustrated 
schematically from their N-termini to the acidic C-termini according to the amino acid sequence of 
mouse tubulin 1. The respective modifications are highlighted in red, whereas the modified tubulin 
subunit (α and/or β) is added in brackets. Numbers give the position of the affected amino acid in the 
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tubulin molecule. Abbreviations: Ac = acetate; C = cysteine; D = aspartic acid; E = glutamic acid; G = 
glycine; H = histidine; K = lysine; P = phosphate; S = serine; Y = tyrosine (adapted from Westermann 
& Weber, 2003). 
 
Apart from the generation of Δ2-Glu-tubulin all posttranslational modifications are 
reversible. Moreover, modifications usually occur at the microtubule surface and 
directly influence interactions with binding partners, except for acetylation, which 
affects the lumen-exposed lysine residue 40 of α-tubulin but still influences 
interactions. The following chapters describe the respective modifications in more 
detail. 
 
1.4.1. Acetylation 
Besides being the only posttranslational modification that takes place in the 
microtubule lumen, acetylation also represents the only modification that appears in 
the N-terminal region. Acetylation occurs at a conserved lysine residue (K40) of α-
tubulin after being incorporated into microtubules. Hence, it mainly accumulates on 
stable microtubules and can be used as a marker for their stability. Although the 
enzyme that acetylates microtubules is still unknown, two deacetylases were 
identified. Both the histone deacetylase 6 (HDAC6) and sirtuin type 2 (SIRT2, human 
orthologue of the silent information regulator 2 protein from Saccharomyces 
cerevisiae) were shown to deacetylate α-tubulin (Matsuyama et al., 2002; North et 
al., 2003). As mutation of the acetylated lysine residue as well as suppression of 
general acetylation activity did not lead to an obvious phenotype, the function of 
microtubule acetylation appears to be non-essential. However, kinesin-1 association 
to microtubules and, thereby, kinesin-mediated transport is promoted by microtubule 
acetylation (Reed et al., 2006). 
 
1.4.2. Palmitoylation and phosphorylation 
Palmitoylation has been mapped to occur predominantly at cysteine residue 376 of 
α-tubulin. The involved enzymes and the exact cellular function of this 
posttranslational modification still remain unclear. A reduction of the palmitoylation 
level by mutating the involved cysteine in Saccharomyces cerevisiae evoked a high 
number of astral microtubules with an abnormal length or wrong orientation. 
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Furthermore, the spindle translocation through the bud neck appeared defective, 
while mitosis itself was not affected. Thus, microtubule palmitoylation could be 
involved in astral microtubule organization during mitosis (Caron et al., 2001; 
Hammond et al., 2008). 
Phosphorylation occurs either at serine residue 441 or 444 of β-tubulin. Although the 
phosphorylated serine is located in the acidic C-terminal tail that is important for 
microtubule interactions, a clear physiological relevance is not known yet. As the 
acidic tubulin tail already is negatively charged, the introduction of a phosphate and 
thereby an additional negative charge may not have a major effect on microtubule 
function (Westermann & Weber, 2003). Interestingly, also unpolymerized tubulin 
heterodimers can be phosphorylated. During early mitosis, the cyclin-dependent 
kinase 1 (Cdk1) phosphorylates serine residue 172 of β-tubulin subunits and, by that, 
inhibits their incorporation into microtubules (Fourest-Lieuvin et al., 2006). 
 
1.4.3. Polyglutamylation and polyglycylation 
Polyglutamylation as well as polyglycylation appear in the acidic C-terminal tail of 
both α- and β-tubulin predominantly at the conserved glutamate residue 445. As both 
modifications could be identified at the same tubulin subunit, the existence of multiple 
modification sites in the neighbourhood of glutamate 445 is very likely (Hammond et 
al., 2008). 
Polyglutamylation involves the attachment of up to 20 acidic glutamate residues as a 
tubulin side-chain and mainly occurs in neurons and stable microtubule structures 
like axonemes, centrioles and the mitotic spindle. In mammals, eight tubulin 
glutamylases are identified. They belong to the family of tubulin-tyrosine-ligase-like 
(TTLL) domain-containing proteins and possess different specificities for α- and β-
tubulin isotypes. Glutamylase activity has been shown for TTLL1, 4 – 7, 9, 11 and 13, 
which either catalyse the initiation or the elongation of the polyglutamate chain 
(Etienne-Manneville, 2009; Hammond et al., 2008). Polyglutamylation influences 
interactions between microtubules and their associated proteins, most probably by 
increasing the negative charge of the microtubule lattice. For example, α-tubulin 
polyglutamylation promotes the loading of kinesin-3, whereas kinesin-1 association is 
promoted by polyglutamylated β-tubulin. Moreover, polyglutamylation marks 
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microtubules for severing proteins. The mutation of polyglutamylation sites in β-
tubulin decreased katanin-mediated microtubule cleavage and inhibited the 
completion of cytokinesis in the ciliate protozoa Tetrahymena thermophila (Sharma et 
al., 2007). Besides affecting microtubule-protein interactions, polyglutamylation plays 
an important role in axonemal structures, and its inhibition results in defective cilia 
and flagella motility (Hammond et al., 2008; Westermann & Weber, 2003). 
The addition of up to 34 neutral glycine residues in polyglycylation of both α- and β-
tubulin occurs at the same glutamate residues as the aforementioned 
polyglutamylation. It is predominantly found at axonemal microtubules and is the 
most common tubulin modification in mammalian sperm cells. Analogous to 
polyglutamylation, the glycylation reactions are most probably catalysed by the TTLL 
domain containing proteins TTLL3, 8, 10 and 12 (Etienne-Manneville, 2009). 
Interestingly, the indicated functions of polyglycylation resemble those of 
polyglutamylation, although the respective polypeptide chains are differently charged. 
Accordingly, site-directed mutagenesis experiments in Tetrahymena thermophila 
demonstrated a major role of polyglycylation in the assembly and maintenance of 
axonemes, the motility of cilia and flagella and in cytokinesis (Thazhath et al., 2002; 
Xia et al., 2000). 
 
1.4.4. Detyrosination/tyrosination and generation of Δ2-Glu-tubulin 
When α-tubulin is incorporated in microtubules, the C-terminal acidic tail is placed in 
an exposed position at the microtubule surface. A still unidentified carboxypeptidase 
then is able to remove the extreme C-terminal tyrosine residue from the α-tubulin 
subunits. This reaction generates detyrosinated α-tubulin subunits with a C-terminal 
glutamic acid residue, which are also called Glu-tubulin. Accordingly, stable 
microtubules are rich of Glu-tubulin, whereas dynamic microtubules contain 
predominantly tyrosinated tubulin (Tyr-tubulin). After disassembly of the Glu-tubulin 
subunits from the depolymerizing microtubule, the tubulin-tyrosine ligase (TTL) adds 
a new tyrosine residue to the C-terminal glutamic acid. Consequently, Tyr-tubulin is 
restored and can again be incorporated in microtubules. The tubulin-tyrosine ligase 
belongs to the glutathione-synthetase ADP-forming enzymes, which are 
characterized by an ATP-dependent ligase activity (Galperin & Koonin, 1997). 
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Surprisingly, the TTL binds to the β-tubulin subunit of the soluble heterodimers and 
catalyzes the tyrosination of the α-tubulin subunit (Wehland & Weber, 1987a). Since 
the TTL-binding site on β-tubulin most probably is masked in microtubules, only non-
assembled heterodimers can be a substrate of the TTL. As the α-tubulin subunits 
cycle through alternating detyrosination and tyrosination events, this process is also 
referred to as tyrosination cycle of α-tubulin (Fig. 12). Newly synthesized α-tubulin 
always possesses the C-terminal tyrosine, since this residue is genetically encoded. 
Additionally, the C-terminal glutamic acid residue of Glu-tubulin can be removed by 
the activity of an unknown peptidase. This reaction generates Δ2-Glu-tubulin, which 
is not a substrate of TTL (Paturle-Lafanechère et al., 1991; Rüdiger et al., 1994; 
Westermann & Weber, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Tyrosination cycle of α-tubulin. Newly translated tubulin subunits assemble to 
microtubules. A yet unknown carboxypeptidase removes the C-terminal tyrosine residue of α-tubulin 
from the incorporated tubulin subunits resulting in detyrosinated tubulin (Glu-tubulin). After 
depolymerization, the tubulin-tyrosine ligase can re-add a tyrosine residue to the soluble Glu-tubulin 
subunits, thus, generating tyrosinated tubulin (Tyr-tubulin) that can be incorporated in the microtubule 
again. Glu-tubulin can also lose the C-terminal glutamic acid resulting in Δ2-Glu-tubulin that cannot be 
tyrosinated. The pool of Tyr-tubulin is steadily filled by ongoing protein biosynthesis. 
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As detyrosinated tubulin predominantly occurs in stable microtubules, detyrosination 
was at first assumed to be a modification for microtubule stabilization. But, notably, 
detyrosination is only a concomitant effect of stable microtubules and does not 
stabilize microtubules by itself (Webster et al., 1990). The formation of detyrosinated 
microtubules has also been connected with interactions with the actin cytoskeleton 
and the intermediate filament system. Detyrosination can be triggered by a signal 
transduction cascade via Rho GTPases, which can also influence actin-based 
cellular functions. Furthermore, vimentin intermediate filaments co-localise 
preferentially with detyrosinated microtubules (Cook et al., 1998; Gurland & 
Gundersen, 1995). In vertebrate cancers, tumour progression is accompanied by 
decreased TTL activity resulting in high levels of Glu-tubulin and reduced Tyr-tubulin 
levels (Lafanechère et al., 1998; Mialhe et al., 2001). 
In order to gain more insight into the physiological importance of the tyrosination 
cycle, TTL knockout mice were generated (Erck et al., 2005). As a consequence of 
ongoing protein biosynthesis, proliferating cells that lack TTL contain a residual pool 
of Tyr-tubulin. In contrast, postmitotic cells like neurons, in which reduced protein 
synthesis occurs, lack Tyr-tubulin. Interestingly, TTL-deficient cells show a correctly 
organized microtubule network. Although homozygous TTL knockout mice pass a 
normal embryonic development, newborns die within 24 hours after birth. Histological 
analyses of embryonic organs revealed a disorganized structure of the cortical layers 
in brains derived from 19.5 days old TTL knockout embryos (Fig. 13). During 
embryogenesis developing neurons migrate in radial direction through the cortex and 
establish the characteristic layered pattern (see scheme and wild type brain section 
in Fig. 13). Obviously, this layer formation in TTL knockout mice is defective and, 
moreover, is accompanied by a higher apoptosis rate resulting in the generation of 
enlarged ventricles. In addition, neuronal differentiation is affected by TTL deficiency. 
Neurons lacking TTL show erratic neurite growth and shrinkage as well as a 
premature and abnormal axonal development. Furthermore, the microtubule plus-end 
tracking protein CLIP-170 is mislocalised in TTL knockout neurons, whereas the 
distribution of EB1 remains unaffected. Compared to wild type neurons, CLIP-170 is 
strongly reduced in neurite extensions and growth cones. 
In fibroblasts lacking TTL, a general mislocalisation of +TIPs containing CAP-Gly 
domains is reported. CLIP-170, CLIP-115 and p150Glued are unable to bind to 
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microtubule plus-ends in TTL knockout mouse embryonic fibroblasts (MEF), which 
completely lack tyrosinated tubulin. On the other hand, the localisation of EB proteins 
and CLASPs is unaffected (Peris et al., 2006). Moreover, defective cell polarization 
and spindle positioning is prominent in TTL-deficient MEFs. These results indicate a 
major role of CAP-Gly domain-containing +TIPs in cell migration and spindle 
orientation by linking microtubule plus-ends to the cell cortex. Finally, detyrosination 
also influences microtubule interactions with motor proteins, as shown by preferential 
binding of kinesin-1 to detyrosinated microtubules (Liao & Gundersen, 1998). 
 
 
 
 
 
 
 
 
 
 
Fig. 13: TTL knockout leads to disorganization of cortical layers in the murine brain. 
Coronal brain sections show the cortical layer organization in brains from 19.5 days old wild type and 
TTL knockout mice. Note the disordered layering in brains derived from TTL knockout mice. 
Abbreviations: MZ = mantle zone; CP = cortical plate zone; SP = subplate zone; IZ = intermediate 
zone; SVZ = subventricular zone; VZ = ventricular zone (from Erck et al., 2005, and Gupta et al., 
2002). 
 
 
1.5. Aim of this study 
The aim of this thesis was the characterization of fibroblasts lacking the tubulin-
tyrosine ligase in order to reveal the physiological impact of the tyrosination cycle.  
So far, irregular cell polarization and migration were assumed to be regulated by 
tubulin tyrosination. The recent generation of TTL knockout mice has opened a wide 
field of possibilities to unravel the cellular functions that are influenced by the 
tyrosination status of α-tubulin. A strong neuronal phenotype accompanied with 
severe malformations of the brain could be observed in TTL knockout mice (Erck et 
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al., 2005), whereas other cell types seemed not to be affected. To study the influence 
of the tubulin tyrosination cycle in a more simple cell system, both immortalized and 
primary mouse embryonic fibroblasts (MEFs) were analysed. Since ongoing protein 
biosynthesis serves for a residual pool of tyrosinated tubulin in TTL knockout cells, 
one aspect of this study was to obtain a comprehensive depletion of Tyr-tubulin in 
TTL-deficient fibroblasts. For that, chemical treatments and microinjection of 
antibodies that specifically bind to the tyrosinated α-tubulin C-terminus and block 
remaining functional Tyr-tubulin subunits were performed. To ascertain the putative 
influence of TTL deficiency on cell polarization and migration, cells with reduced Tyr-
tubulin levels were investigated in wound-healing assays. 
Peris and collegues (2006) published that CAP-Gly domain-containing +TIPs only 
bind to tyrosinated microtubules, since these +TIPs are unable to bind microtubule 
plus-ends in TTL knockout MEFs lacking tyrosinated tubulin. As described in chapter 
1.3.2., +TIPs play a major role in regulating microtubule dynamics and functions. This 
indicates that impaired microtubule binding of CAP-Gly domain-containing +TIPs in 
the absence of TTL would massively affect microtubule-dependent cellular 
processes. Moreover, the exact mechanism of +TIP/microtubule binding and the 
regulation of these interactions are still poorly understood. Therefore, in the 
presented study major focus was appointed to the characterization of wild type and 
TTL-deficient cells regarding the microtubule plus-end tracking proteins CLIP-170, 
CLIP-115 and EB1 by using biochemical and immunological methods. The absence 
of TTL and the subsequent lack of Tyr-tubulin resulted in differences in the 
phosphorylation status and the subcellular localisation of CLIP-115. Site-directed 
mutagenesis experiments on CLIP-115 were performed to unravel potential 
mechanisms of plus-end tracking and to functionally analyse the involvement of 
single amino acid residues in CLIP-115/microtubule association. Finally, mass 
spectrometry analyses of CLIP-115 were used to corroborate the results obtained by 
site-directed mutagenesis and to identify additional putative phosphorylation sites. 
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2. Material and Methods 
 
 
2.1. Chemicals and reagents 
All used chemicals and reagents were, if not specified separately, obtained from 
Becton, Dickinson and Company (BD), Bio mol, Biontex, Bio-Rad, Clontech, Fluka, 
GE Healthcare, Gibco, Interchim, Invitrogen, Lonza, Macherey-Nagel, Mallinckroth 
Baker B.V., MBI Fermentas, Merck, Pierce, Promega, Qiagen, Riedel-de Haën, 
Roche, Roth, Serva, Sigma-Aldrich and Stratagene. 
 
2.2. Media and plastic ware for cell culture 
Media and additives from Gibco and Sigma-Aldrich were used for cell culturing. 
Plastic ware was purchased from Corning, Falcon and Nunc. Tubes, reaction cups, 
sterile pipettes and pipette tips were obtained from Eppendorf, Greiner, Sarstedt, 
Sterilin and Thermo Scientific. 
 
2.3. Bacterial culture 
 
2.3.1. Bacterial strains 
Escherichia coli (E. coli) TG2 cells (Stratagene) were used for amplification of 
plasmids and constructs. Highly competent E. coli XL1-Blue supercompetent cells 
and E. coli Top10 competent cells were from Stratagene and Invitrogen, respectively. 
 
2.3.2. Media for bacterial culture 
All ingredients were solved in deionised water (H2Odeion) followed by sterilization by 
autoclaving. When necessary, 100 µg/ml ampicillin or 50 µg/ml kanamycin was 
added. 
 
LB medium (Luria Bertani broth): 
10 g/l Bacto-tryptone 
5 g/l Bacto-yeast extract 
10 g/l NaCl 
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LB-Agar plates: 
16 g Agar 
in 1 l of LB medium 
 
SOB medium: 
20 g/l Bacto-tryptone 
5 g/l Bacto-yeast extract 
0.6 g/l NaCl 
0.19 g/l KCl 
 
SOC medium: 
SOB medium with 
10 mM MgCl2 
10 mM MgSO4 
2 mM glucose 
 
2.3.3. Growth conditions 
E. coli cultures were incubated at 37 °C overnight. Liquid cultures were additionally 
shaken at 180 rpm.  
 
2.4. Molecular biological methods 
 
2.4.1. Plasmids and constructs 
Plasmids and constructs used in this study are listed in Table 2. Full length CLIP-115 
was ordered from ImaGenes GmbH (AccNo. BC053048, isoform b). 
 
Table 2: Plasmids and constructs used in this study. 
Name Resistance Use Source 
pEGFP-C1 Kanamycin cloning of CLIP-115 C-terminus Clontech 
pEGFP-C3 Kanamycin cloning of CLIP-115 full length Clontech 
pEGFP-N1 Kanamycin cloning of CLIP-115 full length Clontech 
pEGFP-N3 Kanamycin cloning of CLIP-115 C-terminus Clontech 
pEGFP-Actin Kanamycin testing transfection reagents P. Hagendorff 
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pmRFP-Actin Kanamycin testing transfection reagents; EGFP in 
original plasmid (pEGFP) was 
substituted by mRFP 
P. Hagendorff 
pEGFP-C1-CLIP-115 
C-terminus 
Kanamycin testing polyclonal anti-CLIP-115 
antibodies (C. Erck) 
this study 
pEGFP-C3-CLIP-115 Kanamycin site-directed mutagenesis this study 
pEGFP-N1-CLIP-115 Kanamycin site-directed mutagenesis this study 
pEGFP-N3-CLIP-115 
C-terminus 
Kanamycin testing polyclonal anti-CLIP-115 
antibodies (C. Erck) 
this study 
pEGFP-C1-CLIP-170 Kanamycin site-directed mutagenesis C. Erck 
pGEX-6p2-CLIP-115 
C-terminus 
Ampicillin CLIP-115 C-terminus for cloning in 
pEGFP-C1 and -N3 
C. Erck 
pIRES2-EGFP-TTL 
sense 
Kanamycin rescue of WT phenotype in TTL-/- MEFs C. Erck, 
M. van Ham 
pIRES2-EGFP-TTL 
antisense 
Kanamycin control for rescue experiments C. Erck, 
M. van Ham 
pYX-Asc-Clip2 Ampicillin full length CLIP-115 cDNA clone ImaGenes 
 
 
2.4.2. Preparation of plasmid DNA 
To isolate plasmid DNA from bacteria, 2 ml for mini-preparations and 100 ml of LB 
medium for midi-preparations containing the appropriate antibiotic were inoculated 
with material of a single bacterial clone and incubated overnight at 37 °C while 
shaking. The DNA preparations were performed using the NucleoSpin® Plasmid kit 
for mini-, and the NucleoBond® AX100 kit for midi-preparations pursuant to the 
manual (Macherey-Nagel). Harvested bacteria were re-suspended in pre-cooled 
buffer containing RNase (A1 or S1, respectively) and lysed by an alkaline SDS-
containing buffer (A2 or S2, respectively). A potassium acetate-containing buffer (A3 
or S3, respectively) neutralized the lysates and precipitated chromosomal DNA as 
well as proteins. The plasmid DNA was then bound to an anion-exchange column, 
washed (buffers AW and A4 or N3, respectively), and eluted (buffers AE or N5, 
respectively). To increase the concentration after midi-preparation plasmid DNA was 
precipitated by the addition of 2-propanol, washed with 70 % ethanol, and re-
dissolved in 50 – 200 µl of sterile H2Odeion. 
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2.4.3. Isolation of genomic DNA from mouse tails 
Genomic DNA was isolated from mouse tails for genotyping. Therefore, tail tips were 
overnight incubated in 720 µl tail buffer complimented with 30 µl 10 mg/ml Proteinase 
K at 54 °C while shaking. After 10 min centrifugation at 13000 rpm at room 
temperature, supernatants were transferred to reaction cups containing 600 µl 2-
propanol and mixed by inverting. Samples were spun down at 12000 rpm for 5 min 
and supernatants were removed completely. Pellets were washed with 500 µl 70 % 
ethanol, air-dried and dissolved in 200 µl sterile H2Odeion by shaking at 54 °C for 3 – 
12 h. Samples were ready to be used for genotyping as described in 2.4.5. 
 
Tail buffer: 
100 mM Tris base-HCl, pH 8.5 
5 mM EDTA, pH 8.0 
200 mM NaCl 
0.2 % SDS 
 
2.4.4. Quantification of DNA 
Solutions containing nucleic acids show a maximal absorption at a wavelength of λ = 
260 nm. According to the extinction coefficient (ε) the optical density at 260 nm 
(OD260) of 1.0 corresponds to a DNA concentration (cDNA) of 50 ng/µl. The OD260 of in 
water diluted DNA solutions was measured using a photometer (GeneQuant II, 
Pharmacia Biotech) and DNA concentrations were calculated according to the 
following equation: 
cDNA = OD260 x dilution factor x 50 ng/µl 
 
2.4.5. Polymerase Chain Reaction 
The polymerase chain reaction (PCR) is used to amplify specific DNA fragments and 
in this study was employed for genotyping mouse embryos, cloning EGFP-CLIP-115 
constructs and site-directed mutagenesis of both CLIP-115 and CLIP-170. Site-
directed mutagenesis is described in chapter 2.4.7. 
In general, DNA amplification by PCR is performed by repeated cycles of 
denaturation, annealing and elongation. First, the double-stranded template DNA is 
heated at 95 – 98 °C to obtain single stranded DNA. Next, temperature is decreased 
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to allow the primers to anneal thereby generating short parts of double-stranded 
DNA. The annealing- or melting temperature (Tm) is primer-specific and is calculated 
as follows: 
Tm = 69.3 + 0.41 x (GC %) – 650 / (primer length in bp) 
 
Finally, during the elongation step a thermo-resistant DNA polymerase uses the sites 
where primers have bound as starting point for DNA synthesis at 68 – 72 °C. 
Duration of this step depends on the fragment size and is usually calculated with 
1min/kb. The respective PCR-mixes and programmes for genotyping and cloning are 
shown below. The corresponding oligonucleotides used as primers are listed in Table 
3 (chapter 2.4.6.). To perform the PCR reactions the T3 Thermocycler from Biometra 
was used. 
Genotyping: 
PCR-mix: 2.5 µl   5x Green GoTaq® Flexi Buffer (Promega) 
1.0 µl   25 mM MgCl2 (Promega) 
1.0 µl   dNTP-mix (each 2.5 mM) 
0.1 µl   100 µM forward-primer 
0.1 µl   100 µM reverse-primer 
0.0625 µl  5 U/µl Taq polymerase (Promega) 
0.5 µl   DNA (final amount 10 – 50 ng) 
ad 12.5 µl  sterile H2Odeion 
 
Oligonucleotides Del and Neo2 were used as forward primers for genotyping of wild 
type and TTL knockout, respectively. In both reactions DelNeoRev was used as 
reverse primer. 
 
Temperature programme: 
  95 °C  - 3 min 
  95 °C  - 1 min 
  62 °C  - 1 min  35 cycles 
  72 °C  - 1 min 
  72 °C  - 5 min 
  4 °C  - hold 
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CLIP-115 amplification for cloning: 
PCR-mix: 4.0 µl   5x Phusion HF Reaction Buffer (Finnzymes) 
  0.8 µl   dNTP-mix (each 2.5 mM) 
  0.6 µg   forward-primer 
  0.6 µg   reverse-primer 
  0.2 µl   2 U/µl Phusion DNA polymerase (Finnzymes) 
  2.0 ng   DNA 
  ad 20 µl  sterile H2Odeion 
 
Temperature programme: 
  98 °C  - 30 s 
  98 °C  - 10 s 
  65 °C  - 30 s  35 cycles 
  72 °C  - 2 – 4 min 
  72 °C  - 5 min 
  4 °C  - hold 
 
2.4.6. Oligonucleotides 
Oligonucleotide primers for sequencing CLIP-115 and CLIP-170 constructs were 
designed using the online software “Primer3” (freeware from Geneious). Primers for 
cloning of EGFP-CLIP-115 as well as for site-directed mutagenesis were designed 
using the respective sequences. For cloning the EGFP-CLIP-115 constructs 
restriction sites, kozak sequences or stop codons had to be introduced. All 
oligonucleotide primers were purchased from MWG. 
 
Table 3: Oligonucleotide primers used in this study. Introduced restriction sequences are 
underlined, kozak sequences are underlined in italic, and stop codons are in bold. 
Name Sequence (5’ – 3’) Use 
34MGE CCA AAA TCA ACG GGA CTT TCC pEGFP-N sequencing 
35MGE GGT CCT GCT GGA GTT CGT pEGFP-C sequencing 
93MGE GGT GTG GGA GGT TTT TTA AAG C pEGFP-C sequencing 
97MGE GGA CAC GCT GAA CTT GTG G pEGFP-N sequencing 
Del GTC ACA GAC TAG AAA ATG TGC TTA GA genotyping wt forward 
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DelNeoRev CCC AAC ATC ACA TTC TCC AAA TCT CA genotyping wt and TTL-/- 
reverse 
Neo2 GAT TCC CAC TTT GTG GTT CTA AGT AC genotyping TTL-/- forward 
M57 CCG AAT TCT CAG TGT TTG TCC TCC TG CLIP-115 amplification 
M64 GGC CTC GAG ATG CAG AAG CCC AGT G CLIP-115 amplification 
M65 GGC AGG AAC CAG GTT CTT CCA GTG CCC ACC CLIP-115 Y270F forward 
M66 GGT GGG CAC TGG AAG AAC CTG GTT CCT GCC CLIP-115 Y270F reverse 
M67 GGC AGG AAC CAG GGA GTT CCA GTG CCC ACC CLIP-115 Y270E forward 
M68 GGT GGG CAC TGG AAC TCC CTG GTT CCT GCC CLIP-115 Y270E reverse 
M69 GAC CTC TTC GCG CTT TGC CCG GAA GAT CTC CLIP-115 Y348F forward 
M70 GAG ATC TTC CGG GCA AAG CGC GAA GAG GTC CLIP-115 Y348F reverse 
M71 GAC CTC TTC GCG CGA AGC CCG GAA GAT CTC CLIP-115 Y348E forward 
M72 GAG ATC TTC CGG GCT TCG CGC GAA GAG GTC CLIP-115 Y348E reverse 
M73 CAC AGC ATG AGC AGT TTG TTG CAG AAG CCG CLIP-115 Y407F forward 
M74 CGG CTT CTG CAA CAA ACT GCT CAT GCT GTG CLIP-115 Y407F reverse 
M75 CAC AGC ATG AGC AGG AGG TTG CAG AAG CCG CLIP-115 Y407E forward 
M76 CGG CTT CTG CAA CCT CCT GCT CAT GCT GTG CLIP-115 Y407E reverse 
M77 GCT CCA GGA CAA ATT TGA GCA CAT GCT AAA G CLIP-115 Y533F forward 
M78 CTT TAG CAT GTG CTC AAA TTT GTC CTG GAG C CLIP-115 Y533F reverse 
M79 GCT CCA GGA CAA AGA GGA GCA CAT GCT AAA G CLIP-115 Y533E forward 
M80 CTT TAG CAT GTG CTC CTC TTT GTC CTG GAG C CLIP-115 Y533E reverse 
M81 GGC CAA TGA GAA GTT CGC TCA GGA GGT GG CLIP-115 Y554F forward 
M82 CCA CCT CCT GAG CGA ACT TCT CAT TGG CC CLIP-115 Y554F reverse 
M83 GGC CAA TGA GAA GGA GGC TCA GGA GGT GG CLIP-115 Y554E forward 
M84 CCA CCT CCT GAG CCT CCT TCT CAT TGG CC CLIP-115 Y554E reverse 
M85 GAA AAG AAG ATG CTA GAT TTC GAG ATG CTG 
CAG AGG G 
CLIP-115 Y732F forward 
M86 CCC TCT GCA GCA TCT CGA AAT CTA GCA TCT 
TCT TTT C 
CLIP-115 Y732F reverse 
M87 GAA AAG AAG ATG CTA GAT GAG GAG ATG CTG 
CAG AGG G 
CLIP-115 Y732E forward 
M88 CCC TCT GCA GCA TCT CCT CAT CTA GCA TCT 
TCT TTT C 
CLIP-115 Y732E reverse 
M93 GTG GAA TCC CTC ACG CLIP-115 sequencing 
M94 TCA GGC ACC ACA GC CLIP-115 sequencing 
M96 AAG CCA TCG AGT TCC CLIP-115 sequencing 
M97 TAC TCG AGC CGC CAT GCA GAA GC CLIP-115 kozak, Xho Ι 
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M98 CCG AAT TCT CGG TGT TTG TCC TCC TG CLIP-115 stop, Eco RΙ 
M99 GAG GAT CCC ACC ATG ACA TCC CAG ATG GAC CLIP-115C kozak, Bam HΙ 
M100 TGG CAG ACC TCA AGG  CLIP-115 sequencing 
M105 GGG TGG CGT GCG CTT CTT CGA GTG CCC GG CLIP-115 Y130F forward 
M106 CCG GGC ACT CGA AGA AGC GCA CGC CAC CC CLIP-115 Y130F reverse 
M107 GGG TGG CGT GCG CGA GTT CGA GTG CCC GG CLIP-115 Y130E forward 
M108 CCG GGC ACT CGA ACT CGC GCA CGC CAC CC CLIP-115 Y130E reverse 
M122 CTC CGA TCA GCA ACC CLIP-170 sequencing 
M123 GGA ACG GGA TCT GG CLIP-170 sequencing 
M124 TGA AGG AGC ATT TTG G CLIP-170 sequencing 
M125 TTC CGA AGG TAA ATC G CLIP-170 sequencing 
M126 GAA ACA AGC CAC AAC C CLIP-170 sequencing 
M127 GCA GAT GAA GAG AAA GC CLIP-170 sequencing 
M128 GGC AGG AGT TCG GTT TTT CCA GTG TGA AC CLIP-170 Y108F forward 
M129 GTT CAC ACT GGA AAA ACC GAA CTC CTG CC CLIP-170 Y108F reverse 
M130 GGC AGG AGT TCG GGA GTT CCA GTG TGA AC CLIP-170 Y108E forward 
M131 GTT CAC ACT GGA ACT CCC GAA CTC CTG CC CLIP-170 Y108E reverse 
M132 GCT GGA ACA AGG TTT TTT CAG TGT CAA CC CLIP-170 Y261F forward 
M133 GGT TGA CAC TGA AAA AAC CTT GTT CCA GC CLIP-170 Y261F reverse 
M134 GTT GCT GGA ACA AGG GAA TTT CAG TGT CAA CC CLIP-170 Y261E forward 
M135 GGT TGA CAC TGA AAT TCC CTT GTT CCA GCA AC CLIP-170 Y261E reverse 
M159 GGC AGG AAC CAG GGC CTT CCA GTG CCC ACC CLIP-115 Y270A forward 
M160 GGT GGG CAC TGG AAG GCC CTG GTT CCT GCC CLIP-115 Y270A reverse 
T7 TAA TAC GAC TCA CTA TAG GG Sequencing of purchased 
CLIP-115 clone 
 
 
2.4.7. Site-directed mutagenesis 
Point mutations were introduced in CLIP-115 and CLIP-170 sequences by using the 
QuikChange® Site-directed mutagenesis kit (Stratagene) according to the 
manufacture’s protocol. An online-based phospho-scan of the CLIP-115 sequence 
using the NetPhosK 1.0 as well as the NetPhos 2.0 Server (Technical University of 
Denmark, www.cbs.dtu.dk/services/NetPhosK) revealed six tyrosines as putative 
phosphorylation sites. To mimic phosphorylation or dephosphorylation, the tyrosines 
270, 348, 407, 533, 554 and 732 of CLIP-115 were either substituted by glutamic 
acid or phenylalanine, respectively. After initial experiments also tyrosine 130 of 
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CLIP-115 and the tyrosines 108 and 261 of CLIP-170 were substituted as described. 
Tyrosine 270 of CLIP-115 was additionally mutated into alanine as an independent 
control of mimicking dephosphorylation. In site-directed mutagenesis, point mutations 
are introduced into the target gene by PCR-mediated amplification of the complete 
plasmid using primers carrying the changed nucleotides. Thus, the resulting PCR 
products are complete plasmids. The reaction mixture was either prepared according 
to the manual or as described below: 
5 µl   10x reaction buffer 
125 ng  forward-primer 
  125 ng  reverse-primer 
  8 µl   dNTP-mix (each 2.5 mM) 
10 – 20 ng  DNA 
1 µl   3 U/µl Pfu DNA polymerase (Promega) 
 ad 50 µl  sterile H2Odeion 
 
Temperature programme: 
  95 °C  - 30 s 
  95 °C  - 30 s 
  55 °C  - 1 min  16 – 18 cycles 
  68 °C  - 8 – 10 min 
  4 °C  - hold 
 
H2Odeion was used as negative control. After the mutagenesis reaction, template DNA 
was digested by the addition of 10 U Dpn I and 1 h of incubation at 37 °C. This 
restriction enzyme specifically recognizes methylated DNA and therefore digests the 
template DNA, which was isolated from bacteria and consequently carries 
methylations. The reaction product was then checked for correct size by agarose gel 
electrophoresis as described in 2.4.10. and introduced into E. coli by heat-shock 
transformation (see 2.4.13.) for amplification and sequencing. 
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2.4.8. DNA sequencing 
The BigDye® Terminator v3.1 Cycle Sequencing Kit from AB Applied Biosystems was 
employed to sequence the newly generated CLIP-115 and CLIP-170 constructs as 
well as the DNA products obtained by site-directed mutagenesis. 
PCR-mix: 2 μl   Big Dye 
1 μl   5x Sequencing buffer 
3.2 pmol  sequencing primer (see Tab. 3) 
1 μl   DNA (mini-preparation) 
ad 10 μl  sterile H2Odeion 
 
Temperature programme: 
96 °C  - 5 min 
96 °C  - 15 s 
50 °C  - 15 s  25 cycles 
60°C  - 4 min 
  4 °C  - hold 
 
PCR products were sent to GATC Biotech GmbH (Konstanz, Germany) for automatic 
sequencing. The received sequence files (FASTA format) were aligned using Vector 
NTI® Software (Invitrogen). 
 
2.4.9. DNA restriction digests with endonucleases 
Restriction endonucleases are bacterial enzymes used as molecular biological tools 
to digest foreign DNA at specific cleavage sites of usually 4 – 8 nucleotides. 
Restriction digests result in double-stranded DNA fragments with blunt, 5`- or 3`-
sticky ends, depending on the restriction enzyme. 
In this study generally up to 5 µg DNA was digested in 10 – 30 µl 1x restriction buffer 
containing 0.4 U/µl of each restriction enzyme. Depending on the used enzymes the 
reaction could also be performed in 2x restriction buffer, e.g. when Bam H1 and Eco 
R I were used in combination. After 1 – 2 h incubation at 37 °C reactions were mixed 
with 5x DNA loading buffer and analysed by agarose gel electrophoresis (see next 
chapter). 
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2.4.10. Agarose gel electrophoresis 
As DNA fragments are negatively charged, they are motile in an electric field and can 
be separated according to their size in an agarose matrix. Therefore, 1 % (w/v) 
agarose in 1x TAE buffer was heated until the agarose was completely dissolved. 
The solution was cooled to 60 °C and poured in a gel chamber. To visualize the DNA 
after separation 0.5 µM ethidiumbromide (according to standard protocols) was 
added to the agarose solution. Ethidiumbromide is a DNA-intercalating agent and 
fluoresces at UV light. The agarose gel was transferred to an electrophoresis 
chamber (Bio-Rad, Whatman) and soaked in 1x TAE buffer. DNA samples were 
mixed with 5x loading buffer and loaded in the gel slots. Additionally, a DNA standard 
with a fragment size from 200 – 10000 bp (SmartLadder, Eurogentec) was loaded to 
identify the DNA fragment sizes in the samples. For separating the DNA samples a 
voltage of 65 V was applied (powersupply from Biometra). Finally, the gel was 
exposed to UV light and images were recorded. 
 
5x DNA loading buffer: 
15 % (v/v) Ficoll 
50 mM EDTA pH 8 
0.5 % (v/v) SDS 
2 % (v/v) 50x TAE buffer 
0.05 % (w/v) Bromophenol blue 
0.05 % (w/v) Xylencyanol 
 
TAE buffer, pH 7.5: 
40 mM Tris base 
20 mM Sodium acetate 
1 mM EDTA 
 
2.4.11. DNA extraction from agarose gels 
For cloning, DNA fragments obtained from restriction digests were separated by 
agarose gel electrophoresis as described in 2.4.10. The target bands were then cut 
out of the gel under UV light and extracted by using the NucleoSpin® Extract II kit 
from Macherey-Nagel according to the manual. 
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2.4.12. Ligation 
To generate new constructs, DNA fragments were ligated into linearised plasmids. 
For that, a molecular ratio between insert and plasmid of approximately 3:1 
supplemented with 1 U T4 DNA ligase in a total volume of 10 µl 1x ligation buffer was 
incubated overnight at 4 °C. Mixtures were then used to transform E. coli as 
described in 2.4.13. 
 
2.4.13. Bacteria transformation 
To obtain single clones containing the target construct competent the respective PCR 
or ligation products were introduced in E. coli by heat-shock transformation. 
Therefore, 50 µl of competent cells were thawed on ice and mixed with up to 500 ng 
of DNA. After 15 min incubation on ice bacteria were incubated at 42 °C for 90 s in a 
thermomixer (Eppendorf) immediately followed by additional 2 min incubation on ice. 
Then, 900 µl SOC medium was added followed by incubation at 37 °C under 
agitation at 650 rpm for 60 min in a thermomixer. Finally, bacteria were plated on LB-
Agar containing the appropriate antibiotic and incubated overnight at 37 °C. 
 
2.5. Biochemical methods 
 
2.5.1. Standard buffers 
All buffers were prepared in H2Odeion and autoclaved if necessary. Adapted protocols 
as well as not frequently used buffers are mentioned separately in the respective 
paragraphs. 
 
PBS, pH 7.4: 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4·2H2O 
2 mM KH2PO4 
 
TBS, pH 7.6: 
20 mM Tris base 
137 mM NaCl 
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2.5.2. Antibody purification 
In this study, monoclonal antibodies were either purified from cell culture 
supernatants using protein G columns or from rat ascites (Biotem, France) by 
ammonium sulphate precipitation. Non-adherent hybridoma cells release antibodies 
into the culture medium, which then can directly be used in immunofluorescence or 
for purifying the contained antibodies as described in 2.5.2.1. 
 
2.5.2.1. Purification with protein G column 
The mouse antibody 20C6 against tyrosinated α-tubulin was purified from cell culture 
supernatant using the antibody binding capacity of protein G. Columns containing 
protein G-coupled sepharose beads were equilibrated with 10 ml PBS before 
applying up to 150 ml supernatant. After flow-through of the supernatant, the column 
was washed with up to 150 ml PBS corresponding with the loaded volume of 
supernatant. The bound antibodies were then eluted with 20 ml 0.1 M glycine buffer 
(pH 3.0). Aliquots of 1 ml were collected in cups containing 100 µl 1.5 M Tris base 
(pH 8.8) for immediate neutralization. All samples were used to determine antibody 
presence by measuring the protein concentration at OD280 (as described in 2.5.5). 
Antibody-containing fractions were then pooled and concentrated by centrifugation in 
Centricon tubes (Vivaspin, cut-off: 10 kDa). To re-use the protein G sepharose it was 
washed with 0.1 M glycine buffer (pH 3.0) until the flow-through had an OD280 of 
0.10. The sepharose was then stored in PBS at 4 °C. 
 
2.5.2.2. Ammonium sulphate precipitation 
The rat antibody YL1/2 was purified from ascites to obtain sufficient amounts of 
antibody necessary for further experiments. Therefore, the ascites was cleaned from 
cell residues by filtration through a sterile filter with a pore size of 3 µm followed by 
centrifugation at 10000 rpm and 4 °C for 30 min. Antibodies of the type IgG2 
precipitate in an ammonium sulphate concentration of 50 %. For that reason, 3 ml 
ice-cold saturated ammonium sulphate was added drop-wise to 3 ml of ascites 
supernatant over the time of 30 min while stirred on ice. After an additional hour of 
stirring, the mixture was centrifuged at 13000 rpm and 4 °C for 30 min. The pellet 
was re-dissolved in 3 ml of dialysis buffer and transferred to a dialysis skin. To desalt 
the antibody solution, dialysis was performed in a total volume of 2 l of dialysis buffer 
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overnight at 4 °C. To dissolve precipitated antibodies, 3 ml of dialysis buffer was 
added followed by centrifugation for 30 min at 10000 rpm and 4 °C. The supernatant 
was then purified by anion exchange chromatography using a FPLC from Pharmacia 
Biotech. Therefore, the antibody solution was loaded onto a MonoQ 5/5 column. 
Bound antibodies were eluted by increasing NaCl concentration. Therefore, the rate 
of elution buffer increased from 0 – 100 % during the flow-through of 10 – 42 ml after 
sample injection (according to standard protocol). Immediately after sample injection, 
1 ml fractions were collected. Antibody-containing fractions were determined by 
measuring the OD280, pooled and concentrated in PBS using Centricon tubes. 
 
Dialysis buffer: 
20 mM Tris base-HCl, pH 7.9 
 
Elution buffer: 
20 mM Tris base-HCl, pH 7.9 
350 mM NaCl 
 
2.5.3. Production of Fab fragments 
Antibodies consist of an Fc part and two Fab fragments, which are arranged by two 
heavy and two light chains. Each Fab fragment carries an epitope-binding site, so that 
one antibody can bind two antigens. In order to uncouple the two binding sites of an 
antibody and thereby preventing cross-linking of the antigen, single Fab fragments 
were produced employing the ImmunoPure® Fab Preparation Kit from Pierce. 
Antibody cleavage is achieved using immobilized papain followed by a protein A-
mediated purification. For that, 10 mg antibody was concentrated into a volume of 0.5 
ml PBS by using Centricon tubes. Next, 0.5 ml of freshly prepared digestion buffer 
was added. Then, 0.5 ml of washed immobilized papain was added to the sample. 
Antibody digestion was performed at 37 °C overnight while shaking. After 
centrifugation at 1000 xg for 5 min the antibody-containing supernatant was 
transferred to a new tube. The resulting papain-containing pellet was washed twice 
with 1 ml binding buffer. The supernatant from each wash step was added to the 
antibody solution. To isolate the Fab fragments a protein A-coupled sepharose 
column that binds the Fc parts and undigested antibodies was equilibrated with 13 ml 
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binding buffer and loaded with the sample. Next, the column was washed with 6 ml 
binding buffer and the Fab fragment-containing eluate was collected. The eluate was 
dialysed overnight at 4 °C in 3 l PBS and concentrated using Centricon tubes. For re-
usage, the protein A-coupled sepharose was regenerated by washing with 10 ml of 
0.1 M citric acid, pH 3.0, and stored in 0.02 % sodium azide in H2Odeion at 4 °C. 
Alternatively, the Fab fragments could also be purified after the papain digest by 
incubation with 150 µl of protein G-coupled sepharose for 2 h at 4 °C under steady 
rotation. 
 
Phosphate buffer, pH 7.0: 
20 mM Sodium phosphate 
10 mM EDTA 
 
Digestion buffer: 
12 ml provided phosphate buffer (pH 10.0) 
42 mg Cysteine⋅HCl 
 
Provided buffers: 
Phosphate buffer, pH 10.0 
Binding buffer 
 
2.5.4. Protein precipitation 
Proteins from total cell lysates that will be analysed by 2-dimensional SDS-PAGE 
were concentrated and desalted by methanol-chloroform-extraction (Wessel & 
Flügge, 1984). Therefore, 200 µl of total cell lysate were thoroughly mixed with 800 µl 
methanol, 200 µl chloroform and 600 µl H2Odeion. Centrifugation at 9000 rpm for 5 min 
resulted in three phases: a lower chloroform phase, a protein-containing interphase 
and an upper aqueous phase. After removing the upper aqueous phase 600 µl 
methanol was carefully added for washing. The resulting supernatant was completely 
removed and the remaining protein-containing phase air-dried and dissolved in 500 
µl soaking solution by shaking at 500 rpm overnight at 18 °C. Protein concentrations 
were then determined by a Bradford protein assay (Bio-Rad). 
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Soaking solution: 
5.4 g urea solved in 10 ml H2O, then addition of: 
1.5 g Thiourea 
400 mg CHAPS 
2 mg Tris 
30 mM DTT 
0.01 mg Leupeptin 
100 µl of 100 mM Pefablock 
 
Before use, 100 µM sodium vanadate and 1 µM sodium fluoride were added to inhibit 
phosphatase activity. 
 
2.5.5. Protein quantification 
The concentration of antibodies in aqueous solutions was measured at a wavelength 
of λ = 280 nm with a GeneQuant II photometer from Pharmacia Biotech. An optical 
density at 280 nm (OD280) of 1.0 corresponds with a protein concentration (e.g. 
antibody concentration, cantibody) of 0.714 mg/ml. The concentration of diluted 
antibody solutions was calculated as follows: 
 
cantibody = OD280 x dilution factor x 0.714 mg/ml 
 
Additionally, protein concentrations of total cell lysates were determined using the 
MicroBC Assay (Uptima) according to the manual. The kit includes three solutions (A, 
B, C), which were mixed in a ratio of 25:25:1 to produce the reagent for the assay. 
Then, 100 µl protein solution was mixed with 100 µl of reagent in a 96-well plate. 
After incubation at 37 °C for 1 h, the OD562 was measured with an ELISA-reader from 
Tecan and concentrations were calculated using a linear regression. The reference 
solutions had bovine serum albumin (BSA) concentrations of 0, 0.5, 1, 2.5, 5, 10, 15, 
25, 50 and 100 µg/ml. In general, cell lysates were diluted 1:20 and 1:100. Each 
sample was measured in duplicates and the average taken to calculate protein 
concentrations using Microsoft Excel 2000. 
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2.5.6. SDS-PAGE 
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
employed to separate proteins according to their molecular weight as described by 
Laemmli (Laemmli et al., 1970). Recipes of separation gels with acrylamide 
concentrations ranging from 5 % to 12.5 % and of 5 % stacking gels are listed in 
Table 4. 
 
Table 4: Recipes for polyacrylamide gels used in this study. 
 Stacking 
gel [ml] 
Separation gel 
[ml] 
Acrylamide concentration 5 % 5 % 6 % 7.5 % 10 % 12.5 % 
H2Odeion 1.8 3.5 3.3 3.0 2.5 1.75 
0.5 M Tris base-HCl, pH 6.8 0.32 - - - - - 
1.5 M Tris base-HCl, pH 8.8 - 1.5 1.5 1.5 1.5 1.5 
30 % acrylamide, 
0.8 % bisacrylamide 
0.33 1.0 1.2 1.5 2.0 2.75 
10 % SDS 0.025 0.06 0.06 0.06 0.06 0.06 
TEMED 0.0125 0.008 0.008 0.008 0.008 0.008 
25 % APS 0.0125 0.008 0.008 0.008 0.008 0.008 
 
After polymerisation, gels were transferred to a minigel chamber from Biometra. 
Protein samples were mixed with 4x SDS sample buffer, boiled for 10 min at 99 °C 
and loaded on the gel. As molecular weight standard either a pre-stained or an 
unstained protein ladder from MBI Fermentas was used. The molecular weights of 
the pre-stained protein ladder are approximately 11, 17, 25, 34, 43, 55, 72, 95, 130 
and 170 kDa, and of the unstained protein ladder 10, 15, 20, 25, 30, 40, 50, 60, 70, 
85, 100, 120, 150 and 200 kDa. 
Electrophoresis was performed in SDS running buffer at a voltage of 100 V to 180 V 
(powersupply from Biometra) depending on the acrylamide concentration of the gel. 
Finally, gels were analysed either by Coomassie staining or Western blotting (see 
chapterss 2.5.8. and 2.5.9., respectively). 
 
 
 
Material and Methods 
 
 
 
 53 
4x SDS sample buffer: 
3.4 % (w/v) SDS 
25 mM Tris base-HCl, pH 6.8 
2.4 % (v/v) Glycerol 
0.34 % (v/v) Mercaptoethanol 
0.008 % (w/v) Bromophenol blue 
 
SDS running buffer: 
25 mM Tris base 
192 mM Glycine 
0.1 % SDS 
 
2.5.7. Two-dimensional SDS-PAGE 
In this study, 2-dimensional SDS-PAGE was performed by the conventional method 
as well as by NEPHGE (non-equilibrium pH gel electrophoresis). The methods differ 
in the isoelectric focussing, which is either conventionally performed using gel strips 
that include a fixed pH gradient or performed in a urea gel that builds up a pH 
gradient under voltage (NEPHGE). The 2-dimensional SDS-PAGE was performed in 
the “Cellular Proteomics” group at the HZI (Dr. L. Jänsch, Dr. J. Wissing, E. 
Dornbusch, R. Munder). 
 
2.5.7.1. Conventional 2-dimensional SDS-PAGE 
Following the conventional protocol, 24 cm gel strips with a pH gradient from 5.5 to 
6.7 (Immobiline DryStrip from GE Healthcare) were equilibrated in 500 µl soaking 
solution (see 2.5.4.). The samples containing up to 1 mg total protein were mixed 
with 1 % of IPG buffer (pH 5.0 – 6.0 and 5.5 – 6.7, GE Healthcare) and 1.5 µl of 1 % 
bromophenol-blue in soaking solution before loading to the strip. In different 
experiments the samples were either loaded at the acidic or the basic end or evenly 
distributed over the whole strip at a voltage of 30 V for 5 h. The strips were covered 
with silicon oil and protein focussing (1st dimension) was performed by a voltage 
gradient with 150 kVh to maintain a steady ion flow. A typical programme started with 
a rehydration step at 30 V for 14 h. The following steps were 3 h at 100 V, 3 h at 300 
V, 3 h at 3000 V, up to 48 h at 3500 V, 2 h at 8000 V and a final hold at 100 V. After 
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separation in the 1st dimension, strips were washed with equilibration buffer 
containing 1 % (w/v) DTT followed by a second wash step in 4.8 % (w/v) 
iodacetamide in equilibration buffer. Then the strips were transferred onto 8 % SDS-
polyacrylamide gels and embedded in 2 % agarose for fixation. The gels were run in 
SDS running buffer (see 2.5.6.) at 1000 V with an ISO• DALT Electrophoresis 
System (Hoefer) in the 2nd dimension followed either by Commassie-staining or 
Western blotting (wet-blot system, Bio-Rad) as described in 2.5.8. and 2.5.9., 
respectively. 
 
Equilibration buffer: 
50 mM Tris base, pH 8.8 
6 M Urea 
30 % Glycerol 
2 % SDS 
 
2.5.7.2. Non-equilibrium pH gel electrophoresis 
For the performance of NEPHGE (according to Klose & Kobalz, 1995) a 9 M urea gel 
was poured in a glass tube with an inner diameter of 0.9 mm. 100 µg of protein were 
loaded to the urea gel, the gel ends put in electrode buffers and a current gradient 
(see below) applied to build up the pH gradient from a pH of 2 – 11, which is 
necessary for protein focussing. 
Current gradient:  60 min - 100 V 
60 min - 200 V 
    17.5 h  - 400 V 
    60 min - 600 V 
    30 min - 1000 V 
    10 min - 1500 V 
    5 min  - 2000 V 
 
The 2nd dimension was performed by transferring the urea gel onto a 15 % SDS-
polyacrylamide gel that is of high stability followed by a fixation in 2 % agarose. The 
gel was run at a current of 35 mA for 15 min followed by 5 h at 65 mA. After finishing 
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the 2nd dimension, gels were either stained with Coomassie or blotted in a wet-blot 
chamber from Bio-Rad (see chapters 2.5.8. and 2.5.9.). 
 
2.5.8. Coomassie-blue staining 
SDS protein gels as well as PVDF-membranes after Western blotting can be stained 
with Coomassie-blue staining solution for a minimum of 60 min to visualize protein 
bands. Gels and membranes were destained in 40 % methanol containing 10 % 
acetic acid. Since its higher sensitivity to proteins, SDS gels loaded with proteins to 
be analysed by mass spectrometry were stained with colloidal Coomassie. In this 
case gels were destained by wash steps in H2Odeion. 
 
Coomassie-blue staining solution 
0.1 % (w/v) Coomassie brilliant blue R250 
25 % (v/v) 2-Propanol 
10 % (v/v) Acetic acid 
→ Filtration 
 
Colloidal Coomassie: 
2 g Coomassie brilliant blue G250 
1 l H2O 
55.5 ml H2SO4 
→ >3 h stirring, then filtration and addition of 
220 ml 10 N NaOH 
310 ml 100% tri-chloric acid (TCA) 
 
2.5.9. Western blotting 
For protein transfer from SDS gels to PVDF membranes (Immobilon from Millipore) 
either a semi-dry blot system from PHASE or a wet-blot system from Bio-Rad was 
employed. For semi-dry blots two sheets of Whatman paper were soaked in blot 
buffer and put on the cathode. After a short equilibration in blot buffer the SDS gel (7 
cm x 9 cm) was transferred onto the Whatman paper and covered with a methanol-
activated PVDF membrane. Finally, another two pre-wetted sheets of Whatman 
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paper were put on the membrane and covered by the anode. Protein transfer was 
performed at a current of 150 mA for 90 – 120 min. 
Gels from 2-dimensional SDS-PAGE were blotted in a wet-blot system. Therefore, 
the above described construction of Whatman paper, SDS gel, PVDF membrane and 
another layer of Whatman paper was built up in a holder between two stuff mats. The 
holder was then transferred to the blot chamber and soaked in blot buffer, and a 
current of 1 A was applied for a minimum of 3 h. 
After protein transfer membranes were incubated overnight in block buffer at 4 °C 
and incubated with primary antibodies diluted in blocking solution for 1 h at room 
temperature. Next, membranes were washed step-wise with wash buffers A, B and C 
for 10 min followed by short rinsing with wash buffer A to remove the Triton X-100. 
Membranes were then incubated for 1 h at room temperature with the peroxidase-
coupled secondary antibody in blocking solution. Subsequently, membranes were 
washed as described above, incubated for 1 – 2 min in ECL-solution (Enhanced 
Chemiluminescence) and exposed to a film (Amersham Hyperfilm ECL, GE 
Healthcare). Films were developed using the Curex 60 machine (AGFA). Used 
membranes were stained with Coomassie as described in 2.5.8. 
 
Blot buffer: 
50 mM Tris base 
39 mM Glycine 
0.037 % (w/v) SDS 
20 % (v/v) Methanol 
 
Block buffer: 
10 % Fetal calf serum (FCS) in wash buffer A 
 
Wash buffers: 
A) TBS + 0.1 % Tween 20 (= TBS-T) 
 
B) TBS-T + 0.5 M NaCl 
 
C) TBS-T + 0.5 % Triton X-100 
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ECL-solutions: 
1.) Lumi-Light Western blotting solution (Roche) 
 
2.) Home-made ECL-solution: 
Solution 1: 250 mM luminol (0.44 g of 3-aminophtalhydrazide from Sigma in 
10 ml DMSO) 
Solution 2: 90 mM p-coumaric acid (0.15 g p-coumaric acid from Sigma in 
10 ml DMSO) 
Recipe: 
 Solution A: 8.85 ml H2Odeion 
   1 ml 1 M Tris base-HCl, pH 8.5 
   100 µl solution 1 
   44 µl solution 2 
 
 Solution B: 9 ml H2Odeion 
   1 ml 1M Tris base-HCl, pH 8.5 
   6 µl 30 % H2O2 
 
Solutions A and B were mixed and immediately used. 
 
2.5.10. Peptide synthesis 
In this study, peptides used as standards in mass spectrometry (MS) analysis 
(described in 2.5.11.) and for rabbit immunization to produce polyclonal antibodies 
were synthesized by the peptide synthesis facility at the HZI headed by Dr. W. 
Tegge. 
 
Table 5: Peptides synthesized for this study. 
Name Sequence (N – C) Use 
CLIP115Y270 KPPCQFY Reference in MS analysis 
CLIP115Y270P KPPCQFY-phospho Reference in MS analysis 
115 270 QF Y RTGAVAGDNKG Antibody production 
115 phos 270 QF Y(phospho) RTGAVAGDNKG Antibody production 
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2.5.11. Mass spectrometry 
In mass spectrometry (MS) charged peptides are produced from protein samples by 
tryptic cleavage and are separated according to their mass/charge ratio (m/z) 
resulting in a protein-specific fingerprint. The most intense peptides can additionally 
be fragmented and sequenced using MS/MS to analyse peptides in more detail. 
Mass spectrometry was performed in the “Cellular Proteomics” group at the HZI (Dr. 
L. Jänsch, Dr. M. Nimtz, K. Minkhart, R. Munder). 
In this study, MS analysis was employed to identify a potential phosphorylation or 
possible interaction partners of CLIP-115 obtained by immunoprecipitated cell 
lysates. An additional phosphate residue would cause a characteristic shift of 
79.9663 Da (molecular mass of HPO3) divided by the peptide charge, whereas co-
precipitated proteins were identified by the peptide composition. Protein samples 
were separated by SDS-PAGE, and Coomassie-stained protein bands of interest 
were cut out the gel. After rinsing the gel pieces in H2Odest, slices were washed with 
0.1 M NH4HCO3 (Promega). To reduce disulfide bonds and to protect cysteines 
against oxidation samples were exposed to carbaminomethylation. Therefore, the gel 
slices were incubated in 20 mM dithiothreitol (DTT) in 0.1 M NH4HCO3 for 30 min at 
56 °C. Next, gel slices were incubated in 50 mM iodacetamide in 0.1 M NH4HCO3 for 
2 h at room temperature followed by an additional washing step with 0.1 M 
NH4HCO3. The supernatant was removed, whereas the gel slices were incubated for 
15 min with 40 % acetonitrile in 0.1 M NH4HCO3 for shrinking. After that, the 
supernatant was removed again and the gel slices incubated for 5 min in 100 % 
acetonitrile. After removing the supernatant the gel slices were dried using a 
SpeedVac RC 1010 (Thermo Electron Corporation). Samples were then ready to be 
used for trypic digestion. To digest the proteins gel slices were incubated in 30 – 60 
µl 20 ng/ml trypsin in 0.1 M NH4HCO3 at 37 °C overnight. Finally, the peptides were 
extracted from the gel slices in three steps. First, the gel slices were incubated in 300 
µl H2Odest followed by the second incubation in 300 µl 1.0 % trifluoroacetic acid (TFA) 
and the third incubation in 300 µl 40 % acetonitrile in 0.1 % TFA. All incubation steps 
were performed at 37 °C for at least 1 h while shaking. The supernatants of all 
extraction steps were pooled and dried in a SpeedVac. Further purification was 
achieved by using ZipTip C18 microcolumns (Millipore) according to the 
manufacture’s manual. 
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Protein samples were separated by HPLC using a nano Acquity Ultra Performance-
LC system (Waters) with a nano Acquity UPLC BEH300 C18 column (1.7 µm, 75 µm 
x 250 mm, Waters). Subsequently, MS analysis was either performed using a Q-TOF 
micro (Waters) or a LTQ Orbitrap XL (Thermo Fisher). Data gathered by the Q-TOF 
system was analysed using a MASCOT server (version 1.9, Matrix Science) and 
MassLynx 4.1 software (Waters Laboratory Informatics). Data obtained from the 
Orbitrap system was processed using the Xcalibur software (Thermo Scientific). 
 
2.6. Immunological methods 
 
2.6.1. Antibodies 
In Table 6 all commercially available and newly generated primary antibodies used in 
this study are listed. All secondary antibodies used in this study are listed in Table 7. 
 
Table 6: Primary antibodies used in this study. 
Antigen Name Type* Use (dil./conc.)** Source 
Actin A2066 rabbit (pc) WB (1:5000) Sigma-Aldrich 
Actin A5060 rabbit (pc) WB (1:10000) Sigma-Aldrich 
CLASP2 #2358 rabbit (pc) IF (1:300), WB (1:2000) Akhmanova et.al., 2001 
CLIP-115 #2238 rabbit (pc) IF (1:250), WB (1:2000) Hoogenraad et.al., 2000 
CLIP-115 #2163 rabbit (mc) IF (1.9 – 7.6 µg/ml), 
IP (7.6 µg/ml), 
WB (0.38 µg/ml) 
HZI 
CLIP-115 97E11D11 rat (mc) IF (supernatant, 1:2) HZI 
CLIP-115 (pY270)  rabbit (pc) WB (1 µg/ml) BioGenes GmbH 
CLIP-115 (Y270)  rabbit (pc) WB (1 µg/ml) BioGenes GmbH 
CLIP-170 #2360 rabbit (pc) IF (1:250), WB (1:2000) Coquelle et.al., 2002 
EB1 11B11 rat (mc) IF (1:500) Absea 
EB1 clone 5 mouse (mc) IF (1:500), WB (1:2500) BD Biosciences 
EBpan 15H11 rat (mc) IF (1:500) Absea 
FAK pY397 44-624G rabbit (mc) IF (1:100) SySy 
GFP 101G4B2 mouse (mc) IF (6 µg/ml), 
WB (supernatant) 
HZI 
GFP 270F3 mouse (mc) IF (1:500) SySy 
GFP 27F5 mouse (mc) IF (4.44 µg/ml) HZI 
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GFP H5-8 rabbit (pc) IF (1:100), WB (1:1000) HZI 
GFP MAB3580 mouse (mc) IF (1:500) Millipore 
Golgi golgin 97 mouse (mc) IF (1:1000) Santa Cruz Biotech. 
IQGAP1 sc-10792 rabbit (pc) IF (1:100) BD Biosciences 
p150Glued 610474 mouse (mc) IF (1:200) BD Biosciences 
phospho-Serine P3430 mouse (mc) WB (1:500) Sigma-Aldrich 
phospho-
Threonine 
71-8200 rabbit (pc) WB (1:1000) Zymed 
phospho-
Threonine 
P3555 mouse (mc) WB (1:100) Sigma-Aldrich 
phospho-
Tyrosine 
pY99 mouse (mc) IF (1:100), WB (1:1000) Santa Cruz Biotech. 
Tubulin (acetyl.) 6-11B-1 mouse (mc) IF (1:200) Sigma-Aldrich 
Tubulin (α) α3A2 mouse (mc) IF + WB (1:50000) Biotem, France 
Tubulin (β) T4026 mouse (mc) IF (1:300), WB (1:2000) Sigma-Aldrich 
Tubulin (β) 2.3B11 mouse (mc) IF + WB (1:20000) Biotem, France 
Tubulin (γ) GTU-88 mouse (mc) IF (1:250) Sigma-Aldrich 
Tubulin (Δ2-Glu) L4, L7 rabbit (pc) IF (1:1000), WB (1:5000) Paturle-Lafanechère 
et.al., 1994 
Tubulin (Glu) 1D5 mouse (mc) IF + WB (supernatant) Wehland & Weber, 
1987 
Tubulin (Tyr) 20C6 mouse (mc) IF (2 µg/ml, supernatant), 
MI (0.25 – 0.5 mg/ml), 
WB (supernatant) 
Wehland & Weber, 
1987 
Tubulin (Tyr) YL1/2 rat (mc) IF (2.9 µg/ml, 
supernatant), 
MI (0.5 – 4.6 mg/ml), 
WB (supernatant) 
Kilmartin et al., 1982; 
Wehland et.al., 1983 
TTL 1D3 mouse (mc) IF (2.4 µg/ml) Wehland & Weber, 
1987 
*mc = monoclonal, pc = polyclonal 
**IF = immunofluorescence, IP = immunoprecipitation, MI = microinjection, WB = Western blot, 
dil. = dilution, conc. = concentration 
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Table 7: Secondary antibodies used in this study. 
Name Antigen* Tag Use (dilution)** Source 
A1a mouse IgG (H + L) Fluorescein IF (1:100) Dianova 
A2b mouse IgG, F(ab’)2 Rhodamin IF (1:100) Dianova 
A2e mouse IgG, Fc Rhodamin IF (1:100) Dianova 
A4a mouse IgG + IgM (H + L) Peroxidase WB (1:2000) Dianova 
A7a mouse IgG + IgM (H + L) Cy3 IF (1:2000) Dianova 
A9a mouse IgG + IgM (H + L) Cy2 IF (1:100) Dianova 
A12c mouse IgG (H + L) Alexa Fluor 488 IF (1:400), MI (1:4) Invitrogen 
A13c mouse IgG (H + L) Alexa Fluor 594 IF (1:200) Invitrogen 
A16c mouse IgG (H + L) Alexa Fluor 350 IF (1:100) Invitrogen 
B1c rabbit IgG (H + L) Fluorescein IF (1:100) Dianova 
B4c rabbit IgG (H + L) Peroxidase WB (1:2000 – 1:5000) Dianova 
B7c rabbit IgG (H + L) Cy3 IF (1:500) Dianova 
B9c rabbit IgG (H + L) Cy2 IF (1:100) Dianova 
B12c rabbit IgG (H + L) Alexa Fluor 488 IF (1:200 – 1:400), 
MI (1:4) 
Invitrogen 
B13c rabbit IgG (H + L) Alexa Fluor 594 IF (1:400 – 1:500) Invitrogen 
C4a rat IgG + IgM (H + L) Peroxidase WB (1:2000) Dianova 
C4c rat IgG + IgM (H + L) Peroxidase WB (1:2000) Dianova 
C7c rat IgG (H + L) Cy3 IF (1:2000) Dianova 
C12c rat IgG (H + L) Alexa Fluor 488 IF (1:400) Invitrogen 
C13c rat IgG (H + L) Alexa Fluor 594 IF (1:200) Invitrogen 
C16c rat IgG (H + L) Alexa Fluor 350 IF (1:100) Invitrogen 
D12c human IgG (H + L) Alexa Fluor 488 MI (1:4) Invitrogen 
*H = heavy chain, L = light chain 
**IF = immunofluorescence, IP = immunoprecipitation, MI = microinjection, WB = Western blot 
 
2.6.2. Immunoprecipitation 
In this study, immunoprecipitation was used to isolate CLIP-115, and possible 
interaction partners, from total cell lysates for subsequent mass spectrometry 
analyses. Therefore, cells were washed twice with ice-cold PBS and harvested by 
scratching in PBS. After centrifugation for 5 min at 1000 rpm and 4 °C the 
supernatant was removed and the cell pellet lysed on ice in 0.5 – 1 ml of IP lysis 
buffer containing 50 µM sodium vanadate that inhibits tyrosine phosphatases. 
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Lysates were then centrifuged for 10 min at 10000 rpm and 4 °C and supernatants 
transferred to new tubes. Pellets were frozen and stored at -70 °C. 
Protein G-coupled sepharose (Amersham Bioscience) was prepared by three times 
washing with IP wash buffer. Then, 100 µl of 50 % protein G sepharose slurry was 
added to 500 µl cell lysates and incubated at 4 °C under rotation for 30 – 60 min. The 
mixture was centrifuged at 2000 rpm and 4 °C for 1 min, and the pre-cleared 
supernatant was transferred to a new tube. Next, the antibody #2163 against CLIP-
115 was added in a concentration of 7.6 µg/ml followed by incubating for 1 h at 4 °C 
under rotation for protein binding. Then, 100 µl protein G-coupled sepharose was 
added followed by 1 h of rotation at 4 °C. After centrifugation at 2000 rpm and 4 °C 
for 30 s the supernatant was transferred to a new tube and stored at -70 °C for 
further analysis. The sepharose beads, containing the bound CLIP-115, were 
washed four times with 500 µl IP wash buffer. Finally, the beads were transferred to a 
new tube and washed with 500 µl IP wash buffer containing 50 µM sodium vanadate 
to inhibit phosphatases. The beads were resuspended in 8x SDS sample buffer 
followed by boiling at 99 °C for 10 min. After centrifugation, the supernatant was 
loaded on an SDS gel followed by Western blot analysis or mass spectrometry. 
 
IP lysis buffer, pH 7.5: 
20 mM Tris base 
100 mM NaCl 
0.5 % Triton X100 
1 tablet protease inhibitor cocktail, complete, EDTA-free (Roche) in 10 ml 
 
IP wash buffer, pH 7.5: 
20 mM Tris base 
100 mM NaCl 
0.05 % Triton X100 
1 tablet protease inhibitor cocktail, complete, EDTA-free (Roche) in 10 ml 
 
2.6.3. ELISA 
To investigate the specificity of newly generated antibodies against non-
phosphorylated or tyrosine 270-phosphorylated CLIP-115 the Enzyme-linked 
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Immunosorbent Assay (ELISA) was used. Synthetic CLIP-115 peptides (see Tab. 4) 
were immobilized on MaxiSorp 96-well plates (Nunc) and antibody-binding capacity 
quantified using peroxidase-coupled secondary antibodies. 
For immobilization 1 ng peptide per 50 µl PBS was loaded in each well of a 96-well 
plate and incubated overnight at 4 °C. To block unspecific binding sites 200 µl 
blocking solution was added to each well. After incubating at room temperature for 30 
min wells were washed three times with PBS. Next, 200 µl of 1 µg/ml antibody in 
blocking solution was added to each well and incubated for 1 h at room temperature. 
Wells were washed three times with PBS and incubated at room temperature for 1 
hour with 200 µl secondary antibody (B4c) diluted 1:2000 in blocking solution. After 
again three washing steps with PBS, 200 µl of ortho-phenyldiamine solution was 
added to the wells as a substrate for peroxidase. Next, reactions were stopped by 
adding 50 µl 3.5 M H2SO4 to the wells and the OD492 was measured with an ELISA-
reader (Tecan). 
 
Blocking solution: 
10 % FCS in PBS 
 
Ortho-phenyldiamine solution: 
5 ml 0.1 M Citric acid 
5 ml 0.2 M Na2HPO4 
10 ml H2Odeion 
8 mg ortho-phenyldiamine (Sigma) 
8 µl 30 % H2O2 
 
2.6.4. Immunofluorescence 
For immunoflourescent stainings cells were grown on untreated glass coverslips. 
Prior to staining cells were fixed using the following protocol. Cells were washed 
twice with PBS and then fixed in pre-cooled methanol containing 1 mM EGTA for 10 
min at -20 °C. After removing the methanol, the following steps were performed at 
room temperature. For further fixation cells were incubated with 4 % 
paraformaldehyde (PFA) in PBS for 20 min, washed twice with PBS and 
permeabilized with 0.15 % Triton X-100 in PBS for 5 min. Then, cells were incubated 
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with blocking solution for a minimum of 45 min. Depending on the employed primary 
antibodies or when phalloidin was used for actin staining, the fixation step with 
methanol was left out. Cells were incubated with the primary antibody diluted in 
blocking solution for 1 h. Coverslips were twice washed with blocking solution for 5 
min and incubated with the secondary antibody in blocking solution for an additional 
hour. Antibody incubations were performed either in 24-well plates or in a humid 
chamber on parafilm. After incubation with the secondary antibody, coverslips were 
twice washed with blocking solution for 5 min followed by washing steps with 70 % 
ethanol (2 min) and pure ethanol (1 min). Finally, coverslips were air-dried and 
embedded in a drop of pre-warmed mounting medium on microscope glass slides 
(SuperFrost). Embedded samples were stored over night at room temperature in the 
dark and then transferred to 4 °C for long-time storage. 
The employed phalloidin was either coupled to Alexa Fluor 488 (green) or Alexa 
Fluor 594 (red; both from Invitrogen) and diluted 1:200 in blocking solution. 
 
Blocking solution: 
1 % BSA 
0.05 % Tween 20 
in PBS 
 
Mounting medium: 
2.4 g Mowiol 
6 g Glycerol (87 %) 
6 ml H2Odeion 
→ Stir over night at room temperature 
0.2 ml 200 mM Tris base-HCl, pH 8.5 
→ Warm up to 60 °C for 10 min followed by centrifugation at 17000 xg for 30 min 
 
900 µl of mounting medium + 100 µl anti-bleach solution (25 mg/ml n-propylgalate in 
87 % glycerol) 
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2.7. Cell biological methods 
 
2.7.1. Cell lines 
All cell lines used in this study are listed in Table 8. To obtain mouse embryonic 
fibroblasts (MEFs), TTL+/- mice (Erck et.al., 2005) were crossed and fibroblasts were 
isolated as described in 2.7.3. 
  
Table 8: Cell lines used in this study. 
Name Description Source 
CLIP-115 knockout primary mouse embryonic fibroblast, CLIP-115-/- Hoogenraad et.al., 2002 
CLIP double 
knockout 
primary mouse embryonic fibroblast, 
CLIP-115-/-, CLIP-170-/- 
Schober et.al., 2007 
MEF01 primary mouse embryonic fibroblast, TTL+/- this study 
MEF02 primary mouse embryonic fibroblast, WT this study 
MEF03 primary mouse embryonic fibroblast, TTL-/- this study 
MEF04 primary mouse embryonic fibroblast, TTL+/- this study 
MEF05 primary mouse embryonic fibroblast, TTL+/- this study 
MEF06 primary mouse embryonic fibroblast, WT this study 
MEF07 primary mouse embryonic fibroblast, TTL+/- this study 
MEF08 primary mouse embryonic fibroblast, TTL-/- this study 
MEF09 primary mouse embryonic fibroblast, WT this study 
MEF21 primary mouse embryonic fibroblast, TTL-/- this study 
MEF22 primary mouse embryonic fibroblast, TTL-/- this study 
MEF33 primary mouse embryonic fibroblast, TTL-/- this study 
MEF34 primary mouse embryonic fibroblast, WT this study 
MEF59 primary mouse embryonic fibroblast, TTL-/- this study 
MEF67 primary mouse embryonic fibroblast, WT this study 
MEF68 primary mouse embryonic fibroblast, WT this study 
MEF69 primary mouse embryonic fibroblast, TTL-/- this study 
MEF91 primary mouse embryonic fibroblast, TTL-/- this study 
MEF92 primary mouse embryonic fibroblast, WT this study 
MEF103 primary mouse embryonic fibroblast, TTL-/- this study 
MEF107 primary mouse embryonic fibroblast, WT this study 
MEF110 primary mouse embryonic fibroblast, WT this study 
MEF111 primary mouse embryonic fibroblast, TTL-/- this study 
MEF132 primary mouse embryonic fibroblast, WT this study 
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MEF133 primary mouse embryonic fibroblast, TTL-/- this study 
MEF136 primary mouse embryonic fibroblast, TTL-/- this study 
MEF137 primary mouse embryonic fibroblast, TTL-/- this study 
MEF143 primary mouse embryonic fibroblast, WT this study 
NIH 3T3 immortalized murine fibroblast cell line ATCC CRL-1658 
PtK2 Potorous tridactylis (kangaroo rat) kidney cells ATCC CCL-56 
TTL knockout (Ι) TTL-/- MEF immortalized by SV40 large T 
antigen, temperature-dependent (mitosis at 32 °C) 
C. Erck 
TTL knockout (ΙΙ) TTL-/- MEF immortalized by SV40 largeT antigen, 
mitosis depends on availability of doxycycline 
(2 µg/ml) 
C. Erck 
 
 
2.7.2. Cell culture 
All cell lines were grown at 37 °C and 7.5 % CO2 (incubator from Labotect). In 
contrast, immortalized TTL knockout (Ι) cells were grown at 32 °C. All media used for 
cell culturing were prepared in a clean bench (SterilGARD ΙΙΙ Advance from 
Labotect) and stored at 4 °C. Before usage solutions were pre-warmed to 37 °C in a 
water bath (Grant Instruments). To transfer cells to a new culture dish, cells were 
washed with sterile PBS, detached from the dish by an incubation at 37 °C for 5 min 
in 0.25 % Trypsin/1 mM EDTA and finally diluted by adding fresh medium. 
 
Medium for MEFs: 
45 % DMEM (Dulbecco’s Modified Eagle Medium) high glucose (4.5 g/l) 
45 % F10 (Nutrient Mixture, Ham) 
10 % (v/v) FCS lot 047K3395 from Sigma 
2 mM Glutamine 
50 U/ml Penicillin/Streptomycin 
 
Medium for NIH3T3, PtK2 and immortalized TTL knockout cells: 
DMEM (Dulbecco’s Modified Eagle Medium) low glucose (1 g/l) 
10 % (v/v) FCS lot 101K3361 from Sigma 
2 mM Glutamine 
50 U/ml Penicillin/Streptomycin 
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Doxycycline was added to the medium in a final concentration of 2 µg/ml when TTL 
knockout (ΙΙ) cells were cultured. 
 
2.7.3. Isolation of mouse embryonic fibroblasts 
To isolate primary mouse embryonic fibroblasts (MEFs) 13 day old embryos were 
used. First, the head and all red organs were removed and the tail was kept for 
genotyping (see chapters 2.4.3. and 2.4.5.). The remaining parts were transferred to 
0.5 ml 0.25 % Trypsin/1 mM EDTA and cut in small pieces. After 30 min of incubation 
at 37 °C, 0.5 ml growth medium was added and aggregates solved by pipetting up 
and down. Then, cells were transferred to 10 cm plastic dishes that contained 9 ml 
growth medium. During the first few passages fibroblasts do overgrow other cell 
types. 
 
2.7.4. Treatments 
To reduce cell activity, cells were grown in FCS-free medium for two days, whereas 
TTL knockout (ΙΙ) cells were cultured without doxycycline. If necessary, cells were re-
activated by transfer to FCS- or doxycycline-containing medium, respectively. Cell 
starvation was used before wound-healing assays, immunofluorescence or Western 
blot analysis. More specific treatments are described below. 
 
2.7.4.1. Reduction of tyrosinated tubulin levels 
In this study, the effects of the absence of tyrosinated tubulin is examined. Since TTL 
knockout cells still contain tyrosinated tubulin due to ongoing tubulin synthesis, 
different treatments were tested to generate cells that are free of tyrosinated tubulin. 
Cycloheximide: 
To inhibit protein synthesis by blocking the translocation reaction on the ribosomes 
during translation, 0.25 mM cycloheximide was added to the growth medium (Slee 
et.al., 1996). A 0.25 M stock solution was prepared in ethanol. Incubation times 
varied from 3 – 25 h. After that, cells were either fixed for immunofluorescence or 
lysed for Western blot analysis. 
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Forskolin: 
To increase carboxypeptidase activity, cells were treated with 10 µM forskolin (10 
mM stock solution in ethanol) for 8 – 24 h (Wehland & Weber, 1987b). After the 
treatment, cells were washed and fixed for immunofluorescent staining. 
Mitomycin C: 
For blocking the cell cycle, the DNA cross-linker mitomycin C was added to the 
growth medium in a concentration of 10 µg/ml (Celis, 1998). After 3 h, cells were 
washed three times with sterile PBS and kept in culture or lysed in 4x SDS sample 
buffer (see 2.5.6.) for Western blot analysis. 
Nocodazole: 
To reversibly block the cell cycle by depolymerization of microtubules, cells were 
treated with 0.4 µg/ml nocodazole for 2 – 24 h (Wehland & Weber, 1987b). After 
treatment cells were washed and used for immunofluorescence staining. The stock 
solution was prepared in DMSO with a concentration of 0.4 mg/ml nocodazole. 
Taxol®: 
Paclitaxel (Taxol®, 10 mM stock solution in DMSO) was used to block mitosis by 
stabilizing microtubules. Cells were grown in a concentration of 10 µM for 6 – 24 h 
(Wehland & Weber, 1987b), washed and fixed or kept in culture for further 
experiments. 
Thymidine: 
High concentrations of thymidine inhibit DNA synthesis by the reduction of the 
nucleotide precursor pool of dCTP. As cells are only affected when they are in S-
phase, thymidine treatment can be used to synchronize cell populations (Celis, 
1998). 
Thymidine was added in a concentration of 2 mM to the medium for 24 h to stop the 
cell cycle. For a complete synchronization of the cells, a double thymidine block was 
performed. Therefore, cells were kept in medium containing 2 mM thymidine for 17 h. 
After two times washing with FCS-free medium 2 µM dCytidine was added for 9 h 
followed by another washing and 16 h incubation with 2 mM thymidine again. Finally, 
cells were washed and fixed for immunofluorescence or lysed for Western blotting. 
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2.7.4.2. Inhibition of protein kinases and phosphatases 
To test if the observed phosphorylation-caused mass shift of CLIP-115 between wild 
type and TTL-/- MEFs is caused by a serine/threonine or tyrosine phosphorylation, 
cells were treated with different kinase and phosphatase inhibitors. Cells were 
washed with PBS and lysed in 2x destroyer buffer for Western blot analyses after the 
treatments. Control cells were treated with DMSO instead of an inhibitor. 
Staurosporine: 
To inhibit the activity of a broad range of protein kinases, cells were incubated with 
0.5 µM staurosporine for 1 – 3 h (0.5 mM stock solution in DMSO, Bijur et.al., 2000). 
Genistein: 
For the inhibition of tyrosine kinases, 100 µM genistein was added (100 mM stock 
solution in DMSO, Elliot et.al., 2001) to the growth medium followed by an incubation 
of 1 – 3 h. 
Calyculin A: 
The activity of serine/threonine-phosphatases (type PP1) was inhibited in cells by 
incubation with 5 nM calyculin A for 20 min (stock solution of 5 µM in DMSO).  
Okadaic acid: 
Cells were treated with 25 nM okadaic acid (2 µM stock solution in DMSO) for 20 min 
to inhibit serine/threonin-phosphatase (type PP2) activity. 
Vanadate: 
To specifically inhibit tyrosine phosphatases, cells can be treated with ortho-sodium 
vanadate (Na3VO4). For that, 10 µl 100 mM Na3VO4 was mixed with 87 µl H2Odeion 
and 3 µl 30 % H2O2 and incubated for 10 min at room temperature. Then, Na3VO4 
was added to the growth medium at a final concentration of 100 µM and cells were 
incubated for 10 – 120 min. 
 
2.7.5. Transfection 
To test the transfection efficiency of cells, MEFs were transfected with the following 
transfection reagents FuGENE® 6 (Roche), Lipofectamine™ 2000 (Invitrogen), 
METAFECTENE™ (Biontex), SuperFect (Qiagen) and ICAFectin™ 441 (Eurogentec) 
as described by the manufacturers. Since FuGENE® 6 yielded the best transfection 
efficiency and was used in further experiments, the procedure is briefly described 
here. Cells were seeded 24 h before transfection. For the transfection of cells in 3.5 
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cm dishes, 2 µg of DNA was mixed with 6 µl of FuGENE® 6 in OPTI-MEM growth 
medium followed by 30 min incubation at room temperature before adding the 
mixture to the cells. The recipe was doubled for transfecting cells grown in 6 cm 
dishes and expanded to 10 µg of DNA and 30 µl of FuGENE® 6 when cells were 
grown in 10 cm dishes. Cells were fixed for immunofluorescence or lysed for Western 
blotting 16 – 48 h after transfection. 
 
2.7.6. Wound-healing assay 
To observe cell polarization and migration after reducing levels of tyrosinated tubulin, 
cells were grown on glass coverslips until confluency followed by starvation for 2 d. A 
wound was introduced by scratching with a pipette tip followed by re-activating the 
cells by adding FCS-containing medium to the cells 20 min after wounding 
(Gundersen et al., 1994). Cells were fixed at different time points after wounding and 
analysed by immunofluorescence. 
 
2.7.7. Cell lysis 
To lyse cells for Western blot analysis, SDS-containing destroyer buffer was used. 
Therefore, cells were washed twice with PBS and harvested by scratching in 100 µl 
2x destroyer buffer containing protease inhibitor cocktail (Roche). Next, lysates were 
boiled for 10 min at 99 °C and stored at -20 °C for later analysis. 
Basic IP buffer was employed in cell lysis when lysates were subsequently used for 
enzyme-treatments (2.7.8.). In that case, cells were washed twice with PBS and 
scratched in 200 µl basic IP buffer containing protease inhibitor cocktail (Roche). For 
further lysis cells were kept on ice for 15 – 30 min followed by the enzyme treatment. 
 
Destroyer buffer, pH 7.5: 
25 mM Tris base 
1 mM EDTA 
1 mM EGTA 
1 % (v/v) SDS 
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Basic IP buffer: 
15 mM KCl 
50 mM NaCl 
8 mM Tris base 
12 mM Hepes free base 
3 mM MgCl2 
Before use addition of 
1 tablet protease inhibitor cocktail, complete, EDTA-free (Roche) in 10 ml 
1 % (v/v) Triton X100 
 
2.7.8. SAP-treatment of cell lysates 
To test if the observed difference of the molecular weight of CLIP-115 in wild type 
and TTL-/- MEFs was caused by phosphorylation, MEF lysates were treated with 
shrimp alkaline phosphatase (SAP; Roche). Total cell lysates (see 2.7.7.) were mixed 
with 20 U SAP. Dephosphorylation was started by transferring the mixtures to 37 °C. 
After 1 h incubation, samples were stored for further analysis at -20 °C. 
 
2.7.9. Subcloning 
To isolate a clone of the mouse antibody 1D5 against detyrosinated tubulin that 
shows a strong staining in immunofluorescence five stored hybridoma clones were 
thawed and subcloned. Therefore, the non-adherent hybridoma cells were 
transferred to tubes containing 9 ml of growth medium and centrifuged for 5 min at 
1000 rpm. The supernatant was removed, the cell pellet re-suspended in 2 ml of 
medium and cells grown at 37 °C in 6-well plates overnight. Cells were then 
transferred to 10 cm dishes (Corning, untreated) containing 10 ml of medium. After 
three days, 1 ml culture supernatant of each well was centrifuged and tested in 
immunofluorescence on PtK2 cells as described in 2.6.4. Cells of the 1D5 clone with 
the strongest staining were diluted 1:6 in medium and grown for another three days. 
Then, cells were counted in a Neubauer chamber and seeded in 96-well plates in 
concentrations of 50 cells/well, 10 cells/well, 2.5 cells/well (32 wells per 
concentration), 0.5 cells/well, and 0.25 cells/well (48 wells per concentration). After 
two weeks, the supernatant of each well containing a single clone was tested in 
immunofluorescence on PtK2 and TTL knockout cells. Again, clones that showed a 
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strong specific staining were transferred to 6-well plates, grown in 3 ml of medium, 
and fed with another 3 ml after three days. Since different cell lines contain different 
levels of detyrosinated tubulin, PtK2, TTL knockout and NIH 3T3 cells were used to 
gain more detailed information of the tested subclones. The clone, which gave the 
strongest and most specific staining, was expanded. After the addition of 0.02 % 
sodium azide, the supernatant was stored at 4 °C. Additionally, cells were frozen for 
later use. 
 
Growth medium: 
OPTI-MEM Ι from Gibco 
5 % (v/v) FCS lot 101K3361 from Sigma 
2 mM Glutamine 
50 U/ml Penicillin/Streptomycin 
 
2.7.10. Epifluorescence Microscopy 
Immunostained cells were analysed using an inverted microscope (Axiovert S100 TV 
or Axiovert 135 TV, both from Zeiss), which was equipped for epifluorescence and 
phase contrast microscopy. In general, a 63x/NA 1.4 plan-apochromatic objective 
(Zeiss) in combination with immersion oil (Immersol™ 518F, Zeiss) was employed. 
For epifluorescence, the microscopes were connected to a mercury lamp (HBO 
100W/2 from Osram, later changeover to HXP 120 from Kübler). Images were 
acquired with a back-illuminated, cooled charge-coupled-device (CCD) camera, 
either driven by IPLab software from Scanalytics Inc. (camera: TE-CCD 800PB, 
Princeton Scientific Instruments) or by MetaMorph® software from Molecular Devices 
(camera: Cool Snap HQ2, Visitron Systems). Images were then processed using 
Adobe Photoshop 7.0. Microtubule plus-end lengths were measured in ImageJ 1.42 
(http://rsbweb.nih.gov/ij/download.html) with a scale of 9.800 pixels/µm. Data was 
further processed in Microsoft Excel 2000, and statistic analyses were performed 
using Minitab software. 
 
2.7.11. Microinjection 
Cells for microinjection were seeded on 12 mm glass coverslips and kept in the 
plastic dish at room temperature during the injection procedure. To control the flow 
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through the injection needle under UV light and to identify injected cells after fixation, 
the antibodies for microinjection were mixed with an Alexa Fluor 488-coupled 
antibody that was chosen to avoid cross-reactions. The antibody mix was centrifuged 
at 13000 rpm and 4 °C for a minimum of 10 min to remove aggregates that could 
clog the needle. Microinjections were performed using sterile capillaries (Femtotips Ι, 
Eppendorf), which were loaded from the backside with the antibody solution using a 
flexible pipette tip. To guarantee an undisturbed flow-through it was important to 
avoid air bubbles. The needle was transferred to an injection unit (Narishige, Nikon) 
connected to a Transjector 5246 (Eppendorf) that served as a pressure supply. The 
transjector provided a constant pressure up to 100 hPa. Microinjection was 
performed manually. The employed microscope (Axiovert S100 TV, Zeiss) was 
equipped with a 20x or 40x/LD Achroplan objective depending on the cell size. Cells 
were fixed 2 – 4 h after injection and analysed by immunofluorescence (see 2.6.4.). 
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3. Results 
 
 
In this study, the physiological role of the α-tubulin tyrosination cycle was 
investigated by using fibroblasts that lack tubulin-tyrosine ligase (TTL). As reported 
previously, mitotic TTL knockout cells still contain tyrosinated (Tyr-) tubulin (Erck et 
al., 2005). Therefore, chemical treatments were employed to reduce Tyr-tubulin 
levels enabling the analysis of cellular processes in the absence of Tyr-tubulin. 
Furthermore, microinjection of antibodies that block the remaining C-terminal tyrosine 
residues of α-tubulin was performed as alternative approach to obtain cells without 
any functional Tyr-tubulin. In wound-healing assays the impact of reduced Tyr-tubulin 
amounts on cell polarization and migration was investigated. 
As it was not possible to generate viable cells that completely lack Tyr-tubulin, freshly 
isolated TTL knockout mouse embryonic fibroblasts (MEFs) were used to 
characterize different tubulin pools. In a population of TTL knockout MEFs both Tyr-
positive and Tyr-negative cells were present, which were separately analysed. 
Although it has been reported that the subcellular localisation of microtubule plus-end 
tracking proteins (+TIPs) is affected by TTL deficiency (Erck et al., 2005; Peris et al., 
2006), the mechanism of microtubule binding of +TIPs and its regulation is still 
unknown. Therefore, the localisation and biochemical properties of several +TIPs 
were investigated in this study. 
One of the analysed +TIPs, namely CLIP-115, showed differences in its localisation 
towards microtubules in wild type and Tyr-negative TTL knockout MEFs. Additionally, 
CLIP-115 appeared at a different molecular weight in the presence and absence of 
TTL. Since inhibitor treatments pointed to differential tyrosine phosphorylation of 
CLIP-115 in wild type and TTL-deficient MEFs, site-directed mutagenesis 
experiments were performed to identify potential phosphorylation sites. Subsequent 
mass spectrometry analysis of CLIP-115 was employed to validate the results 
obtained by the mutagenesis experiments and to identify putative additional 
phosphorylation sites that may reveal new aspects in the plus-end tracking 
mechanism of CLIP-115. 
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3.1. Depletion of tyrosinated tubulin in TTL knockout cells 
Fibroblasts that lack the tubulin-tyrosine ligase still contain residual amounts of 
tyrosinated tubulin. This pool most probably results from ongoing protein 
biosynthesis. However, to investigate the effects of TTL deficiency on processes like 
cell migration and cell polarity, and on the intracellular distribution of microtubule-
associated proteins, the aim was to obtain cells that were completely free of 
tyrosinated tubulin. For this purpose, different chemical treatments in cell culture 
were performed to inhibit transcription and/or translation. In addition, microinjection of 
antibodies was used to specifically block the extreme C-terminal tail of α-tubulin. 
 
3.1.1. Chemical treatments 
To interrupt transcription by cross-linking the DNA and thereby stop the production of 
Tyr-tubulin, immortalized TTL knockout (Ι) cells that only divide at 32 °C (see Tab. 8 
in chapter 2.7.1.) were treated with mitomycin C. Cells were then tested for the 
presence of tyrosinated (Tyr-), detyrosinated (Glu-) and Δ2-Glu-tubulin by 
immunofluorescence. Mitomycin-treated cells were also kept in culture for a total 
duration of 10 days after treatment. Although the cells showed high amounts of Glu- 
and Δ2-Glu-tubulin, microtubules were still labelled by antibodies against Tyr-tubulin 
(not shown). In addition, translation was inhibited by cycloheximide, which blocks the 
translocation reaction on eukaryotic ribosomes. Therefore, cells were incubated with 
cycloheximide alone or subsequent to the mitomycin C treatment for different time 
intervals. During treatments, the temperature-sensitive cells were transferred to 37 
°C to additionally inhibit mitosis. Western blot analysis using YL1/2 antibody revealed 
a strong reduction of Tyr-tubulin after cycloheximide treatment, whereas treatments 
with mitomycin C alone or followed by a cycloheximide treatment did not efficiently 
decrease the Tyr-tubulin levels (not shown). However, the cell viability was severely 
impaired by treatments with cycloheximide. 
Furthermore, thymidine, nocodazole, taxol and forskolin were alternatively applied to 
the cells (as described in chapter 2.7.4.). Thymidine and nocodazole were both 
employed to inhibit mitosis and additionally combined with a cycloheximide treatment 
of 16 h. Thymidine reduces the nucleotide precursor pool of dCTP and by that blocks 
DNA synthesis. Hence, a doublefold thymidine block was performed to synchronize 
and arrest the cells in mitosis. In addition to the treatment with thymidine, the 
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cytotoxin nocodazole was applied in order to block the cell cycle by its 
depolymerizing effect on microtubules. Both the thymidine treatment as well as the 
depolymerization of microtubules by nocodazole only reduced Tyr-tubulin levels in 
combination with cycloheximide (not shown). Again, all studied cells were in poor 
condition after treatments. Another approach to inhibit mitosis was the application of 
the microtubule-stabilizing drug taxol. Taxol was also used in conjunction with 
forskolin, which activates carboxypeptidases (Wehland & Weber, 1987b) and, thus, 
should further decrease Tyr-tubulin levels in TTL knockout cells. Moreover, cells 
were subsequently treated with cycloheximide. However, none of these treatments 
turned out to be effective to lower Tyr-tubulin amounts (not shown). 
Additionally, another immortalized TTL knockout cell line (TTL knockout (ΙΙ), see Tab. 
8 in chapter 2.7.1.) was used. TTL knockout (ΙΙ) cells only divide in medium 
containing 2 µg/ml doxycycline. All treatments were performed as described above. 
In summary, the treatments failed in an efficient reduction of Tyr-tubulin levels (not 
shown). Interestingly, TTL knockout (ΙΙ) cells reacted more sensitive to the 
treatments than the temperature-sensitive TTL knockout (Ι) cells. As many of the TTL 
knockout (ΙΙ) cells died after the mentioned treatments, it was also tested whether 
starvation already reduces Tyr-tubulin levels. Therefore, cells were cultivated for two 
days without FCS and doxycycline before analysing the Tyr-tubulin levels in 
immunofluorescence and Western blotting. The withdrawal of either FCS or 
doxycycline itself did not evoke any obvious reduction in Tyr-tubulin, whereas 
culturing without both additives resulted in lower Tyr-tubulin levels. However, again 
many cells did not survive starvation. Results of all chemical treatments are 
summarized in Table 9.  
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Table 9: Chemical treatments of immortalized TTL knockout cells to reduce Tyr-tubulin levels. 
Treatment Reduction of Tyr-tubulin in 
 TTL knockout (Ι) cells TTL knockout (ΙΙ) cells 
Cycloheximide (CHX) ++ - 
Forskolin - - 
Forskolin + Taxol - - 
Forskolin + Taxol + CHX - - 
Mitomycin C - - 
Mitomycin C + CHX - - 
Nocodazole - - 
Nocodazole + CHX + + 
Starvation: 
- Doxycycline 
- FCS 
- FCS   - Doxycycline 
n. d. - 
- - 
n. d. + 
Taxol - - 
Thymidine - - 
Thymidine + CHX + + 
++ Strong reduction of Tyr-tubulin level 
+ Moderate reduction of Tyr-tubulin levels 
- No reduction of Tyr-tubulin levels 
n. p. not determined 
 
3.1.2. Investigation of cell migration and cell polarity 
To reveal a potential effect of the reduced Tyr-tubulin amount on cell polarity, starved 
TTL knockout (ΙΙ) cells were studied in wound-healing assays. In this assay, a 
confluent layer of serum-starved cells is wounded by scratching with a pipette tip. 
After the addition of serum, cells at the wound edge start to polarize by reorientation 
of their microtubule organizing centre (MTOC) in the direction of the wound (green 
area in Fig. 14a). In parallel, stabilized microtubules are formed in the leading edge, 
whereas the cells start to migrate into the wound in order to close it. As the Golgi 
apparatus is closely associated with the MTOC it can be used to visualize cell 
polarity (Palazzo et al., 2001). 
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In this study, TTL knockout (ΙΙ) cells were grown on coverslips until confluency and 
kept in serum- and doxycycline-free medium for two days before a wound was 
introduced into the cell layer. Twenty minutes later, the medium was substituted by 
normal growth medium for cell re-activation as described in chapter 2.7.6. Cells were 
fixed 0, 1, 2, 3 and 4 h after changing the medium and stained with a Golgi-marker to 
visualize cell polarity. One hour after wounding, cells started to orient the Golgi 
towards their leading edge at the cell-free wounding area. After 2 h, all cells at the 
wound edge showed a localisation of the Golgi between nucleus and leading edge. 
Apparently, the induced reduction of Tyr-tubulin in starved TTL knockout (ΙΙ) cells 
had no influence on the ability of cells to polarize (Fig. 14b). Furthermore, the cells 
closed the wound without being hindered in migration (not shown). 
 
a)      b) 
 
 
 
 
 
 
 
 
 
Fig. 14: Wound-healing assay with TTL knockout (ΙΙ) cells after 2 days of starvation. a) Scheme 
to show MTOC reorientation in fibroblasts (from Palazzo et al., 2001). In polarized cells the MTOC is 
localised in the green area facing the wound, whereas an unoriented MTOC would be located in the 
red area. b) Starved TTL knockout (ΙΙ) cells at time point T after wounding and transfer to FCS-
containing medium (the dashed line marks the wound edge). Cell polarity was analysed using the 
Golgi-specific antibody golgin 97. All peripheral cells showed polarization 2 h after wounding. 
 
T = 0 h T = 1 h
T = 2 h T = 3 h
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In summary, the aim was to obtain TTL-deficient fibroblasts without any residual 
tyrosinated tubulin. Unfortunately, all chemical treatments used in this study did only 
result in slightly decreased levels of tyrosinated tubulin and therefore had no obvious 
effects on cellular processes such as cell polarization. 
 
3.1.3. Microinjection of antibodies 
Since, as described above, chemical treatments of TTL-deficient fibroblasts did not 
result in the complete loss of tyrosinated tubulin levels, microinjection of antibodies 
that specifically recognize the α-tubulin C-terminus containing the ultimate tyrosine 
was used to block the remaining tyrosinated tubulin. 
To obtain pure antibodies that could be used for microinjection, the murine antibody 
20C6 was successfully purified from hybridoma supernatants using protein G affinity 
chromatography (see 2.5.2.1.). Since rat antibodies possess a very weak affinity for 
protein A or G, the rat monoclonal antibody YL1/2 was purified from ascites (Biotem, 
France) by ammonium sulfate precipitation and FPLC (see 2.5.2.2.). Both the 
precipitation and the FPLC-mediated purification were successful as observed by 
SDS-PAGE and subsequent Coomassie-staining (not shown). Antibody-containing 
FPLC fractions were pooled and used for microinjection. 
First, different purified YL1/2 antibody concentrations, ranging from 0.5 mg/ml to 3.0 
mg/ml, were tested in manually performed microinjections on immortalized TTL 
knockout (ΙΙ) cells to determine an appropriate antibody concentration. After 
microinjection, cells were kept in culture for an additional 2 – 4 h followed by 
methanol/PFA fixations and analysis by immunofluorescence. Non-injected cells 
showed a normal cellular distribution of tyrosinated microtubules. In contrast, cells 
that were microinjected with 0.5 mg/ml YL1/2 antibody showed the appearance of 
thicker microtubules indicating the presence of microtubule bundles. This effect 
became more prominent with increasing antibody concentrations (not shown) as 
previously described (Wehland et al., 1983). Since antibodies possess two epitope 
binding sites, one on each Fab fragment, they can in principle bind two separate 
microtubules resulting in the observed microtubule bundles. 
To avoid this cross-linking of microtubules by the injected antibody, Fab fragments of 
both 20C6 and YL1/2 antibodies were digested from the respective Fc parts followed 
by purification. For that, a specific papain-mediated digest was performed using the 
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ImmunoPure® Fab Preparation Kit from Pierce (see chapter 2.5.3.). To ensure the 
exclusive presence of Fab fragments, additional purification steps were performed. 
In case of the murine 20C6 antibody, remaining Fc-fragments were depleted from 
purified Fab fractions by a subsequent purification step using protein A. The success 
of the procedure was validated by SDS-PAGE in reducing and non-reducing 
conditions followed by Coomassie-staining. After papain digestion, Fab fragments of a 
molecular weight of about 25 kDa could be detected. In non-reducing conditions, the 
purified Fab fragments gave a clean band at about 40 kDa (not shown). 
Also the generation of YL1/2 Fab fragments was documented by SDS-PAGE in both 
reducing and non-reducing conditions. After papain digest, Fab and Fc fragments 
were visible as a double band at about 25 kDa and a single band at about 28 kDa, 
respectively (not shown). To achieve separation of YL1/2 Fab from Fc fragments, an 
additional purification by FPLC using anion exchange chromatography was 
performed. Fc fragment-depleted fractions of Fab fragments were then pooled, 
concentrated in PBS and employed in microinjection. 
In parallel, commercial purification of Fab fragments of both 20C6 and YL1/2 
antibodies by the Pineda Antibody Service (Berlin) was performed to obtain larger 
amounts of Fab fragments. Unfortunately, SDS-PAGE analysis of the received 
samples revealed that these samples were contaminated and could not be used for 
further analysis. 
Although only little amounts of self-purified Fab fragment were obtained, still a few 
initial experiments could be performed. Freshly isolated wild type and TTL knockout 
primary mouse embryonic fibroblasts were employed (see chapters 2.7.3.). Cells 
were fixed 2 h after microinjection and stained for the microtubule plus-end tracking 
protein CLIP-170 that was reported to be mislocalised in cells lacking Tyr-tubulin 
(Peris et al., 2006). Indeed, about 25 % of microinjected wild type and TTL knockout 
MEFs showed CLIP-170 bound to very few microtubule plus-ends. In non-injected 
MEFs, CLIP-170 normally localised at microtubule plus-ends. However, the 
differences in the localisation of CLIP-170 in wild type and TTL knockout MEFs 
described by Peris and colleagues (2006) could not be confirmed. 
In summary, microinjection of both undigested antibodies as well as isolated Fab 
fragments did not give clear results in our experimental set-up. Since the 
aforementioned experiments did not sufficiently reduce Tyr-tubulin levels in 
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immortalized TTL knockout MEFs, it was decided to focus further studies on a 
detailed characterization of primary TTL knockout mouse embryonic fibroblasts in 
order to gain deeper insight into the impact of TTL deficiency. 
 
3.2. Characterization of tubulin pools in TTL-deficient mouse 
embryonic fibroblasts 
To unravel the physiological meaning of the α-tubulin tyrosination cycle, the lack of 
the tubulin-tyrosine ligase was investigated on cellular level in this study. Besides 
morphological anomalies, Erck et al. (2005) reported a mislocalisation of the 
microtubule plus-end tracking protein CLIP-170 in TTL-/- neurons. To identify 
potential effects of TTL deficiency in another cell type we chose primary mouse 
embryonic fibroblasts (MEF) for our investigations. Compared to neurons, fibroblasts 
are much easier to culture and for that suitable for the experiments of this study. 
By crossing heterozygous TTL+/- mice (Erck et al., 2005) and isolating 13 days old 
embryos MEFs could be established (see chapter 2.7.3.). After confirmation of the 
genotype by PCR (described in chapter 2.4.5.), MEF cell lines were starved for two 
days to enhance potential differences in tubulin pools. Subsequently, wild type, 
TTL+/- and TTL-/- MEFs were analysed by immunofluorescence to show different 
pools of α-tubulin, whereas β-tubulin was used as a control to check microtubule 
integrity. Images were acquired with the same exposure times and settings by IPLab 
software to enable a comparison of the specific tubulin pools in different genotypes. 
Representative images are shown in Figure 15. As expected, the presence of β-
tubulin was independent of the genotype and showed an intact microtubule network. 
Similar intensities of tyrosinated tubulin were only recognizable in wild type and 
TTL+/- MEFs. In TTL-/- MEFs, stainings of Tyr-tubulin exhibited only pale microtubule 
structures. Beside TTL-dependent changes in the amount of Tyr-tubulin, levels of 
detyrosinated tubulin considerably differed between the studied cell lines. Whereas 
the level of Glu-tubulin was low in wild type and heterozygous MEFs, TTL-deficient 
MEFs possessed a highly enriched amount of Glu-tubulin. Moreover, TTL-/- MEFs 
were the only cells containing Δ2-Glu-tubulin. 
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Fig. 15: Tubulin staining in wild type (+/+), TTL+/- and TTL-/- MEFs. Immunofluorescence of β-
tubulin, Tyr-tubulin, Glu-tubulin and Δ2-Glu-tubulin using antibodies 2.3B11, YL1/2 cell culture 
supernatant, 1D5 clone H4 cell culture supernatant and antibody L4, respectively. Note the clear 
differences in tubulin pools in wild type and TTL+/- MEFs compared to TTL-deficient MEFs. 
 
To confirm the results of the immunofluorescence studies, Western blot analyses 
were additionally performed by using the same set of antibodies. Actin served as an 
additional loading control besides β-tubulin (Fig. 16). Consistent with the results of 
the immunofluorescent stainings, tyrosinated tubulin could only be identified in wild 
type and heterozygous MEFs (cell lines 1, 2, 7 and 9), whereas detyrosinated and 
Δ2-Glu-tubulin were exclusively found in TTL-deficient MEFs (cell lines 3, 8, 21 and 
22). As expected, the amounts of β-tubulin and actin appeared to be independent of 
the presence or absence of the TTL gene. 
β-Tubulin Tyr-tubulin Glu-tubulin Δ2-Glu-tubulin
+/+
+/-
-/-
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Fig. 16: Tubulin amounts in wild type (+/+), TTL+/- and TTL-/- MEFs. Western blot analysis of β-
tubulin (2.3B11), Tyr-tubulin (YL1/2 hybridoma supernatant), Glu-tubulin (1D5 clone H4 hybridoma 
supernatant), Δ2-Glu-tubulin (L4) and actin (A5060) in wild type, TTL+/- and TTL-/- MEF lysates. Cells 
were serum-starved for 2 d before lysis. 
 
Although Tyr-tubulin could neither be recognized by immunofluorescence nor by 
Western blotting with YL1/2 hybridoma supernatant, labelling with highly 
concentrated YL1/2 antibody revealed a heterogeneous population of TTL-/- MEFs 
as described by Peris et al. (2006). A small percentage of cells still contained Tyr-
tubulin, while the majority of cells were negative for Tyr-tubulin in immunofluorescent 
stainings. In our cell culture, the amount of Tyr-negative MEFs increased with 
numerous passages, whereas most of the freshly isolated TTL-/- MEFs were still 
positive for Tyr-tubulin. 
 
3.3. Microtubule plus-end tracking proteins in MEFs 
For further analysis of TTL deficiency, the characterization of wild type and TTL 
knockout MEFs was subsequently focussed on microtubule plus-end tracking 
proteins (+TIPs). In previous studies, Erck et al. (2005) demonstrated a 
mislocalisation of the microtubule plus-end tracking protein CLIP-170 in TTL-/- 
neurons. Additionally, Peris et al. (2006) published binding of CAP-Gly domain-
containing proteins such as CLIP-170, CLIP-115 and p150Glued only to plus-ends of 
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tyrosinated microtubules in fibroblasts. Therefore, we investigated microtubule plus-
end tracking proteins by immunofluorescence and Western blot analyses regarding 
their localisation and biochemical properties. Since heterozygous MEFs showed the 
same phenotype as wild type MEFs, further experiments were focussed only on wild 
type and TTL-deficient MEFs. 
 
3.3.1. Localisation of microtubule plus-end tracking proteins 
The end-binding protein 1 (EB1) was reported to bind microtubule plus-ends 
independently of the tyrosination state of the microtubule and is therefore unaffected 
by the presence or absence of the TTL gene (Peris et al., 2006). As expected, 
stainings of EB proteins labelled the microtubule plus-ends in wild type MEFs and in 
Tyr-positive as well as Tyr-negative TTL-/- MEFs (Fig. 17, third panel). Consequently, 
EB staining could be used as a plus-end marker in further experiments. 
In contrast, CLIP-170 localisation was reported to be dependent on tyrosinated α-
tubulin in neurons (Erck et al., 2005) and fibroblasts (Peris et al., 2006). However, in 
this study, staining of CLIP-170 showed a persistent localisation at microtubule plus-
ends in MEFs, independently from the presence or absence of Tyr-tubulin (Fig. 17, 
second panel). Merged images demonstrate the co-localisation of CLIP-170 and EB1 
not only in wild type MEFs, but also in both Tyr-positive and Tyr-negative TTL-/- 
MEFs (Fig. 17, right panel). The length of CLIP-170 plus-end comets was not 
influenced by the presence or absence of Tyr-tubulin. 
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Fig. 17: CLIP-170 localisation in wild type and TTL-/- MEFs. Wild type (+/+), Tyr-positive TTL 
knockout (-/- Tyr-pos.) and Tyr-negative TTL knockout MEFs (-/- Tyr-neg.) were immunostained for 
Tyr-tubulin using purified YL1/2, CLIP-170 using #2360 antibody and EB1 using clone 5 antibody. 
Merged images show co-localisation of CLIP-170 (green) and EB1 (red). 
 
Interestingly, the localisation of CLIP-115, which is a close family member of CLIP-
170, appeared to be different in Tyr-positive and Tyr-negative MEFs. In both cell 
types, CLIP-115 was bound to the microtubule plus-ends but showed significantly 
longer plus-end comets in TTL-/- MEFs lacking Tyr-tubulin. In contrast, TTL-/- MEFs 
that still contained Tyr-tubulin resembled wild type MEFs in the CLIP-115 phenotype 
(Fig. 18). 
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Fig. 18: Elongated CLIP-115 plus-end comets in Tyr-negative TTL-/- MEFs. CLIP-115 and Tyr-
tubulin immunostaining in wild type, Tyr-positive and Tyr-negative TTL-/- MEFs using antibodies 
#2163 and purified YL1/2, respectively. 
 
Although it was reported for the dynactin complex component p150Glued to exclusively 
bind to plus-ends of tyrosinated microtubules (Peris et al., 2006), in this study 
stainings of p150Glued did not reveal any difference between wild type and TTL-/- 
MEFs. Instead, p150Glued co-localised with CLIP-170 (not shown). As stainings were 
very weak and did not differ in the studied MEF cell lines, p150Glued was not further 
analysed. 
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3.3.2. Length of CLIP-170 and CLIP-115 plus-end comets 
To quantify the length of CLIP-170 and CLIP-115 plus-end comets, images were 
reversed and brightened in Adobe Photoshop (“Input Levels” set to 50 – 1.00 – 230) 
to decrease background signal. Furthermore, the nucleus and the flanking 
perinuclear space of 2 µm were marked and excluded in following measurements. By 
that, an artificial shortening of the comets caused by the angle of the plus-ends was 
minimized (Fig. 19a). Measurements were then performed manually in the peripheral, 
flat cell area using ImageJ 1.42 software. Images were acquired from two wild type 
and two TTL-/- MEF cell lines in two independent experiments. 500 plus-end comets 
per cell line and experiment were measured in wild type, Tyr-positive and Tyr-
negative TTL-/- MEFs giving 1000 values that were taken together for statistical 
analysis. Measurements revealed CLIP-170 plus-end comets to be of similar length 
in wild type, Tyr-positive and Tyr-negative TTL-/- MEFs with medians between 0.64 
µm and 0.70 µm (Fig. 19b). In contrast, CLIP-115 plus-end comets are significantly 
longer in Tyr-negative TTL-/- MEFs with a median of 1.06 µm compared to 0.61 µm 
in Tyr-positive TTL-/- and 0.60 µm in wild type MEFs (Fig. 19c). According to the 
Anderson-Darling normality test the data set did not show a Gaussian distribution 
due to a higher percentage of plus-ends shorter than the average. Consequently, a 
student’s t-test would not be legitimate for statistical analysis and therefore, the 
Mann-Whitney-Rank sum test was alternatively chosen using MiniTab 10.5 software. 
 
a)  
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Fig. 19: Analysis of CLIP-170 and CLIP-115 plus-end length. a) Representative image of CLIP-115 
localisation in a Tyr-negative TTL-/- MEF processed in Adobe Photoshop for measuring the lengths of 
plus-end comets. The circle marks the nucleus and the grey zone outside the nucleus correlates with 
a 2 µm perinuclear space. Only plus-end comets outside this area were measured. b) Box plot 
diagram of the CLIP-170 plus-end lengths. The horizontal line marks the median, the boxes include 50 
% of all values from 25th to 75th percentile (interquartile range IQR), the whiskers include the 1.5x IQR, 
and the dots mark the 5th and 95th percentile, respectively. Each box plot implies the lengths of 1000 
plus-end comets, the numbers of cells are n = 18 (wild type), n = 20 (Tyr-pos.) and n = 13 (Tyr-neg.). 
c) Box plot diagram of the CLIP-115 plus-end lengths as described for CLIP-170. Each box plot 
implies the lengths of 1000 plus-end comets; the numbers of analysed cells are n = 14 (wild type), n = 
21 (Tyr-pos.) and n = 20 (Tyr-neg.). *Statistical analysis with Mann-Whitney-Rank sum test gave 
significantly longer CLIP-115 plus-end comets in Tyr-negative MEFs (P < 0.001). 
 
To verify the elongation of CLIP-115 plus-end comets in the absence of Tyr-tubulin, 
TTL-/- MEFs were transfected with an expression vector containing the TTL cDNA to 
reconstitute the wild type phenotype. The TTL cDNA was cloned into a pIRES2-
EGFP vector resulting in a bicistronic construct that allowed the translation of the 
exogenous TTL and the GFP reporter independent of each other. As a control, cells 
were also transfected with the same vector containing the TTL cDNA in antisense 
direction. Wild type MEFs were transfected with both constructs as well. Cells were 
fixed 16 – 24 h after transfection and stained for Tyr-tubulin, Glu-tubulin, CLIP-115 
and GFP that lost most of its autofluorescence during methanol fixation. Expression 
of an exogenous TTL in TTL-deficient cells leads to an increase of the Tyr-tubulin 
WT TTL-/-
Tyr-pos.
TTL-/-
Tyr-neg.
*
CLIP-115 plus-end length
WT TTL-/-
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level, whereas the amount of detyrosinated tubulin decreases. In contrast, cells 
expressing the antisense construct do not change their levels of Tyr- and Glu-tubulin 
(Fig. 20a). Consistently, all studied TTL knockout MEFs overexpressing exogenous 
TTL exhibit a significant shortening of the CLIP-115 plus-end comets with a median 
length of 0.54 µm. Overexpression of the antisense construct did not evoke any 
effect on the CLIP-115 plus-end length. The expression of both the sense as well as 
the antisense construct did not cause any effect in wild type MEFs (Fig. 20b). Hence, 
the shortening of plus-end comets in TTL-/- MEFs overexpressing the TTL gene was 
obviously based on the reappearance of Tyr-tubulin. 
For quantification, images were acquired and processed as described above followed 
by measuring the length of CLIP-115 plus-end comets. Again, experiments were 
performed independently with two different wild type and TTL-/- MEF cell lines. As 
mentioned above, quantification of CLIP-115 plus-end length illustrates a significant 
shortening in TTL-/- MEFs expressing an exogenous TTL (Fig. 20c). 
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Fig. 20: Shortening of CLIP-115 plus-end comets in TTL-/- MEFs overexpressing TTL. a) Staining 
of Glu-tubulin using 1D5 clone H4 hybridoma supernatant and GFP using antibody MAB3580 in TTL-/- 
MEFs expressing the sense or antisense TTL-construct, respectively. White arrows mark transfected 
cells. b) CLIP-115, Tyr-tubulin and GFP stained in TTL-/- and wild type MEFs using antibodies #2163, 
purified YL1/2 and MAB3580, respectively. Cells were transfected with the TTL gene cloned in sense 
and antisense direction (wild type transfected with TTL antisense not shown). White arrows mark 
transfected cells. Note the shorter CLIP-115 plus-end comets in a TTL-/- MEF overexpressing TTL 
compared to a non-transfected TTL-/- MEF. c) Box plot diagram of the CLIP-115 plus-end lengths in 
TTL-/- MEFs either untransfected and Tyr-negative, transfected with the TTL gene or transfected with 
a TTL antisense construct. Each box plot implies the lengths of 1000 plus-end comets, the numbers of 
cells are n = 8 (untransfected, Tyr-negative TTL-/- MEFs), n = 12 (expressing TTL) and n = 17 
(expressing TTL antisense). * Statistical analysis with Mann-Whitney-Rank sum test gave significantly 
shorter CLIP-115 plus-end comets in TTL-overexpressing TTL-/- MEFs (P < 0.001). 
 
Additionally, CLIP-170 and EB1 were analysed in the above described TTL rescue 
experiments (Fig. 21a, b; TTL antisense construct and wild type MEFs not shown). 
All studied wild type and TTL-/- MEFs possessed the same subcellular distribution of 
both CLIP-170 and EB1. The overexpression of the TTL gene did neither influence 
CLIP-170 nor EB1 localisation or plus-end length (Fig. 21a and b). 
 
a)  
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b)  
 
 
 
 
 
 
 
 
Fig. 21: CLIP-170 and EB1 in TTL-/- MEFs transfected with TTL. TTL-/- MEFs were transfected 
with the sense TTL-construct and immunostained for a) CLIP-170 (#2360) and b) EB1 (clone 5 
antibody). Cells were co-stained for Tyr-tubulin (purified YL1/2) and GFP (MAB3580) to show 
functionality of the TTL-construct. White arrows mark transfected cells. Both CLIP-170 and EB1 plus-
end lengths were not influenced by TTL expression. 
 
In summary, the absence of Tyr-tubulin led to elongated plus-end comets of CLIP-
115, as demonstrated in immunofluorescence analysis and rescue experiments of 
TTL-deficient MEFs. In contrast, neither the close family member CLIP-170 nor EB1, 
which belongs to a completely different +TIP family, were affected by the lack of Tyr-
tubulin. 
 
3.3.3. Biochemical analysis of microtubule plus-end tracking proteins 
Besides analysing their localisation, the microtubule plus-end tracking proteins CLIP-
115, CLIP-170 and EB1 were biochemically investigated by Western blotting. Signal 
intensities of the investigated +TIPs did not differ between the genotypes. 
Surprisingly, CLIP-115 possessed a slightly smaller molecular weight in lysates 
obtained from TTL-/- MEFs compared to heterozygous and wild type MEFs indicating 
a genotype-depending modification (compare CLIP-115 signal of cell lines 7, 8 and 9 
in Fig. 22). Again, heterozygous MEF cell lines revealed a comparable phenotype to 
wild type MEFs. As CLIP-170 is expressed in two splice variants (Griparic & Keller, 
1998) it gave a double band in Western blotting. Within each sample both bands 
showed the same intensity. Furthermore, CLIP-170 signals appeared to be similar in 
all studied genotypes (Fig. 22, middle blot). Analogously, the EB1 signal did not 
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reveal any difference between wild type, heterozygous and TTL-deficient MEFs (Fig. 
22, lower blot). 
 
 
 
 
 
 
 
 
 
 
Fig. 22: CLIP-115 mass shift in MEFs. Western blot analysis of wild type, TTL+/- and TTL-/- MEF 
lysates using antibodies against CLIP-115 (#2238), CLIP-170 (#2360) and EB1 (clone 5). Obviously, 
CLIP-115 appears at a lower molecular weight in TTL-/- MEF lysates. Different signal intensities 
between the MEF cell lines are due to unequal loading. 
 
The different molecular weights of CLIP-115 in MEFs containing or lacking the TTL 
gene could be a consequence of differential posttranslational modifications. Among 
these modifications, phosphorylation is very common and, as previously reported, 
involved in binding of microtubule-associated proteins like CLIP-170 (Rickard & 
Kreis, 1991) or CLASP (Kumar et al., 2009). Hence, it was conceivable that 
phosphorylation could evoke the observed shift of CLIP 115 in SDS-PAGE. To test 
this, wild type and TTL-/- MEF lysates were treated with the unspecific shrimp 
alkaline phosphatase (SAP). After the treatment, cell lysates were separated by 
SDS-PAGE and analysed by Western blotting. Indeed, the phosphatase treatment 
reduced the molecular weight of CLIP-115 in wild type MEF lysates to the level 
observed in the TTL knockout lysates. In contrast, this treatment did not show any 
effect on the molecular weight of CLIP-115 in TTL-/- MEF lysates and, therefore, 
indicated a less phosphorylated occurrence of CLIP-115 in the absence of TTL (Fig. 
23, upper blot). Control blots stained for CLIP-170, EB1, Tyr-tubulin and actin did not 
reveal any shifts in molecular weight after phosphatase treatment (Fig. 23, Tyr-
tubulin and actin not shown). 
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Fig. 23: CLIP-115 is less phosphorylated in TTL-/- MEFs. Western blot analysis of wild type and 
TTL-/- MEF lysates using antibodies against CLIP-115 (#2238), CLIP-170 (#2360) and EB1 (clone 5). 
Lysates that were treated with shrimp alkaline phosphatase (SAP) are marked with “P”. Note the shift 
of the CLIP-115 molecular weight in wild type MEF lysate after SAP-treatment. Different signal 
intensities result from unequal loading. 
 
Since the observed mass shift in CLIP-115 could be the product of a single or 
multiple phosphorylation events, 2-dimensional SDS-PAGE was employed to reveal 
a phosphorylation-dependent shift of CLIP-115 from its isoelectric point (pΙ). An 
observed shift is indicative for the number of additional phosphate residues. Non-
phosphorylated CLIP-115 has a pΙ of 6.13 as calculated using online calculation 
facilities from Scansite (http://scansite.mit.edu/index.html). According to that, each 
phosphorylation should cause a pΙ reduction of 0.03 – 0.05 units (Tab. 10). 
 
Table 10: Number of phosphate residues with corresponding calculated 
molecular weight and isoelectric point of CLIP-115. 
Number of 
phosphates 
Molecular weight 
[Da] 
Isoelectric point 
0 111868.5306 6.13 
1 111946.4946 6.08 
2 112024.4586 6.04 
3 112102.4226 6.00 
4 112180.3866 5.96 
5 112258.3506 5.92 
6 112336.3146 5.88 
7 112414.2786 5.85 
8 112492.2426 5.81 
34
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Two-dimensional SDS-PAGE starts with an isoelectric focussing of the sample 
proteins in a pH gradient followed by a mass-dependent separation using SDS-
PAGE. Therefore, 24 cm Immobiline Dry Strips (GE Healthcare) with a pH gradient 
from 5.5 – 6.7 were employed guaranteeing a resolution of 0.05 pH units/cm. Total 
protein samples from wild type and TTL-/- MEF lysates were loaded on the gel strips 
and focussed by an applied current gradient. After the subsequent SDS-PAGE, gels 
were stained with Coomassie to control correct protein focussing or analysed by 
Western blotting. In Coomassie-stained SDS gels proteins were visible as focussed 
dots ensuring a successful isoelectric focussing of the samples. In contrast to that, 
Western blots probed with anti-CLIP-115 antibody showed a signal distributed over 
the whole pH range resulting from a failed isoelectric focussing of CLIP-115 (not 
shown). Variation of loaded protein amounts as well as different loading techniques 
did not improve CLIP-115 focussing. 
Alternatively, non-equilibrium pH gel electrophoresis (NEPHGE; Klose & Kobalz, 
1995) was employed. In this method, the pH gradient for isoelectric focussing is 
established after current application. By that, the focussing of sample proteins can be 
improved. The first dimension was run in a 9 M urea gel while building up a gradient 
from pH 2 – 11 followed by SDS-PAGE for the second dimension. The 2-dimensional 
SDS gels were then blotted and probed with an anti-CLIP-115 antibody followed by 
Coomassie-staining of the membranes. Whereas the isoelectric focussing of most 
sample proteins was successful, as demonstrated on the Coomassie-stained 
membranes, this method also failed to focus CLIP-115 (not shown). 
In summary, both the traditional 2-dimensional gel electrophoresis as well as 
NEPHGE failed in isoelectric focussing of the CLIP-115 polypeptide. Since other 
proteins were focussed in the different experimental set-ups, the inability of CLIP-115 
focussing must be based on the molecular protein properties. Therefore, we were 
unfortunately not able to predict the number of CLIP-115 phosphorylation sites, which 
was indicated to depend on TTL genotype. 
 
3.3.4. Effects of phosphatase and kinase inhibition on CLIP-115 
As Western blot analysis unravelled different molecular weights of CLIP-115 in wild 
type and TTL-/- MEFs resulting from differential phosphorylation states, cells were 
then treated with phosphatase inhibitors to reveal the engaged amino acids. 
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Therefore, sodium vanadate was employed to inhibit tyrosine phosphatases, and 
calyculin A and okadaic acid were used as inhibitors of serine/threonine 
phosphatases (types PP1 and PP2, respectively). Furthermore, MEFs were treated 
with the broad range kinase inhibitor staurosporine as well as the tyrosine kinase 
inhibitor genistein. After the treatments, total MEF lysates were obtained and 
analysed by Western blotting. Wild type MEFs did not show any effect of any 
treatment. In contrast, after treatment of TTL-/- MEFs with sodium vanadate (V), a 
second CLIP-115 band appeared on the level similar to that observed in wild type 
(Fig. 24a, second lane from left side). Okadaic acid (OA) and calyculin A (CA) 
treatments did not result in an obvious effect, only a smear above the primary CLIP-
115 signal was visible (Fig. 24a, third and fourth lane from left side). These results 
indicate a tyrosine phosphorylation to be involved in the observed difference of CLIP-
115 molecular weight in wild type and TTL-/- MEFs. In contrast to the treatments with 
phosphatase inhibitors, protein kinase inhibition did not influence the molecular 
weight of CLIP-115 in MEFs (Fig. 24b). Additionally, blots were probed with an anti-
CLIP-170 antibody but the molecular weight of CLIP-170 was not affected by any 
inhibitor treatment (Fig. 24a; blots after kinase inhibition not shown). 
 
  a)  
 
 
 
 
 
b)  
 
 
 
Fig. 24: Inhibition of tyrosine phosphatases leads to a mass shift of CLIP-115 in TTL-/- MEFs. 
a) Western blot analysis of TTL-/- and wild type MEF lysates using antibodies against CLIP-115 
(#2238) and CLIP-170 (#2360). MEFs were either untreated or treated with sodium vanadate (V), 
okadaic acid (OA) or calyculin A (CA). b) Western blot of TTL-/- and wild type MEF lysates stained for 
CLIP-115 using antibody #2238. MEFs were untreated, treated with staurosporine (SS) or treated with 
genistein (G) before lysis. Different signal intensities result from unequal loading. 
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In order to receive a complete phosphorylation of CLIP-115 in TTL-/- MEF lysates, 
sodium vanadate treament was optimized by cultivating cells in vanadate-containing 
medium for up to 2 h. Subsequently, cell lysates were obtained and analysed by 
Western blotting. Unfortunately, these experiments failed to reveal an obvious 
change in the molecular weight of CLIP 115. Additionally, wild type and TTL-/- MEFs 
were analysed by immunofluorescence after increasing incubation times with sodium 
vanadate. As expected, stainings of CLIP-115 showed a decrease of microtubule 
plus-end comets with increasing duration of the vanadate exposure in wild type and 
TTL-deficient MEFs. After 1 h incubation in vanadate-containing medium, CLIP-115 
completely disappeared from microtubule plus-ends in wild type MEFs (Fig. 25b). In 
general, TTL-deficient MEFs reacted less sensitive to the treatment with a few CLIP-
115-stained plus-ends still present after 1 h of vanadate exposure (Fig. 25b). 
Nevertheless, inhibition of tyrosine phosphatase activity by sodium vanadate 
obviously eliminated most of CLIP-115 binding at microtubule plus-ends. In addition, 
localisation studies of CLIP-170 and EB1 revealed a removal from microtubule plus-
ends after 15 min and 30 min of vanadate treatment in wild type MEFs, respectively. 
In contrast, even after 1 h of treatment only a reduction of CLIP-170 and EB1 plus-
ends was visible in TTL-/- MEFs (not shown). Longer treatment predominantly 
destroyed the microtubule network, as observed in β-tubulin staining (not shown).  
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Fig. 25: Reduction of CLIP-115 at microtubule plus-ends after vanadate treatment. CLIP-115 and 
β-tubulin stained in wild type and TTL-/- MEFs either treated with DMSO as control (a) or after 1 h of 
sodium vanadate treatment (b) using antibodies #2238 and T4026, respectively. In wild type MEFs, 
CLIP-115 was completely released from microtubule plus-ends (b, upper panel), whereas CLIP-115 
binding to plus-ends was only reduced in TTL-/- MEFs (b, lower panel). 
 
Furthermore, it could be demonstrated that the vanadate effects were reversible. In 
washout experiments CLIP-115, CLIP-170 and EB1 reappeared at microtubule plus-
ends after 2 – 4 h cultivation in vanadate-free medium. Representative images of 
CLIP-115 in wild type and TTL-/- MEFs after 30 min of sodium vanadate treatment 
and 4 h after vanadate washout are shown in Fig. 26 (CLIP-170 and EB1 not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26: CLIP-115 reappears at microtubule plus-ends after vanadate washout. CLIP-115 
immunostaining of wild type and TTL-/- MEFs using antibody #2238. Cells were treated with sodium 
vanadate for 30 minutes resulting in a reduced CLIP-115 localisation at microtubule plus-ends (left 
panel). Four hours after vanadate washout, CLIP-115 reappeared at microtubule plus-ends (right 
panel). 
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Taken together, only vanadate treatment had an effect on the localisation and 
biochemical properties of CLIP-115, whereas okadaic acid and calyculin A as well as 
kinase inhibition did not show any effect. This data support tyrosine phosphorylation 
as a mechanism to modulate the binding of CLIP-115 to microtubule plus-ends. 
 
3.3.5. Identification of putative phosphorylation sites in CLIP-115 
As described in chapters 3.3.3. and 3.3.4., the apparent shift in molecular mass of 
CLIP-115 obviously depends on its phosphorylation status. To identify potential 
phosphorylation sites in the CLIP-115 amino acid sequence, the online NetPhosK 1.0 
as well as the NetPhos 2.0 Server (Technical University of Denmark) was used. 
Inhibitor experiments already indicated that most probably tyrosine phosphorylation 
results in the differences in the molecular mass of CLIP-115 in wild type and TTL-/- 
MEF lysates. By using both the general as well as the kinase-based scanning 
modus, six tyrosines in the CLIP-115 polypeptide were revealed as putative 
phosphorylation targets with a higher score than 0.5 (listed in Tab. 11). The scores 
give the probability of a phosphorylation at the respective amino acid predicted by the 
servers NetPhosK 1.0 and NetPhos 2.0. 
 
Table 11: Putative CLIP-115 tyrosine phosphorylation sites with potential 
kinases and probability score as predicted by the NetPhosK 1.0 and the 
NetPhos 2.0 Servers (Technical University of Denmark). 
Tyrosine residue Predicted kinase Score 
(NetPhosK/NetPhos) 
Y-270 EGFR* 0.52 / 0.299 
Y-348 INSR** 0.51 / 0.287 
Y-407 - - / 0.841 
Y-533 - - / 0.816 
Y-554 - - / 0.938 
Y-732 EGFR* 
INSR** 
0.52 / 0.910 
0.50 / 0.910 
*Epidermal Growth Factor Receptor 
**Insulin Receptor 
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All identified tyrosines, except for tyrosine 270, are located in the coiled-coil domain 
of CLIP-115. The tyrosine at position 270 is part of the second CAP-Gly domain that 
is responsible for microtubule binding (Mishima et al., 2007). Closer identification of 
all CAP-Gly domain-containing proteins revealed this tyrosine to be conserved in all 
proteins indicative for a crucial role in domain structure and/or microtubule binding. 
The position of all tyrosines identified as possible phosphorylation sites are 
schematically shown in Figure 27. All six tyrosines were used in mutation analysis to 
be described in chapter 3.3.5.2. 
 
 
 
 
 
Fig. 27: Scheme of CLIP-115 domains and location of potentially phosphorylated tyrosines. 
Schematic drawing of CLIP-115 with the CAP-Gly domains in red and the coiled-coil domain in yellow. 
Asterisks mark the positions of the putative tyrosine phosphorylation sites Y270, Y348, Y407, Y533, 
Y554 and Y732 (from left to right). 
 
3.3.5.1. Cloning of CLIP-115 
To study the influence of a putative phosphorylation of the predicted tyrosine 
residues, CLIP-115 mutants were generated as GFP fusion proteins. Therefore, the 
respective tyrosines were substituted either with glutamic acid mimicking 
phosphorylation or with phenylalanine blocking phosphorylation. By overexpression 
in multiple cell lines GFP-CLIP-115 fusion proteins were tested for their ability to bind 
microtubule plus-ends. 
For cloning of CLIP-115, forward and reverse primers were designed to amplify the 
full length CLIP-115 sequence while introducing an Xho Ι and an Eco RΙ restriction 
site for directed ligation in pEGFP-C3 vector (primers M64 and M57, respectively). 
Full length CLIP-115 coding sequence was purchased from ImaGenes GmbH 
(AccNo BC053048). Sequencing using T7 primer confirmed the received sequence 
to be CLIP-115 isoform B. Compared to isoform A, the coiled-coil domain of isoform 
B is 35 amino acids shorter and consequently consists of 1012 amino acids 
corresponding to 3036 bp. An additional primer was designed to introduce an Xho Ι 
** *
CAP-Gly1 CAP-Gly2 Coiled-coil
* * *
CLIP-115 domains
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restriction site and a kozak sequence upstream of the CLIP-115 start codon (primer 
M97). Moreover, sequencing primers for CLIP-115 were designed using “Primer3” 
software (Geneious). Next, the CLIP-115 full length sequence was amplified by PCR 
resulting in 3 kb fragments as confirmed by agarose gel electrophoresis. After 
extracting the PCR products from the agarose gel they were digested with the 
restriction enzymes Xho Ι and Eco RΙ to generate correct fragment ends for directed 
cloning. In addition, the vector pEGFP-C3 was linearised using Xho Ι and Eco RΙ 
enzymes as well. After purification of the digested DNA fragments by agarose gel 
electrophoresis, the PCR product was ligated into pEGFP-C3 resulting in CLIP-115 
with an N-terminal EGFP. Additionally, a CLIP-115 construct with a C-terminal EGFP 
was generated by cloning into the pEGFP-N2 vector. Therefore, a primer to remove 
the CLIP-115 stop codon while introducing an Eco RΙ site was designed (primer 
M98). Ligation mixes were used in E. coli transformation followed by plasmid DNA 
mini-preparation from grown colonies in order to select constructs containing inserts. 
The isolated plasmid DNA was tested by restriction analysis using Xho Ι and Eco RΙ 
to select for constructs carrying an insert. DNA from midi-preparations of the 
identified clones was then sent for sequencing. Verified CLIP-115 constructs with 
EGFP either at the N- or the C-terminus were overexpressed in NIH 3T3 cells, which 
were either fixed for immunofluorescence or lysed for Western blot analyses. Total 
cell lysates of transfected NIH 3T3 fibroblasts were separated by SDS-PAGE and 
investigated by Western blotting using both anti-GFP as well as anti-CLIP-115 
antibodies. As expected, both antibodies revealed signals at a molecular weight of 
approximately 150 kDa corresponding to the fusion protein of CLIP-115 and EGFP. 
Consistent with endogenous CLIP-115, both fusion proteins localised at microtubule 
plus-ends when expressed at a low level. When expressed at higher levels, 
exogenous CLIP-115 proteins decorated the whole microtubule network (not shown; 
Hoogenraad et al., 2000). 
In summary, cloning of full length CLIP-115 into pEGFP-vectors was successful and 
resulted in fusion proteins of the expected molecular weight and localisation at 
microtubule plus-ends. 
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3.3.5.2. Mutation of CLIP-115 tyrosines 
For the introduction of either a glutamic acid as phosphomimic or a phenylalanine as 
non-phosphomimic at the position of the above-mentioned potential CLIP-115 
phosphosites (Tab. 11) the pEGFP-C3-CLIP-115 (see 3.3.5.1.) construct was used 
as template DNA in site-directed mutagenesis (see 2.4.7.). Primers carrying the 
respective mutation were designed from the CLIP-115 sequence. Following the 
mutagenesis reaction, PCR products were transformed into E. coli and selected on 
Kanamycin-containing LB agar plates. Colonies were picked, plasmid DNA was 
isolated and sent for sequencing. Constructs with a correct sequence including the 
targeted mutation were then used in midi-preparations. The isolated constructs were 
overexpressed in NIH 3T3 cells as well as in wild type and TTL-/- MEFs to 
investigate their ability to bind microtubules. Additionally, the localisation of mutant 
fusion proteins was examined in CLIP-115 knockout and CLIP-115/CLIP-170 double 
knockout MEFs (kind gift of N. Galjart) to eliminate the endogenous CLIP-115 and 
CLIP-170 background. Representative images of Tyr-tubulin, CLIP-115, CLIP-170, 
EB1 and p150Glued stained in CLIP-115/CLIP-170 double knockout MEFs are shown 
in Figure 28. CLIP-115 and CLIP-170 labelling revealed a slight background 
confirming the genotype of the cells. Endogenous EB1 decorated the microtubule 
plus-ends and demonstrated the existence of an intact microtubule network (Fig. 28, 
upper panel). Immunofluorescent staining of Tyr-tubulin revealed areas in a number 
of CLIP-115/CLIP-170 double knockout MEFs, which were free of microtubules. In 
these areas, p150Glued appeared to be accumulated (Fig. 28, lower panel). 
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Fig. 28: Characterization of CLIP-115/CLIP-170 double knockout MEFs. Immunostainings of CLIP-
115/CLIP-170 double knockout MEFs using antibodies against Tyr-tubulin (YL1/2), CLIP-115 (#2163), 
EB1 (clone 5), CLIP-170 (#2360) and p150Glued (610474). 
 
Except for CLIP-115 Y270E, all mutant CLIP-115 variants showed a localisation at 
microtubules comparable to the wild type protein (Fig. 29). Hence, it is conceivable 
that these mutations did not affect the binding ability of CLIP-115 to microtubule plus-
ends at all. When overexpressed on a high level, EGFP-CLIP-115 even decorated 
the whole microtubule network. In contrast, the mutation of tyrosine 270 into glutamic 
acid strongly reduced microtubule binding of CLIP-115 and resulted in a severely 
reduced number of plus-end comets and microtubule structures. Instead of a distinct 
localisation on microtubules, the CLIP-115 mutant tended to a predominantly 
cytoplasmatic distribution. These experiments indicate that a phosphorylation at 
tyrosine 270 could hinder CLIP-115 microtubule binding. 
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Fig. 29: Substitution of CLIP-115 tyrosine 270 by glutamic acid strongly reduced binding to 
microtubule plus-ends. Wild type and mutant EGFP-CLIP-115 overexpression in CLIP-115/CLIP-
170 double knockout MEFs. The respective tyrosines (Y) were either substituted by glutamic acid (E) 
or by phenylalanine (F). Images marked with an asterisk show cells immunostained for CLIP-115 
using antibody #2163 to enhance the fluorescent signal of the fusion protein. All other images show 
GFP autofluorescence. 
 
As already mentioned, the tyrosine residue 270 is located within the second CAP-Gly 
domain of CLIP-115 and is conserved through CAP-Gly domain sequences of other 
proteins. Analogous to tyrosine 270, tyrosine 130 is present in the first CAP-Gly 
domain of CLIP-115. To verify an effect on the microtubule binding capacity of CLIP-
115, tyrosine 130 was also substituted either with glutamic acid or phenylalanine, 
although it was not predicted to be a putative phosphorylation site. In addition, 
tyrosines 130 and 270 of CLIP-115 were simultaneously mutated resulting in four 
different constructs. To validate the results obtained by the mutation Y270E, tyrosine 
270 was additionally mutated in alanine as an independent mimic of non-
phosphorylation. Representative images of CLIP-115/CLIP-170 double knockout 
MEFs overexpressing the mutant EGFP-CLIP-115 constructs are shown in Figure 
30. In multiple experiments, specific antibodies against either CLIP-115 or GFP were 
used to enhance the signal of the overexpressed fusion proteins as methanol fixation 
could decrease GFP autofluorescence. 
The mutation of tyrosine 130 into glutamic acid only slightly reduced the binding 
capacity of CLIP-115 to microtubules. However, microtubule binding was completely 
disrupted by the double mutants Y130E-Y270E and Y130E-Y270A (Fig. 30a, c and 
h). In contrast, the single Y130F mutant did not show any effect on the CLIP-115 
localisation (Fig. 30b). The mutation of tyrosine 270 into alanine also slightly reduced 
the binding efficiency of CLIP-115 to microtubules as indicated by an increased 
cytoplasmic localisation (Fig. 30g). The introduction of phenylalanine at position 130 
either combined with glutamic acid or alanine at position 270 led to the identical 
effects on CLIP-115 microtubule binding as observed for the CLIP-115 mutant Y270E 
(Fig. 30e and i).  
In summary, only the mutations of tyrosine 270 into glutamic acid or alanine 
combined with a simultaneous substitution of tyrosine 130 with glutamic acid entirely 
abolished the binding of CLIP-115 to microtubules. The fact that also the CLIP-115 
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mutant Y270A binds microtubules with less affinity indicates severe conformational 
changes as a result of this mutation. Results from all overexpression experiments of 
CLIP-115 mutations in the employed cell lines are summarized in Table 12. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30: Characterization of CLIP-115 double mutants. Mutant EGFP-CLIP-115 overexpression in 
CLIP-115/CLIP-170 double knockout MEFs. The respective tyrosines (Y) were either substituted by 
glutamic acid (E) or by phenylalanine (F). Note that the substitution of CLIP-115 tyrosine 270 by 
glutamic acid or alanine in combination with the mutation of tyrosine 130 into glutamic acid completely 
disrupted binding to microtubules. Images marked with one asterisk show cells stained for CLIP-115 
(#2163), whereas two asterisks mark cells stained for GFP (270F3). Images without asterisk show 
GFP autofluorescence. 
 
a) Y130 E* b) Y130 F* c) Y130 E-Y270 E*
d) Y130 E-Y270 F* e) Y130 F-Y270 E* f) Y130 F-Y270 F
g) Y270 A** h) Y130 E-Y270 A** i) Y130 F-Y270 A
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Table 12: Microtubule binding of mutant EGFP-CLIP-115 overexpressed in CLIP-115/CLIP-170 
double knockout MEFs, CLIP-115 knockout MEFs, NIH 3T3 cells, wild type and TTL-/- MEFs. 
Mutations with reduced binding to microtubules are in bold. 
Mutation CLIP-115/ 
CLIP-170-/- 
CLIP-115-/- NIH 3T3 WT MEFs TTL-/- MEFs 
Y130 E + + n. d. + + 
Y130 F ++ ++ n. d. ++ ++ 
Y130 E – Y270 A - - n. d. - - 
Y130 E – Y270 E - - n. d. - - 
Y130 E – Y270 F + + n. d. + + 
Y130 F – Y270 A + + n. d. + +/- 
Y130 F – Y270 E +/- +/- n. d. +/- - 
Y130 F – Y270 F ++ ++ n. d. ++ ++ 
Y270 A + + n. d. + + 
Y270 E +/- +/- +/- + +/- 
Y270 F ++ ++ ++ ++ ++ 
Y348 E ++ ++ ++ ++ ++ 
Y348 F ++ ++ ++ ++ ++ 
Y407 E ++ ++ ++ ++ ++ 
Y407 F ++ ++ ++ ++ ++ 
Y533 E ++ ++ ++ ++ ++ 
Y533 F ++ ++ ++ ++ ++ 
Y554 E ++ ++ ++ ++ ++ 
Y554 F ++ ++ ++ ++ ++ 
Y732 E ++ ++ ++ ++ ++ 
Y732 F ++ ++ ++ ++ ++ 
 
++ Wild type-like binding to microtubules 
+ Reduced binding to microtubules 
+/- Strongly reduced binding to microtubules with cytoplasmic background 
- No binding to microtubules, only cytoplasmic 
n. d. not determined 
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In comparable experiments, mutation analysis of CLASP2 phosphorylation sites 
resulted in a shift of the molecular weight in SDS-PAGE (Kumar et al., 2009). 
Analogously, mutant EGFP-CLIP-115 fusion proteins were investigated in Western 
blot analysis. Therefore, lysates were obtained from MEFs and NIH 3T3 cells 
overexpressing EGFP-CLIP-115 constructs and analysed by Western blotting using 
either an anti-CLIP-115 or an anti-GFP antibody. However, Western blot analysis did 
not reveal any mass shift caused by tyrosine substitutions. All mutant CLIP-115 
fusion proteins possessed the same molecular weight as wild type CLIP-115 fused to 
EGFP (Fig. 31). The mutation of tyrosine 270 into alanine and the double mutations 
of tyrosines 130 and 270 did not change the molecular weight of the EGFP-fused 
CLIP-115 as well (not shown). 
 
  
 
 
 
Fig. 31: EGFP-CLIP-115 fusion proteins show the same molecular weight. 
Western blot analysis using antibody #2163 against CLIP-115 show endogenous CLIP-115 
(approximately 130 kDa, red arrow) and exogenous EGFP-CLIP-115 (approximately 150 kDa, green 
arrow). Overexpression of EGFP-CLIP-115 in TTL-/- and wild type MEFs did not reveal any difference 
regarding the molecular weight (first two lanes on the left side), whereas endogenous CLIP-115 
appeared at a smaller molecular weight in TTL-/- MEFs. Mutant EGFP-CLIP-115 proteins were 
overexpressed in NIH 3T3 cells. The respective tyrosines (Y) were substituted either by phenylalanine 
(F) or glutamic acid (E). Again, no differences in molecular mass could be observed. 
 
3.3.5.3. Mutation of tyrosines in CLIP-170 CAP-Gly domains 
Analogous to CLIP-115, the CAP-Gly domains of the closely related protein CLIP-
170 contain conserved tyrosines at corresponding positions (tyrosines 108 and 261). 
Therefore, also CLIP-170 mutations were analysed in further studies. To investigate 
the impact of the conserved tyrosines on microtubule binding, the residues were 
substituted either by glutamic acid or phenylalanine in EGFP-CLIP-170 expression 
constructs. EGFP fusion proteins containing wild type or mutant CLIP-170 were 
overexpressed in CLIP-115/CLIP-170 double knockout, wild type and TTL-/- MEFs 
followed by investigating their subcellular localisation. In contrast to CLIP-115 
GFP-CLIP-115
130
TTL-/- WT  
__Y270__ __Y348__ __Y407__ __Y533__ __Y554__ __Y732__
F F F F F FE E E E E E
kDa
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mutants, only the combined mutation of both CLIP-170 tyrosines into glutamic acid 
decreased the microtubule-binding efficiency. Interestingly, disruption of microtubule 
binding could only be observed in a few cells, whereas the majority of overexpressing 
cells still show binding of CLIP-170 to microtubules, although an increasing 
cytoplasmic localisation was present (Fig. 32d). Again, this effect was more drastic in 
TTL-/- MEFs. All results for CLIP-170 mutations are summarized in Table 13. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32: Characterization of CLIP-170 mutants in MEFs. Wild type and mutant GFP-CLIP-170 
overexpression in CLIP-115/CLIP-170 double knockout MEFs. The respective tyrosines (Y) were 
either substituted by glutamic acid (E) or by phenylalanine (F). Cells were stained for CLIP-170 using 
antibody #2360. Note the clear reduction of microtubule association of the CLIP-170 double mutant 
Y108E-Y261E (*). Expression of this mutant revealed different subcellular distributions, i. e. variation 
from plus-end localisation to complete loss of microtubule binding. Therefore, two representative 
images are shown. 
b) Y108 Ea) WT CLIP-170 c) Y108 F
d) Y108 E-Y261 E* e) Y108 E-Y261 F f) Y108 F-Y261 E
g) Y108 F-Y261 F h) Y261 E i) Y261 F
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Table 13: Microtubule binding of mutant EGFP-CLIP-170 overexpressed in CLIP-115/CLIP-170 
double knockout MEFs, wild type and TTL-/- MEFs. For codings see Table 11. 
Mutation CLIP-115/ 
CLIP-170-/- 
WT MEFs TTL-/- MEFs 
Y108 E ++ ++ ++ 
Y108 F ++ ++ ++ 
Y108 E – Y261 E + + +/- 
Y108 E – Y261 F ++ ++ ++ 
Y108 F – Y261 E ++ ++ ++ 
Y108 F – Y261 F ++ ++ ++ 
Y261 E ++ ++ ++ 
Y261 F ++ ++ ++ 
 
Taken together, CLIP-170 behaved differently than CLIP-115 when tyrosines 
positioned in the microtubule-binding CAP-Gly domains were substituted by glutamic 
acid. Though, mutating tyrosines of both CAP-Gly domains could decrease the 
binding efficiency of CLIP-170 proteins, but did not necessarily evoke a complete 
loss of microtubule binding, as observed for CLIP-115. These data indicate a 
different impact of those tyrosines on the affinity of CLIP-115 and CLIP-170 to 
microtubules. 
 
3.3.5.4. Search for CLIP-115 phosphorylation sites by mass spectrometry 
The results from CLIP-115 mutation experiments indicated tyrosine 270 to be a 
potential phosphorylation site being involved in microtubule binding. However, not 
only the tyrosine substitution by glutamic acid mimicking phosphorylation but also the 
introduction of alanine reduced CLIP-115 binding to microtubule plus-ends. As a 
consequence, a structural change of the CAP-Gly domain caused by the mutation 
instead of a different phosphorylation pattern could be the reason for the observed 
CLIP-115 mislocalisation. Nevertheless, treatments of MEF lysates with a 
phosphatase as well as treatments of the MEFs with sodium vanadate revealed a 
differential phosphorylation state of CLIP-115 in wild type and TTL-/- MEFs. To 
identify the affected CLIP-115 regions, the protein was enriched by 
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immunoprecipitation from total cell lysates obtained from wild type and TTL-/- MEFs 
and analysed by mass spectrometry (MS). 
For the first MS analysis, wild type and TTL-/- MEF cell lysates were obtained from 
20 confluent 10 cm dishes. As the obtained CLIP-115 amount was still very little, total 
cell lysates from 75 confluent 10 cm dishes were employed in a second experiment. 
Samples of the different immunoprecipitation steps were separated by SDS-PAGE 
followed by Western blotting to examine the efficiency of the immunoprecipitation 
(Fig. 33a). The different molecular weights of CLIP-115 from wild type and TTL-/- 
MEFs was visible in the total cell lysates (lanes 1) and the precleared lysates (lanes 
2), but disappeared after immunoprecipitation (lanes 3 and 4). Nevertheless, CLIP-
115 could partly be precipitated from MEF lysates. CLIP-115-enriched samples were 
separated from co-precipitated proteins by SDS-PAGE followed by staining of the gel 
with colloidal Coomassie (Fig. 33b). Stained protein bands were cut out of the gel 
and employed in a tryptic digest. After extraction from the gel, peptides were 
separated by HPLC and analysed by mass spectrometry using a Q-TOF micro mass 
spectrometer. The CLIP-115 bands resulting from the second, larger approach were 
first stored at –20 °C and later analysed using the more sensitive LTQ Orbitrap XL. 
 
a)  
 
 
 
 
b)  
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Fig. 33: Immunoprecipitation of CLIP-115 from TTL-/- and wild type MEF lysates. a) Western blot 
analysis of CLIP-115 immunoprecipitation fractions using antibody #2163. Loaded samples were total 
cell lysates from TTL-/- and wild type MEFs (1), lysates after preclearing with protein G-coupled 
sepharose (2), lysates after immunoprecipitation (3) and the immunoprecipitated proteins (4). Note the 
CLIP-115 mass shift between TTL-/- and wild type in samples 1 and 2. b) Immunoprecipitated proteins 
from TTL-/- and wild type MEF lysates separated by SDS-PAGE and stained with colloidal 
Coomassie. Marked bands were cut off the gel and analysed by mass spectrometry. Predicted 
proteins are given. 
 
Data obtained by MS analysis was processed using a MASCOT server as online 
database. MS/MS-based sequencing of the most intensive signals of identified CLIP-
115 peptides did not reveal any phosphorylation at all and consequently no 
difference between wild type and TTL knockout samples. In total, 14 peptides could 
be identified and sequenced covering 15.7 % of the complete CLIP-115 sequence 
(159 amino acids from a total of 1012). Co-immunoprecipitated proteins from both 
experiments were analysed by Q-TOF micro and turned out to be contaminations 
instead of genuine CLIP-115 interaction partners. The protein band of about 250 kDa 
remained undefined, whereas that of around 100 kDa was identified to be most 
probably keratin and that of around 75 kDa to be heat shock protein 70 
(HSP70/GRP78; Fig. 33b). 
As the first MS experiments did not show any indication of a differential CLIP-115 
phosphorylation, the immunoprecipitation was subsequently optimized to maintain 
the mass shift of CLIP-115 in wild type and TTL-/- MEFs. Therefore, the protocol was 
shortened and phosphatase inhibitors were added. Samples of the different 
immunoprecipitation steps were separated by SDS-PAGE followed by Western 
blotting to examine the efficiency of the immunoprecipitation (Fig. 34). Again, CLIP-
115 could successfully be precipitated from total cell lysates (lanes 4). Due to the 
shorter incubation times a higher amount of the protein remained in the lysates after 
the immunoprecipitation (lanes 3). The difference in CLIP-115 phosphorylation 
between wild type and TTL-/- could partly be conserved as shown by the CLIP-115 
double band in wild type samples (lanes 3 and 4, wild type).  
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Fig. 34: Optimized immunoprecipitation of CLIP-115 from TTL-/- and wild type MEF lysates. 
Western blot analysis of CLIP-115 immunoprecipitation fractions pooled from three independent 
experiments using antibody #2163. Loaded samples were the total cell lysates from TTL-/- and wild 
type MEFs (1), lysates after preclearing with protein G-coupled sepharose (2), lysates after 
immunoprecipitation (3) and the immunoprecipitated proteins (4). In all wild type samples CLIP-115 
appeared as a double band indicating the presence of multiple phosphorylation states. 
 
Protein samples obtained from three independent CLIP-115 immunoprecipitations 
using lysates from three 14 cm dishes were pooled and separated by SDS-PAGE. 
The gel was again stained with colloidal Coomassie and the CLIP-115 bands 
analysed by mass spectrometry. In this new set-up, the mass spectrometer was 
calibrated for the CLIP-115 peptide containing tyrosine 270 to optimize sensitivity. 
For this purpose, synthetic peptides of the CLIP-115 region around tyrosine 270 were 
used to mirror phosphorylated and non-phosphorylated fragments of endogenous 
CLIP-115 after tryptic digestion and served as calibration standards for MS (see 
chapter 2.5.10., Tab. 5, and chapter 2.5.11.). After calibration, CLIP-115 protein 
bands from wild type and TTL-/- MEFs were analysed. However, with the known 
retention times and peptide masses, in three independent experiments only the non-
phosphorylated peptide could clearly be identified in samples from both wild type and 
TTL-/- MEFs, whereas the phosphorylated peptide could not be determined. 
As the shift of the CLIP-115 molecular weight obviously is caused by phosphorylation 
(as described in chapters 3.3.3. and 3.3.4.), all peptides produced by tryptic digest 
were compared with potential phosphorylation sites predicted by the NetPhos 2.0 
server to search the obtained MS data for the existence of other phosphorylation 
sites. In total, 32 peptides containing one or multiple predicted phosphorylation sites 
were identified. Subsequently, their molecular masses with or without phosphate 
residues were calculated. Therefore, the mass of one or several phosphate residues 
(HPO3 = 79.9663 Da) divided by the charge was added to the peptide mass divided 
by the charge (m/z). By that, 249 mass/charge ratios for two-, three- and fourfold 
kDa
130
-/- -/- -/- -/-WT WT WT WT
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charged peptides carrying up to four phosphate residues were calculated. MS data 
obtained from the general peptide scans combined with MS/MS in two independent 
experiments and processed using the MASCOT server were screened for the 
presence of the calculated peptide mass/charge ratios using MassLynx 4.1 and 
Xcalibur software. In total, 13 non-phosphorylated peptides were detected by this 
analysis. Phosphorylated equivalents could be identified in two cases. Both peptides 
contained predicted phosphorylation sites at serine residues. Table 14 summarizes 
the results of the MS data analysis. 
 
Table 14: Summary of identified CLIP-115 peptides by mass spectrometry. Bold mass/charge 
ratios were clearly detected at the expected retention time and with the correct charge. Amino acids 
predicted to be phosphorylation sites in the respective peptide are bold, whereas the numbers give the 
first residue of the respective CLIP-115 peptide. 
Mass/charge of 
peptide [m/z], z = 2 
Mass/charge of 
phosphorylated 
peptide [m/z], z = 2 
Amino acids predicted as 
phosphorylation sites 
459.2506 WT/TTL-/- 499.2337 TTL-/- 720EQISLAEK 
467.7400 WT/TTL-/- 507.7232 TTL-/- * 450VEEESITK 
480.2615 WT/TTL-/- - 817AQVSALENK 
481.7613 WT/TTL-/- - 190ESVLNSSVK 
492.2377 TTL-/- - 539TYQTEVDK 
502.7742 WT/TTL-/- 542.7574 WT ** 289IGFPSTSPAK 
518.7691 WT/TTL-/- - 554YAQEVADLK 
525.7750 WT/TTL-/- - 338SGLLTETSSR 
558.7984 WT/TTL-/- - 843LEAELEAVSR 
588.3114 WT/TTL-/- 628.2945 WT *** 458GDLELTTVAEK 
664.8747 WT 704.8578 TTL-/- **** 471VLQLEEELSLR 
769.8501 WT/TTL-/- 809.8333 TTL-/- 199TGNESGSNLSDSGSVK 
771.9243 WT - 938YSLIDPASPPELLK 
WT/TTL-/- Peptide identified in wild type and TTL-/- samples 
WT Peptide identified only in wild type sample  TTL-/- Peptide identified only in TTL-/- sample 
* Signal masked from similar mass/charge  ** Peptide with wrong charge 
*** Signal with wrong retention time   **** Signal very insecure 
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In this screen, two CLIP-115 peptides (bold in Tab. 14) derived from TTL-/- MEFs 
exhibited a molecular weight corresponding to an additional phosphate residue and 
an earlier retention time as their non-phosphorylated equivalents. In contrast, data 
from wild type MEF samples did only contain clear signals from non-phosphorylated 
peptides, which could be justified with the higher purity of the TTL-/- MEF samples. 
According to an increased incorporation of C13 molecules besides the more frequent 
C12, a peptide gives multiple peaks in MS. The characteristic peak patterns with an 
increasing mass/charge ratio of 1/z per incorporated C13 molecule are shown for the 
two identified CLIP-115 peptides in Figure 35. Additionally, the corresponding 
chromatograms with the respective retention times of the non-phosphorylated 
peptide and the phosphorylated equivalent are included. As all identified peptides 
were double charged, the shift of the mass/charge ratio for each additional C13 
molecule is 0.5. 
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a)             b)  
 
 
 
 
 
 
 
 
 
 
 
 
c)             d)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 35: Analysis of MS data obtained from TTL-/- MEF CLIP-115 samples revealed two non-
phosphorylated peptides with phosphorylated equivalents. a) Mass spectra showing the signal 
intensity at the corresponding mass/charge ratio of the CLIP-115 peptide from amino acid 720 to 727. 
The upper spectrum shows the non-phosphorylated (calculated m/z = 459.2506) and the lower 
spectrum the phosphorylated form (calculated m/z = 499.2337). b) Chromatograms of the overall 
peptide flow intensity with the respective retention time in minutes corresponding to the peptides in a). 
c) Mass spectra showing the signal intensity at the corresponding mass/charge ratio of the CLIP-115 
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peptide from amino acid 199 to 214. The upper spectrum shows the non-phosphorylated (calculated 
m/z = 769.8501) and the lower spectrum the phosphorylated form (calculated m/z = 809.8333). d) 
Chromatograms of the overall peptide flow intensity with the respective retention time in minutes 
corresponding to the peptides in c). Due to their higher polarity phosphorylated peptides eluted earlier 
from the column. 
 
In summary, MS analysis of enriched CLIP-115 samples from wild type and TTL-/- 
MEFs did not confirm the data of our mutagenesis experiments. Instead, MS data 
supported a non-phosphorylated state of tyrosine 270 as shown by direct search for 
the corresponding CLIP-115 peptides. Together with the absence of changes in the 
molecular weight of CLIP-115 mutants, these results indicate a differential 
phosphorylation of CLIP-115 in TTL-/- MEFs at a different position than tyrosine 270. 
Nevertheless, the tyrosine 270 occupies a key position for binding of CLIP-115 to 
microtubules, at least by determining the conformation of the second CAP-Gly 
domain. Moreover, CLIP-115 shows a differential phosphorylation pattern as well as 
a different phenotype when bound to microtubule plus-ends in wild type and TTL-/- 
MEFs. Hence, phosphorylation seems to be a major mechanism to regulate the 
binding behaviour of CLIP-115. Further analysis of the obtained MS data already 
revealed two peptide candidates that seem to carry a serine phosphorylation. 
Although they were both identified in TTL-/- samples, their existence in wild type 
samples cannot be excluded as those contained more contaminating proteins 
decreasing the quality of the MS data. 
Additionally, rabbit antibodies against CLIP-115 peptides containing either 
phosphorylated or non-phosphorylated tyrosine 270 were generated (BioGenes 
GmbH). Antibodies were tested on synthetic CLIP-115 peptides in ELISA and on cell 
lysates in Western blotting. In both experiments, the antibodies turned out not to be 
highly specific. The amount of bound antibody was low in ELISA and the antibody 
against phosphorylated tyrosine 270 also recognized overexpressed mutant CLIP-
115 containing tyrosine-substitutions in Western blot analysis (not shown). 
Nevertheless, the antibody against phosphorylated tyrosine 270 detected 
endogenous CLIP-115 in wild type and TTL-/- MEF lysates including the observed 
shift in molecular weight. Again, these results support the differential phosphorylation 
of CLIP-115 in wild type and TTL-deficient MEFs, albeit by a different origin than the 
predicted tyrosine 270. 
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4. Discussion 
 
 
Microtubule dynamics and functions are regulated by the interaction with numerous 
microtubule-associated proteins. Binding of interaction partners depends on their 
affinity for microtubules, which can be influenced by regulation mechanisms as 
phosphorylation, autoinhibition, interaction with other proteins or the structure of the 
microtubule itself. The incorporated αβ-tubulin heterodimers are targets for several 
posttranslational modifications. Therefore, the binding sites for interacting proteins 
change their structural and electrostatic properties. Both can either promote or impair 
the interaction with specific binding partners. For example, posttranslational 
acetylation as well as detyrosination of α-tubulin is reported to affect the interaction 
between microtubules and kinesins. Acetylation promotes kinesin-1 loading onto 
microtubules (Reed et al., 2006), whereas detyrosination inhibits the interaction with 
microtubule-depolymerizing kinesin-13 motors (Peris et al., 2009). 
In several cases, the impact of a posttranslational tubulin-modification was examined 
by mutating the respective modification sites within the tubulin subunits (see chapter 
1.4.; Sharma et al., 2007; Westermann & Weber, 2003; Xia et al., 2000). The exact 
functions and mechanisms of posttranslational modifications of microtubules are still 
under investigation. One of the main problems in recent years was the fact that many 
of the involved enzymes were still unknown. The only enzyme being identified 
already many years ago is the tubulin-tyrosine ligase (TTL; Arce et al., 1975), which 
is involved in the tubulin tyrosination cycle (see chapter 1.4.4.). After incorporation of 
the αβ-tubulin heterodimers into microtubules, the C-terminal tyrosine residue of the 
α-tubulin subunits is removed by a yet unknown carboxypeptidase. Subsequent to 
depolymerization, TTL re-adds a tyrosine to the C-terminus of soluble detyrosinated 
α-tubulin. Detyrosination appears especially on stable microtubules, but does not 
directly increase stability by itself (Webster et al., 1990). Furthermore, TTL activity is 
decreased in tumour progression leading to a high level of detyrosination of 
microtubules (Lafanechère et al., 1998). The physiological meaning of the 
tyrosination cycle, though, remained unclear. 
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The identification of the TTL gene (Erck et al., 2003) and the subsequent generation 
of TTL knockout mice (Erck et al., 2005) allow the direct investigation of the 
tyrosination cycle of α-tubulin and its relevance for cellular processes in more detail. 
The importance of the tyrosination cycle became obvious since TTL-deficient mice 
died within 24 hours after birth due to malformations in the brain. However, the 
molecular basis still remained unknown. In TTL knockout neurons, the microtubule 
plus-end tracking protein CLIP-170 is mislocalised indicating an influence of tubulin 
detyrosination on the binding of microtubule-associated proteins (MAPs). 
Several groups reported an interaction between the microtubule network and the 
actin cytoskeleton. This interaction is believed to promote cell polarization and is 
proposed to be linked to the tyrosination state of the microtubules. One example is a 
signal transduction cascade mediated through the actin-regulating small GTPase 
Rho that triggers microtubule detyrosination (Cook et al., 1998). Furthermore, the 
linkage of microtubules to actin by a complex of CLIP-170 and another actin-
associated protein, IQGAP1, was discovered (Fukata et al., 2002; Gundersen, 2002). 
As CLIP-170 is mislocalised in neurons (Erck et al., 2005) and in Tyr-negative cells 
(Peris et al., 2006), a disruption of the cross-talk with the actin network can be 
assumed. Accordingly, Tyr-negative TTL knockout MEFs showed a disturbed 
development of lamellipodia indicating a defect in polarization (Peris et al., 2006). 
Due to ongoing protein biosynthesis TTL knockout cells still contain residual amounts 
of tyrosinated (Tyr-) tubulin (Erck et al., 2005; Peris et al., 2006). To gain more 
insight into the relevance of the tubulin tyrosination state for cell polarity and 
migration as well as for interactions with plus-end tracking proteins in non-neuronal 
cells, it was necessary to generate a homogeneous cell population free of Tyr-tubulin 
for further experiments. 
 
4.1. Depletion of tyrosinated tubulin in TTL knockout cells and 
investigation of cell polarity 
Two strategies were followed to obtain Tyr-negative cells. First, TTL knockout cells 
were chemically treated either to inhibit protein synthesis or to arrest the cell cycle. 
Cells were then used in wound-healing experiments to investigate their ability to 
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polarize and migrate. Secondly, microinjection of blocking antibodies was performed 
to generate cells without any available tyrosine residue at the α-tubulin C-termini. 
 
4.1.1. Chemical treatments 
For testing chemical treatments to deplete the remaining Tyr-tubulin in TTL-deficient 
cells, two immortalized TTL knockout cell lines (see Tab. 8 in chapter 2.7.1.) were 
employed due to their higher stability in cell culture compared to primary cells. 
The application of the DNA cross-linker mitomycin C alone did not result in the 
reduction of Tyr-tubulin in TTL-deficient cells. Therefore, cycloheximide was 
additionally used to inhibit mRNA synthesis. In contrast to mitomycin C-treatment, the 
application of cycloheximide strongly reduced the level of Tyr-tubulin (see Tab. 9). 
Unfortunately, due to the complete loss of protein biosynthesis and, by that, the 
ability to divide, cells died and could not be used for further experiments. 
A more gentle approach to suppress ongoing protein biosynthesis is the arrest of the 
cell cycle. For that, cells were exposed to thymidine, nocodazole or taxol. However, 
none of the treatments succeeded in a complete inhibition of the tubulin synthesis, 
since TTL knockout cells still contained residual Tyr-tubulin amounts. Again, only in 
combination with cycloheximide, the application of these chemicals led to a reduction 
of the Tyr-tubulin level in TTL knockout cells, but once more cell viability was 
severely impaired and made further experiments impossible. Finally, the 
carboxypeptidase-activating drug forskolin was employed in combination with taxol to 
promote the detyrosination reaction (Wehland & Weber, 1987b). As TTL is missing, 
an increased carboxypeptidase activity should clearly reduce levels of Tyr-tubulin, 
but this effect could not be observed here (see Tab. 9). Cells obviously produced 
sufficient tubulin to compensate the increased carboxypeptidase activity. 
Notably, the performed chemical treatments affected TTL knockout (ΙΙ) cells more 
drastically than the temperature-sensitive TTL knockout (Ι) cells (see Tab. 8 and 9). 
Two days of serum starvation combined with doxycycline-withdrawal inactivated the 
cells sufficiently to reduce the Tyr-tubulin amount by at least 50 %, as determined by 
Western blotting (not shown). Since TTL knockout (ΙΙ) cells were in good condition 
after starvation, it was decided to use these cells in wound-healing experiments. 
Previously, defective cell polarization in the absence of TTL has been reported (Peris 
et al., 2006). In those studies only the shape of single cells was analysed without 
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considering the ability of Golgi reorientation or cell migration. The observed 
mislocalisation of CLIP-170 in the absence of TTL in those studies may have 
influenced the cross-talk with the actin cytoskeleton and, by that, resulted in the 
reported defects in cell polarization. Despite the reduced amount of Tyr-tubulin, 
starved TTL knockout (ΙΙ) cells still polarized in our experimental set-up as 
demonstrated by Golgi reorientation after wounding a cell monolayer (Fig. 14; 
Palazzo et al., 2001). Furthermore, cells migrated into the wound until closure. 
Consequently, a reduction of tyrosinated tubulin did not obviously hinder cell 
polarization and migration, so that a complete depletion of Tyr-tubulin is necessary to 
gain more convincing results. 
 
4.1.2. Microinjection of antibodies 
As chemical treatments did not completely eliminate Tyr-tubulin levels, antibodies 
specific for the tyrosinated α-tubulin C-terminus were microinjected in TTL knockout 
cells to block the remaining C-terminal tyrosines. For microinjection experiments, the 
monoclonal antibodies 20C6 from mouse and YL1/2 from rat were successfully 
purified and microinjected into TTL knockout (ΙΙ) cells in different amounts. Already 
an antibody concentration of 0.5 mg/ml resulted in clearly visible microtubule bundles 
originating from antibody-mediated microtubule cross-linking (Wehland et al., 1983). 
To avoid microtubule cross-linking, antibody Fab fragments were employed. 
Besides the immortalized TTL knockout cells, also primary wild type and TTL-
deficient mouse embryonic fibroblasts (MEFs) were used for injections. As expected, 
Fab fragments did not cross-link microtubules but obviously affected the localisation of 
the plus-end tracking protein CLIP-170. Approximately 25 % of microinjected wild 
type and TTL-deficient MEFs lacked CLIP-170 at the microtubule plus-ends. Notably, 
the majority of injected MEFs had a normal distribution of CLIP-170. These results 
indicate that CLIP-170 mislocalisation in microinjected cells is not necessarily a 
consequence of a Fab fragment-mediated masking of the C-terminal tyrosine residues 
of α-tubulin. Thus, high amounts of injected Fab fragments might disturb the 
microtubule plus-end-associated protein complex. 
Interestingly, all non-injected TTL knockout MEFs that were stained for CLIP-170 in 
the microinjection experiments, did show a normal CLIP-170 localisation at 
microtubule plus-ends similar to wild type MEFs. This result is in contrast to the 
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published mislocalisation of CLIP-170 in Tyr-negative TTL knockout MEFs (Peris et 
al., 2006). As microinjection experiments did not give clear results, but raised 
discrepancies to recently published data, we decided to focus the further studies on a 
detailed characterization of primary TTL-deficient MEFs. 
 
4.2. Characterization of tubulin pools in TTL-deficient mouse 
embryonic fibroblasts 
For the characterization of non-neuronal TTL knockout cells, 13 days old embryos 
were isolated from heterozygous mice followed by the establishment of primary 
MEFs in cell culture. Mitotic TTL-deficient cells were reported to still contain a 
residual pool of tyrosinated tubulin due to ongoing protein biosynthesis (Erck et al., 
2005), which could also be observed in our TTL knockout MEFs. To decrease cell 
activity and thereby protein synthesis, MEFs were starved in serum-free medium for 
two days. Subsequent immunofluorescence analysis revealed high levels of Tyr-
tubulin in cells containing the TTL gene (wild type and TTL heterozygous MEFs), 
whereas TTL-deficient MEFs possessed only weak Tyr-tubulin-like structures (Fig. 
15). Moreover, wild type and TTL heterozygous MEFs contained very low levels of 
detyrosinated (Glu-) and Δ2-Glu-tubulin, an α-tubulin variant that is missing both the 
C-terminal tyrosine and the penultimate glutamic acid residue. As expected, those 
tubulin pools were present at high levels in TTL knockout MEFs. In Western blot 
analysis, the results were even more obvious: Tyr-tubulin could only be identified in 
cell lysates from TTL-containing MEFs, whereas Glu- and Δ2-Glu-tubulin were 
exclusively present in lysates obtained from TTL-deficient MEFs (Fig. 16). According 
to the lack of TTL activity, Glu-tubulin and, as a consequence, also Δ2-Glu-tubulin 
accumulates in TTL knockout MEFs. 
However, immunofluorescent staining using highly purified and concentrated YL1/2 
antibody against the C-terminus of Tyr-tubulin identified a population of TTL knockout 
MEFs that still contained Tyr-tubulin (Tyr-positive), as has been reported previously 
(Peris et al., 2006). Interestingly, the content of Tyr-positive MEFs was observed to 
be negatively correlated to increasing passages in our cell culture set-up. Therefore, 
TTL-deficient MEFs containing and lacking Tyr-tubulin were considered separately in 
the following analysis of microtubule plus-end tracking proteins. 
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4.3. Characterization of microtubule plus-end tracking proteins in 
mouse embryonic fibroblasts 
Microtubule-associated proteins play a major role in regulating microtubule dynamics 
and functions. An important group of those proteins is formed by the plus-end 
tracking proteins (+TIPs), which specifically bind growing microtubule plus-ends and 
largely influence their dynamic behaviour. As mentioned above, a mislocalisation of 
the +TIP CLIP-170 in TTL knockout neurons as well as a depleted microtubule 
binding of CAP-Gly domain-containing +TIPs in MEFs lacking Tyr-tubulin have 
already been reported (Erck et al., 2005; Peris et al., 2006). In order to gain deeper 
insight in the effects of TTL deficiency on the interaction between microtubules and 
+TIPs, wild type and TTL knockout MEFs were analysed by immunofluorescence and 
Western blotting. 
 
4.3.1. Localisation and comet length of +TIPs 
Consistent with published results, immunofluorescent stainings for end binding 
proteins (EBs) revealed a localisation to microtubule plus-ends independently from 
the genotype and the presence of Tyr-tubulin (Erck et al., 2005; Peris et al., 2006). 
EB proteins could thus be used as plus-end markers (Fig. 17). As EB proteins 
possess a higher affinity for GTP-loaded tubulin than for GDP-loaded tubulin, they 
most probably recognize the growing microtubule plus-ends due to the newly 
incorporated GTP-loaded tubulin heterodimers (Dragestein et al., 2008; Zanic et al., 
2009). For that reason, the tyrosination state of the α-tubulin subunits does not 
influence EB binding. 
Surprisingly, the CAP-Gly domain-containing proteins CLIP-170, CLIP-115 and 
p150Glued all localised to microtubule plus-ends in the absence of tyrosinated tubulin. 
Staining of Tyr-tubulin using highly concentrated YL1/2 antibody divided the TTL 
knockout MEF population into Tyr-positive and Tyr-negative cells, as described by 
Peris et al. (2006). In contrast to their results, CLIP-170 clearly co-localised with EB1 
at microtubule plus-ends in all investigated MEFs in this study (Fig. 17). Since the 
length of CLIP-170 plus-end comets also was similar in all MEFs (Fig. 19), no 
genotype- or Tyr-tubulin-dependent localisation of CLIP-170 could be observed. A 
mislocalisation of CLIP-170 was also reported in TTL-deficient neurons, but even 
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though the neuronal cell body lacked Tyr-tubulin, CLIP-170 was concentrated in that 
region (Erck et al., 2005). If only the tyrosination state of microtubules controlled 
CLIP-170 localisation, the cellular CLIP-170 distribution should correlate with the 
distribution of Tyr-tubulin. In the absence of Tyr-tubulin, CLIP-170 would be evenly 
distributed in the neuronal cytoplasm. This already indicates a different regulatory 
mechanism for CLIP-170 binding to microtubules than tubulin detyrosination itself. 
However, the C-terminal tyrosine residue of α-tubulin strongly increases CLIP-170 
affinity for microtubule binding (Mishima et al., 2007). CLIP-170 binding is only 
reduced and not completely abolished at microtubules lacking the complete acidic 
tails of α- and β-tubulin. Especially the second CAP-Gly domain of CLIP-170, 
together with the adjacent serine-rich regions, also binds to the so-called H12 helices 
of α- and β-tubulin, which precede the acidic C-terminal tails (Fig. 36; Gupta et al., 
2010). Furthermore, CLIP-170 recruitment to plus-ends depends on the presence of 
EB1 (Komarova et al., 2005; Bieling et al., 2008). This indicates that the observed 
CLIP-170 localisation at microtubule plus-ends of Tyr-negative MEFs is mediated 
through a direct interaction with EB1 and the tubulin H12 helices. Taken together, the 
results presented here are not in agreement with an essential role of the C-terminal 
tyrosine of α-tubulin in CLIP-170 plus-end tracking and support the existence of 
additional binding sites for CAP-Gly domain-containing proteins on tubulin. 
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Fig. 36: Schematic structures of CLIP-170 and the respective target sites on α- and β-tubulin. 
The CLIP-170 domain structure is illustrated schematically including both CAP-Gly domains, the 
adjacent serine-rich regions (S1 – S3), the coiled-coil domain and both zinc knuckles (Zn). 
Additionally, the C-terminal structures of α- and β-tubulin are shown including the H12 helices and the 
acidic tails. The amino acid sequences of murine α- and β-tubulin 1 are listed. Interaction targets of 
CLIP-170 are coloured in green. The CAP-Gly domains and the serine-rich regions of CLIP-170 are 
able to interact with the acidic tail of α-tubulin as well as with the H12 helices of both α- and β-tubulin. 
The C-terminal tyrosine of the α-tubulin acidic tail (bold) ensures high affinity of CLIP-170 for α-tubulin, 
but is not essential for microtubule binding (adapted from Gupta et al., 2010; Mishima et al., 2007). 
 
Additionally, p150Glued co-localised with CLIP-170 demonstrated by equivalent 
staining patterns in all investigated MEFs. This observation corresponds with the 
reported recruitment of the dynein/dynactin complex to microtubule plus-ends 
through the interaction of CLIP-170 with p150Glued (Weisbrich et al., 2007). 
Furthermore, the p150Glued CAP-Gly domain possesses only a weak affinity for 
microtubules, but a much higher affinity for the CLIP-170 zinc knuckles and, 
therefore, binds predominantly to CLIP-170 (Mishima et al., 2007). 
The only difference between Tyr-positive and Tyr-negative MEFs concerning the 
+TIPs could be observed in the CLIP-115 localisation. Although CLIP-115 was 
present at microtubule plus-ends in all MEFs, the CLIP-115 plus-end comets were 
significantly elongated in TTL knockout MEFs lacking Tyr-tubulin (Fig. 18 and 19). 
This result has not been reported in literature yet. To confirm the connection of CLIP-
115 plus-end length with the presence of Tyr-tubulin, an exogenous TTL cDNA was 
expressed in TTL-deficient MEFs. These rescue experiments could completely 
restore the CLIP-115 phenotype of Tyr-positive MEFs (Fig. 20). In contrast to CLIP-
115, CLIP-170 and EB1 comet lengths were not influenced by the expression of the 
exogenous TTL (Fig. 21). The determined comet lengths varied from approximately 
0.4 – 2.0 µm (Figures 19 and 20), which is consistent with a published plus-end 
length of 0.5 – 2.0 µm (Akhmanova & Steinmetz, 2008; also compare Bieling et al., 
2008, and Peris et al., 2006). Thus, comet lengths at single plus-ends varied in a 
broad range, which can be explained by different angles and growth speeds. 
Although a higher speed of microtubule growth results in longer comet tails of plus-
end associated proteins (Bieling et al., 2008), the demonstrated overall elongation of 
CLIP-115 plus-end comets in Tyr-negative MEFs seems to originate from a different 
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mechanism since both CLIP-170 and EB1 comet lengths were unaffected. 
Furthermore, the microtubule growth rate measured in TTL knockout MEFs appears 
to be in the same range as in wild type MEFs (Peris et al., 2009). A temporally longer 
existence of +TIP binding sites due to a delay in structural changes or GTP-
hydrolysis at the microtubule plus-ends in cells lacking Tyr-tubulin can also be 
excluded as this would influence all +TIPs. This indicates that the absence of Tyr-
tubulin directly affects CLIP-115 or reactions concerning CLIP-115 binding. Since 
CLIP-115 functions as a rescue factor (Galjart, 2005), modulated binding to 
microtubules may, therefore, influence microtubule dynamics. 
 
4.3.2. Biochemical analysis of +TIPs 
To gain a deeper insight in effects of TTL deficiency on plus-end tracking proteins, 
EB1 and the CLIPs were investigated in biochemical experiments. By Western blot 
analysis, differences in the expression pattern as well as putative posttranslational 
modifications of the proteins can be uncovered. For further characterization of +TIPs 
in wild type, heterozygous and TTL knockout MEFs, cell lysates were examined in 
Western blot analyses using specific antibodies against EB1, CLIP-170 and CLIP-
115. As expected from previous results, the presence of one TTL allele in 
heterozygous MEFs was enough to maintain the wild type phenotype for all proteins. 
Consistent with the immunofluorescence analyses, EB1 and CLIP-170 were similar in 
all genotypes regarding their molecular weight. Also the respective expression levels 
did not reveal any genotype dependency (Fig. 22). Notably, CLIP-170 appeared as a 
double band in Western blotting, as it is expressed in two isoforms resulting from 
alternative splicing (Griparic & Keller, 1998). Although CLIP-115 also exists in two 
splice variants, a single band was visible on Western blots representing either the 
presence of only one isoform in the investigated MEFs or isoform-specific antibody 
specificity. In contrast to EB1 and CLIP-170, CLIP-115 possessed a slightly lower 
molecular weight in TTL-deficient MEFs compared to wild type and heterozygous 
MEFs. The different molecular weights of CLIP-115 in the presence and the absence 
of TTL indicate a genotype-specific posttranslational modification. Since +TIPs often 
are targets of phosphorylation events, which modulate their microtubule affinity, as 
shown for CLIP-170 (Yang et al., 2009), CLASP2 (Kumar et al., 2009), MAP1B 
(Trivedi et al., 2005) and tau (Drewes et al., 1997), a phosphorylation could also be 
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the origin of the observed CLIP-115 mass shift. Indeed, phosphatase treatment 
decreased the molecular weight of CLIP-115 in wild type MEF lysates, but had no 
effect in TTL knockout MEF lysates (Fig. 23). Thus, CLIP-115 is additionally 
phosphorylated in wild type MEFs and exists in a less phosphorylated state in the 
absence of TTL. The observed difference in the molecular weight, therefore, does not 
derive from alternative splicing. Since in many cases phosphorylation of microtubule-
associated proteins reduces the affinity for microtubules (Rickard & Kreis, 1991), it 
may be assumed that the pool of less phosphorylated CLIP-115 in TTL-deficient 
MEFs results in higher affinity to microtubules. This in turn can explain the origin of 
the observed elongated CLIP-115 microtubule plus-ends in TTL knockout MEFs 
lacking Tyr-tubulin. 
As described above, phosphorylation of CLIP-115 results in a higher molecular 
weight visible in SDS-PAGE. To determine the number of additional phosphate 
residues that evoke the mass shift, total protein samples obtained from wild type and 
TTL knockout MEF lysates were analysed in two-dimensional SDS-PAGE. Every 
additional phosphate residue causes a shift of the isoelectric point of a protein and, 
therefore, the number of phosphorylations on CLIP-115 should be quantified. 
Unfortunately, variable protein amounts, loading techniques and different methods for 
isoelectric focussing did not succeed in an appropriate separation of CLIP-115. 
Although other proteins in the samples were focussed in the first dimension as 
demonstrated in Coomassie-stained SDS gels, CLIP-115 remained distributed over a 
broad pH range. Therefore, the inability of CLIP-115 focussing most probably 
originates from the specific protein properties. For instance, the relatively large size 
of CLIP-115 could be one reason why this protein could not be focussed. 
Additionally, single or several unknown modifications resulting in a higher 
hydrophobicity of CLIP-115 or even the presence of other proteins could explain the 
inability of isoelectric focussing. Direct after starting isoelectric focussing, some 
proteins tend to precipitate due to increasing condensation of the protein sample 
(Klose & Kobalz, 1995), which may explain the inability of CLIP-115 focussing 
observed in our studies. 
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4.3.3. Effects of phosphatase and kinase inhibition on CLIP-115 
In order to identify the type of amino acid that is targeted by phosphorylation of CLIP-
115, wild type and TTL knockout MEFs were treated with different phosphatase and 
kinase inhibitors. Western blot analysis of cell lysates revealed an obvious effect only 
after application of sodium vanadate, a tyrosine phosphatases inhibitor. After 
vanadate treatment, the CLIP-115 signal appeared as two bands in TTL knockout 
MEFs. The new appearing band could be observed at the molecular weight of CLIP-
115 as seen in wild type MEFs. Thus, the inhibition of tyrosine dephosphorylation 
seems to restore the wild type phenotype of CLIP-115 in TTL-deficient MEFs at least 
partly. In contrast, inhibition of serine/threonine phosphatases by okadaic acid and 
calyculin A did not affect the molecular weight of CLIP-115 in TTL-deficient MEFs. 
The molecular weight of CLIP-115 remained constant in wild type MEFs through all 
treatments. Moreover, the molecular weight of CLIP-170 was unaffected after all 
treatments (Fig. 24). Additionally, wild type and TTL knockout MEFs were 
investigated by immunofluorescence after variable incubation times with 
phosphatase inhibitors. Again, only sodium vanadate affected the localisation of 
+TIPs. Interestingly, EB1, CLIP-170 and CLIP-115 were all eliminated from 
microtubule plus-ends after sodium vanadate treatment. Effects evoked by sodium 
vanadate were completely reversible since +TIPs reappeared after vanadate 
washout (Fig. 25 and 26). 
Taken together, Western blot and immunofluorescence analyses revealed an 
influence of vanadate on CLIP-115 phosphorylation and plus-end localisation, 
respectively. These results indicate the phosphorylation of a tyrosine residue of 
CLIP-115, which is involved in microtubule plus-end binding and reduces the affinity 
for microtubules. Accordingly, either the CLIP-115 phosphorylation by a kinase is 
decreased or the dephosphorylation by a phosphatase is increased in TTL-deficient 
MEFs. Although sodium vanadate did not affect EB1 and CLIP-170 molecular 
weights, it abolished their binding to microtubule plus-ends analogous to CLIP-115. 
The inhibition of tyrosine phosphatases results in a substantial intervention in cell 
function and most probably affects numerous processes. Therefore, a secondary 
effect of vanadate must be taken into consideration for the observed removal of 
CLIP-115, CLIP-170 and EB1 from microtubule plus-ends instead of a 
phosphorylation on the proteins themselves. 
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Both the inhibition of kinases by staurosporine as well as the more specific inhibition 
of tyrosine kinases by genistein did not affect CLIP-115 or CLIP-170 molecular 
weights (Fig. 24). 
 
4.3.4. Identification of putative phosphorylation sites in CLIP-115 
As the inhibition of tyrosine phosphatases influenced CLIP-115 localisation and 
biochemical properties, we expected a tyrosine phosphorylation to be the most 
probable origin of the observed difference in CLIP-115, derived from wild type and 
TTL knockout MEFs. Using the online NetPhosK 1.0 and NetPhos 2.0 Servers 
(Technical University of Denmark), six tyrosines were predicted as potential 
phosphorylation sites. One of them (tyrosine residue 270) is located in a conserved 
region of the second CAP-Gly domain (see Tab. 11 and Fig. 27). A corresponding 
tyrosine residue, although not predicted as a phosphosite, is also present in the first 
CAP-Gly domain (tyrosine residue 130) and, therefore, was included in the 
subsequent experiments. The respective tyrosines were substituted either by 
glutamic acid mimicking phosphorylation or by non-phosphorylatable phenylalanine 
in full length CLIP-115-EGFP fusion constructs. Mutant CLIP-115-EGFP fusion 
proteins were then overexpressed for example in CLIP-115 knockout and CLIP-
170/CLIP-115 double knockout MEFs, which were employed to eliminate the 
competition with endogenous CLIP-115. 
Only mutations of tyrosines 130 and 270 into glutamic acid influenced CLIP-115 
binding to microtubules. The respective mutation of tyrosine 270 strongly reduced the 
localisation of CLIP-115 at microtubules, whereas the mutation of tyrosine 130 only 
moderately reduced microtubule binding. In contrast, the introduction of 
phenylalanine had no effects. The combined mutation of both tyrosines into glutamic 
acid completely removed EGFP-CLIP-115 fusion proteins from microtubules. Since 
the second CAP-Gly domain possesses a higher affinity for microtubules 
(Hoogenraad et al., 2000), it can almost completely compensate for a mutation in the 
first CAP-Gly domain. In contrast, the first CAP-Gly domain can scarcely maintain 
CLIP-115 binding to microtubules when the second CAP-Gly domain is mutated. As 
a consequence, EGFP-CLIP-115 fusion proteins carrying mutations in both CAP-Gly 
domains were not able to bind microtubules anymore (Fig. 29 and 30). In conclusion, 
these results indicate that a phosphorylation of tyrosine 270 would severely decrease 
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CLIP-115 binding to microtubule plus-ends and could, therefore, act as a regulatory 
mechanism for CLIP-115 interaction with microtubules. Binding of CLIP-115 to 
microtubules is based on electrostatic interaction. Thereby, the major interaction 
takes place between the positively charged, hydrophobic cavity of the CAP-Gly 
domain and the negatively charged acidic tail of α-tubulin (Weisbrich et al., 2007). 
Phosphorylation of the CAP-Gly domain in its binding area would introduce a 
negative charge and by that reduce the affinity for tubulin. On the other hand, the 
mutation can also induce a conformational change of the domain structure leading to 
an impaired microtubule-binding capacity. This could be the case when tyrosine is 
substituted with glutamic acid, a structurally different amino acid that introduces a 
negative charge (Fig. 37a). In contrast, phenylalanine resembles the structure and 
hydrophobicity of tyrosine (Fig. 37a) and, thereby, the protein conformation most 
probably is maintained. 
Additionally, a mutation of tyrosine 270 into alanine was performed as an alternative 
non-phosphorylation mimic. Similar to glutamic acid, alanine reduced CLIP-115 
localisation at microtubules and completely disrupted microtubule binding in 
combination with a glutamic acid at position 130 (Fig. 30). Also alanine differs 
structurally from tyrosine (Fig. 37a) and seems to cause conformational changes of 
the CAP-Gly domain, as shown by a substantial reduction in the microtubule-binding 
capacity of CLIP-115. The structure of the closely related CAP-Gly domain of 
p150Glued including amino acids of the conserved hydrophobic cavity and the 
investigated tyrosine is illustrated in Figure 37b. The hydrophobic cavity mainly 
consists of four conserved amino acids (highlighted in red in Fig. 37b), whereas the 
corresponding tyrosine (blue) stabilizes the structure from the backside. 
Consequently, the substitution of this tyrosine with glutamic acid or alanine could 
destabilize the hydrophobic cavity by introducing a negative charge in a hydrophobic 
environment or removing the aromatic ring. Both changes most probably affect the 
domain structure and, therefore, can result in disturbed microtubule binding. 
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Fig. 37: Relevant amino acids and structure of the p150Glued CAP-Gly domain. a) Structural 
formulas of tyrosine, phenylalanine, glutamic acid and alanine. b) Ribbon plot of the p150Glued CAP-Gly 
domain with the conserved amino acids phenylalanine 52, tryptophan 57, valine 73 and phenylalanine 
88 of the hydrophobic cavity depicted in stick and ball presentation in red. Tyrosine 78 (highlighted in 
blue) corresponds to the investigated CLIP-115 tyrosine residues 130 and 270 as well as to the CLIP-
170 tyrosine residues 108 and 261. The ribbon plot is overlaid with a surface presentation including 
the hydrophobic cavity highlighted in red (Protein Data Bank code 2PZO; Weisbrich et al., 2007). 
 
For example, site-directed mutagenesis experiments on tau showed that the aromatic 
ring of tyrosine residue 310, which is located in the microtubule-binding domain of 
tau, is necessary for correct protein folding and, thereby, for microtubule binding 
(Nishiura et al., 2009). The presence of an aromatic ring, which is part of both 
tyrosine and phenylalanine, at amino acid residue 270 of CLIP-115 might therefore 
Tyrosine (Y) Phenylalanine (F) Glutamic acid (E) Alanine (A)
a)
F52
Y78
W57
F88
V73
b)
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be essential for domain conformation or folding. Thus, the structural data support the 
hypothesis that phosphorylation of CLIP-115 tyrosine 270 could function as 
regulative mechanism for CLIP-115. 
In studies on CLASP2 fragments, the mutation of phosphorylation sites influenced 
the molecular weight in SDS-PAGE, whereas mutations of residues that are no 
phosphorylation targets did not affect the molecular weight (Kumar et al., 2009). In 
our experiments, all mutant fusion proteins appeared at the same molecular weight. 
This indicates that the mutated tyrosine residues are probably not affected by 
phosphorylation. However, the fusion of CLIP-115 to EGFP might occlude the 
changes in charge evoked by the introduced mutations and, therefore, alters its 
behaviour during SDS-PAGE. Furthermore, the engagement of full length CLIP-115 
might mask weak effects caused by mutagenesis. 
As CAP-Gly domains are highly conserved through different proteins and organisms, 
the respective domains of CLIP-115 and CLIP-170 share great identity. Therefore, 
tyrosines 130 and 270 of CLIP-115 possess conserved homologues in CLIP-170, 
tyrosines 108 and 261, respectively. In order to compare the impact on microtubule 
binding, also these tyrosines were mutated either into phenylalanine or glutamic acid. 
Interestingly, only a combined mutation of both tyrosine residues into glutamic acids 
significantly reduced binding to microtubules. In some cells, CLIP-170 localisation to 
microtubule plus-ends was completely disrupted (Fig. 32 and Tab. 13). Remarkably, 
the mutations had a clearly less drastic effect in CLIP-170 than in CLIP-115. The 
second CAP-Gly domain of CLIP-170 contains two additional basic residues, 
arginines 297 and 298, compared to CLIP-115. Consequently, it possesses a more 
positively charged binding groove and, by that, a higher binding affinity for 
microtubules (Mishima et al., 2007). The introduction of a negative charge by the 
phosphorylation-mimicking mutation of tyrosine 261 into glutamic acid therefore has 
a weaker effect on the total domain charge and the structure than the corresponding 
mutation in CLIP-115. 
In conclusion, these results demonstrate a vital role of tyrosine residues 130 and, 
especially, 270 in microtubule binding of CLIP-115. The introduction of a 
phosphorylation-mimicking mutation significantly reduced microtubule binding, while 
mimicking non-phosphorylation had opposite effects. Tyrosine-resembling 
phenylalanine did not alter microtubule binding, whereas alanine reduced CLIP-115 
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localisation at microtubules. Mutation analysis unfortunately did not clearly reveal 
whether the respective tyrosine residues within the CLIP-115 and CLIP-170 CAP-Gly 
domains appear as phosphorylation sites or as structure-stabilizing elements. 
 
4.3.5. Search for CLIP-115 phosphorylation sites by mass spectrometry 
As described above, treatments of TTL knockout MEFs with sodium vanadate 
indicated a tyrosine phosphorylation of CLIP-115. Subsequent mutation experiments 
could identify tyrosine residue 270 to be important for microtubule binding, but the 
exact role of this tyrosine could not be unravelled. Since CLIP-115 definitely appears 
differentially phosphorylated in wild type and TTL knockout MEFs, mass 
spectrometry (MS) was used to identify the involved phosphorylation site(s). 
In order to enrich CLIP-115 from lysates obtained from wild type and TTL-deficient 
MEFs, immunoprecipitation was performed. Unfortunately, in first experiments the 
mass shift of CLIP-115 could not be maintained during the procedure (Fig. 33a). 
Therefore, the subsequent MS analysis failed in detecting a phosphorylation-based 
difference between CLIP-115 from wild type and TTL knockout MEFs. Furthermore, 
the identified peptides only covered 15.7 % of the complete CLIP-115 sequence 
limiting the probability for identifying a phosphorylated residue. 
In subsequent experiments, the different molecular masses of CLIP-115 from wild 
type and TTL knockout MEFs could partly be maintained (Fig. 34). Synthetic peptides 
corresponding to the phosphorylated or non-phosphorylated CLIP-115 tryptic digest 
product containing tyrosine 270 were used as calibration standards in mass 
spectrometry. As the respective retention times and peptide masses were known, the 
CLIP-115 samples were specifically analysed by mass spectrometry regarding the 
tyrosine residue 270-containing peptide. The peptide with a non-phosphorylated 
tyrosine 270 was clearly identified in both wild type and TTL knockout samples. In 
contrast, in three independent experiments a peptide containing a phosphorylation at 
tyrosine 270 could not be detected. In conclusion, either the phosphorylation state of 
CLIP-115 could not be maintained during the experimental procedure or the tyrosine 
residue 270 is not phosphorylated in vivo indicative for a different origin of the 
observed mass shift of CLIP-115 in wild type and TTL-/- MEFs. 
Previous experiments clearly demonstrated a phosphorylation of CLIP-115. However, 
the expected tyrosine phosphorylation could not be confirmed in our experimental 
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set-up. Since antibodies raised against phosphorylated tyrosine 270 of CLIP-115 also 
detected a different molecular weight of CLIP-115 in wild type and TTL knockout 
MEFs, a phosphorylation at a different amino acid residue is supported. Therefore, 
the received MS data was searched for the presence of other phosphorylated 
peptides. All possible CLIP-115 peptides produced by tryptic digest that contain a 
predicted phosphorylation site for serines, threonines and tyrosines were compared. 
Peptide masses were then calculated for different charges and the presence or 
absence of phosphate residues. Screening the CLIP-115 MS data revealed only two 
peptides derived from TTL knockout samples that were most probably 
phosphorylated (Tab. 14, Fig. 35). According to previous results demonstrating CLIP-
115 to be phosphorylated to a higher degree in wild type, the detection of 
phosphorylated peptides in TTL knockout samples might be surprising. Here, the 
higher purity of the TTL knockout samples improved peptide detection in general. 
One of the identified phosphopeptides contains serine residue 723, which is located 
in the coiled-coil domain of CLIP-115 and for that is most probably not involved in 
microtubule binding. However, phosphorylation of this residue might influence CLIP-
115 dimerization, which is mediated by the coiled-coil domain. 
Interestingly, the other identified peptide is located in the second serine-rich region 
and therefore covers a section of the microtubule-binding area of CLIP-115. This 
peptide includes serine residues 203, 208, 210 and 212 as predicted phosphorylation 
sites. Notably, CLIP-115 serines 203, 208 and 212 are conserved and correspond to 
CLIP-170 serines 194, 199 and 203. A screen of phosphopeptides derived from 
CLIP-170 already identified those serine residues as potentially phosphorylated 
amino acids (personal communication with A. Akhmanova, Department of Cell 
Biology, Erasmus Medical Center, Rotterdam). 
In summary, the CLIP-115 peptide from amino acid residue 199 to 214 is a 
promissing candidate harbouring a phosphorylation site. Since it covers a region 
within the microtubule-binding area of CLIP-115, phosphorylation of one or multiple 
serines could act as a regulatory mechanism for CLIP-115 binding to microtubules. 
To identify potential interaction partners of CLIP-115, proteins that were co-
immunoprecipitated with CLIP-115 were also analysed by mass spectrometry and 
identified to be keratin and heat shock protein 70 (glucose-related protein 78). Most 
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probably, these proteins do not interact with CLIP-115, as they are common 
contaminations of protein preparations and frequently occur in MS analyses. 
 
4.4. Conclusions and outlook 
In order to gain more insight in the role of tubulin detyrosination, MEFs lacking the 
tubulin-tyrosine ligase were characterized. Wound-healing experiments using TTL 
knockout cells could not reveal an impact of reduced Tyr-tubulin levels on cell 
polarization and migration, as assumed in previous studies (Erck et al., 2005; Peris et 
al., 2006). Since we did not succeed in generating a population of Tyr-negative cells, 
future experiments should concentrate on the analysis of single Tyr-negative TTL 
knockout cells in order to unravel a potential impairment of cellular processes like 
polarization and migration in TTL-deficient MEFs. Furthermore, Golgi reorientation as 
well as the migration velocity should be determined in standardized wound-healing 
assays using live cell imaging and cell tracking. To enable single cell recovery after 
cell tracking, cells could be grown on coverslips containing a grid or coordinate 
system. By that, Tyr-negative cells could be detected in subsequent Tyr-tubulin 
staining. Finally, commercial Transwell migration assays could be performed to 
investigate the chemotactic behaviour of wild type and TTL-deficient MEFs. Serum-
starved cells migrate in the direction of increasing serum concentration and can be 
fixed after a defined migration time for subsequent immunofluorescence analysis. 
Moreover, primary TTL knockout neurons could be used in further investigations of 
TTL deficiency since these cells show a more drastic TTL knockout phenotype than 
fibroblasts and are free of Tyr-tubulin (Erck et al., 2005). 
Here we clearly demonstrated the ability of CAP-Gly domain-containing proteins to 
bind microtubule plus-ends independently from the presence of tyrosinated tubulin. 
Thus, the physiological relevance of the α-tubulin tyrosination cycle cannot be 
pinpointed to the regulation of microtubule interactions with CAP-Gly proteins alone 
(Peris et al., 2006). Remarkably, CLIP-115 even showed significantly elongated plus-
end comets in TTL knockout MEFs lacking Tyr-tubulin. Additionally, CLIP-115 
possessed a slightly smaller molecular weight in TTL-deficient MEFs compared to 
wild type MEFs. This mass shift turned out to be a consequence of differential 
phosphorylation most probably at a tyrosine residue. Although results from vanadate 
treatments indicate a tyrosine phosphorylation, more detailed experiments with other 
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phosphatase inhibitors as okadaic acid or calyculin A should be performed. 
Interestingly, in vitro co-sedimentation experiments revealed a slightly higher 
molecular weight of CLIP-115 peptides that were not bound to microtubules in the 
presence of the serine phosphatase inhibitor okadaic acid (Hoogenraad et al., 2000). 
Soluble CLIP-115 obviously was phosphorylated at a serine residue, whereas non-
phosphorylated CLIP-115 co-sedimented with microtubules. As we used okadaic acid 
in a concentration of only 25 nM according to a standard protocol, the concentration 
probably was too low to evoke a shift of the molecular weight of CLIP-115. 
This study already delivers some supporting results for a phosphorylation of CLIP-
115 at a serine residue within the second serine-rich region, a section that is involved 
in microtubule binding. Screening of MS data identified a CLIP-115 peptide most 
probably carrying a phosphate residue. This peptide consists of amino acids 199 – 
214 and contains three serine residues that are predicted as phosphorylation sites. 
Furthermore, those serines are conserved and phosphorylated in CLIP-170. Site-
directed mutagenesis of the respective serine residues in CLIP-115 would facilitate 
the identification of phosphorylation sites and their potential involvement in 
microtubule targeting. Additionally, CLIP-115 deletion fragments including those 
residues could be used in Western blot analyses to reveal possible effects of the 
introduced mutations on the molecular weight in analogy to CLASP2 mutation studies 
described above (Kumar et al., 2009). For mapping phosphorylation sites in CLIP-
115, phosphoserine and phosphothreonine residues from immunoprecipitated CLIP-
115 from wild type and TTL knockout MEFs could be chemically converted into 
aminoethylcysteine and β-methylaminoethylcysteine, respectively. The modified 
amino acid residues are recognized by proteases that cleave at lysines. Subsequent 
mass spectrometry could then be used to identify the cleavage sites (Knight et al., 
2003). 
Detyrosination of α-tubulin definitely affects CLIP-115 localisation at microtubule 
plus-ends, as the absence of Tyr-tubulin leads to elongated plus-end comets in TTL 
knockout MEFs. Since, in addition, CLIP-115 appears less phosphorylated in the 
absence of TTL, the effect of detyrosination might be indirect by influencing 
microtubule interactions with other proteins or enzymes that affect CLIP-115 
properties. Therefore, immunoprecipitation experiments of CLIP-115 could be 
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performed to identify potential interaction partners by subsequent Western blot or 
mass spectrometry analyses. 
Phosphorylation of microtubule-associated proteins often alters the affinity for 
microtubules and could also be involved in regulating CLIP-115 binding to 
microtubules, which is supported by the differential phosphorylation of CLIP-115 in 
wild type and TTL knockout MEFs. The less phosphorylated state of CLIP-115 
together with elongated plus-end comets in the absence of TTL indicates either an 
impaired kinase activity or an increased phosphatase activity close to the microtubule 
plus-ends. Therefore, TTL deficiency obviously alters the cellular phosphorylation 
pattern. 
Kinases as well as phosphatases were already identified to be associated with 
microtubules either directly or via the interaction with other microtubule-associated 
proteins as for instance molecular motors. For example, kinesin-1 associates with the 
c-Jun N-terminal kinase (JNK), the JNK-interacting protein 1 (JIP1) and the mitogen-
activated protein kinase-kinases 4 or 7 (MKK4 or MKK7; Daire et al., 2009). 
Additionally, kinesin-1 preferentially moves along detyrosinated microtubules, 
although with a slower velocity than on tyrosinated microtubules (Dunn et al., 2008). 
A modulation of kinesin-1 movement along microtubules provoked by an enhanced 
detyrosination level could affect local kinase activity at microtubule plus-ends and by 
that influence the phosphorylation of MAPs like CLIP-115. A potentially altered 
velocity of kinesin-1 by a lack of Tyr-tubulin could be measured by live cell imaging 
using wild type and TTL-deficient MEFs that express GFP-labelled kinesin-1 heavy 
chains. 
Very recently, CLIP-170 has been reported to be phosphorylated by cdc2 kinase 
(Yang et al., 2009), which in turn is activated in the presence of JNK (Goss et al., 
2003). Thus, a cdc2-mediated phosphorylation of CLIP-115 could be assumed and 
tested in experiments using specific cdc2- or JNK-inhibitors. Furthermore, 
immunoprecipitation either of CLIP-115 or cdc2 should help to unravel an interaction 
of those proteins. Since the phosphorylation target is already known in CLIP-170 
(threonine residue 287; Yang et al., 2009), the corresponding amino acid in CLIP-115 
(serine residue 295) could be mutated into non-phosphorylatable alanine to 
investigate its impact on CLIP-115 localisation. 
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Next to altered kinase activities in wild type versus TTL-deficient MEFs (as described 
above), also a misregulation of phosphatase activities should be considered. For 
example, the protein tyrosine phosphatase ε (PTPε) can bind microtubules. This 
association subsequently leads to a decrease of its phosphatase activity (Sines et al., 
2007). When, for instance, enhanced microtubule detyrosination, as present in TTL 
knockout cells, impairs PTPε association with microtubules, a locally increased 
phosphatase activity would occur. Although a direct connection between PTPε and 
+TIPs is not described yet, such a mechanism could explain the less phosphorylated 
state of CLIP-115 observed in TTL-deficient MEFs. Immunofluorescent staining of 
PTPε in wild type and Tyr-negative TTL knockout MEFs could already reveal a 
difference in microtubule binding. Co-sedimentation experiments or microtubule 
polymerization assays could be used to quantify the amount of microtubule-bound 
PTPε in order to test this hypothesis. 
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5. Summary 
 
 
The cytoskeleton is built up from microtubules, the microfilament network and the 
intermediate filaments. Together, they play an important role in numerous cellular 
processes. For example, microtubules are involved in the establishment of cell shape 
and cell polarity, build the mitotic spindle and function as intracellular railways for 
molecular motors. The involvement in such a large variety of cellular functions is, on 
the one hand, based on the polar structure and the highly dynamic behaviour of the 
microtubule itself. On the other hand, interaction partners and several post-
translational modifications influence microtubule properties. 
This study focuses on the tyrosination cycle, an α-tubulin-specific posttranslational 
modification. In order to uncover the physiological role of the tyrosination cycle, 
mouse embryonic fibroblasts (MEFs) lacking tubulin-tyrosine ligase (TTL) were 
characterized regarding different tubulin pools. Additionally, the influence of 
detyrosination/tyrosination of α-tubulin on microtubule plus-end tracking proteins 
(+TIPs) was analysed. 
In the past, a mislocalisation of the +TIP CLIP-170 in TTL knockout neurons (Erck et 
al., 2005) as well as the inability of CAP-Gly domain-containing +TIPs to bind 
microtubule plus-ends in Tyr-negative MEFs have been reported (Peris et al., 2006). 
In contrast, here we clearly demonstrate that CAP-Gly domain-containing proteins 
localise at microtubule plus-ends independently from the presence or absence of 
tyrosinated tubulin. Interestingly, CLIP-115-decorated microtubule plus-end comets 
are elongated in Tyr-negative TTL-deficient MEFs. Furthermore, as compared to wild 
type MEFs, CLIP-115 appears to be in a less phosphorylated state in TTL knockout 
MEFs. The decreased phosphorylation status of CLIP-115 could either result from 
impaired kinase activity or increased phosphatase activity in the absence of TTL. 
Experiments using phosphatase inhibitors indicated the involvement of a tyrosine 
residue in the differential phosphorylation state of CLIP-115. Site-directed 
mutagenesis revealed an important role for tyrosine 270 in microtubule binding. 
However, mass spectrometry analyses did not confirm tyrosine 270 phosphorylation. 
While this residue is heavily involved in the establishment of the α-tubulin-binding 
hydrophobic cavity in the second CAP-Gly domain, it obviously plays a major role in 
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the maintenance of the three-dimensional structure instead of being a regulatory 
residue for microtubule binding. 
Furthermore, mass spectrometry analyses identified two CLIP-115 peptides that 
most probably contain a serine phosphorylation. One of these peptides covers a part 
of the second serine-rich region of CLIP-115, which is involved in microtubule plus-
end tracking. This peptide contains three conserved serine residues that are also 
present in CLIP-170. Mass spectrometry revealed these CLIP-170 residues to be 
phosphorylated (personal communication with A. Akhmanova). Moreover, in in vitro 
studies, a negative effect of serine phosphorylation on CLIP-115 binding to 
microtubules has already been demonstrated (Hoogenraad et al., 2000). Therefore, 
one or multiple serine residues within the identified CLIP-115 peptide could be target 
of a phosphorylation that influences or regulates CLIP-115 binding to microtubules. 
Future experiments should concentrate on the involvement of these serine residues 
in microtubule binding. Additionally, the identification of kinases or phosphatases that 
affect CLIP-115 in TTL knockout cells will ultimately reveal a new +TIP/microtubule 
binding mechanism. 
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MT   microtubule 
MTOC  microtubule-organizing centre 
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red.   reducing 
RNA   ribonucleic acid 
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Tm   melting temperature 
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